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Abstract 
Strenuous exercise can result in structural damage to the skeletal muscle. Muscle 
damage, which can be experienced by both recreational and elite athletes, is 
accompanied by signs and symptoms such as strength loss, and increases in 
soreness, oxidative stress, and inflammation. If excessive or unabated muscle 
damage can result in performance decrements. Hence, accelerating recovery has 
been the focus of much research. Cryotherapy has become an increasingly popular 
recovery modality for its purported ability to reduce blood flow, metabolism and the 
inflammatory response at the site of the muscle damage. Cold water immersion (CWI) 
is most commonly used following exercise for reducing muscle soreness, but 
evidence to support its use for accelerating recovery of strength loss, muscle damage, 
or inflammation remains conflicting. All cryotherapy modalities are limited in their 
duration of application. Phase change material (PCM), a novel cryotherapy modality, 
is capable of overcoming this limitation by extending the duration of treatment for 
longer than other more traditional cryotherapy modalities. Thus, PCM might present 
a practical alternative to CWI as a recovery modality. However, the application of 
PCM for accelerating recovery from exercise has not been examined. Therefore, this 
course of investigation aimed to elucidate the effects of PCM on recovery from 
strenuous exercise. Firstly, this research focused on determining the efficacy of 
prolonged PCM cooling for recovery from mechanically and metabolically stressful 
exercise. Secondly, the effects of prolonged PCM cooling on intramuscular, core 
temperature, and the cardiovascular response were determined and compared with 
a CWI protocol. Finally, this research investigated whether PCM cooling blunted the 
acute adaptive response to eccentric exercise, following a repeated bout of exercise. 
 
Study 1: This study established the proof of concept that wearing a garment fitted 
with PCM at a temperature of 15°C administered to the quadriceps for 6 hours could 
improve recovery from damaging eccentric exercise. The PCM treatment was 
effective in accelerating recovery of strength loss and soreness. Results also 
demonstrated that prolonged PCM cooling accelerated recovery of these variables in 
the leg that did not directly receive PCM cooling. This finding suggested that 
prolonged PCM cooling might deliver a systemic, and not just a local effect.  
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Study 2: This investigation examined the efficacy of PCM as a recovery intervention 
following exercise with a large metabolic component (a marathon run). Unlike the 
results from Study 1, recovery of strength loss and perceived soreness were not 
accelerated from 3 hours of PCM cooling. The results also indicated that PCM cooling 
was not effective in accelerating recovery of vertical jump height, or blood markers of 
muscle damage or systemic inflammation. 
Study 3: This study determined the effects of 3 hours of PCM cooling and 15 minutes 
of CWI controlled for treatment temperature (15°C PCM and 15 ± 1°C CWI) on 
intramuscular-, core-, skin-temperature and cardiovascular responses. Although the 
magnitude of temperature reduction from both PCM and CWI was comparable, PCM 
maintained a reduction in intramuscular temperature throughout the duration of 
application. This study also confirmed that, during application, both modalities exerted 
a central effect on core temperature and heart rate (HR). These effects on core 
temperature and HR suggested that the effect observed from indirect PCM cooling in 
Study 1 was a true systemic effect.  
Study 4: The final study of this thesis expanded on the findings of the pilot study, by 
repeating the same exercise protocol 2 weeks later, in order to examine whether 
acute adaptation (the repeated bout effect; RBE) was influenced by the PCM 
intervention. In contrast to the first investigation, the PCM were applied to both legs 
in the treatment condition, and blood markers of muscle damage and inflammation 
were additionally measured. The results demonstrated that PCM cooling accelerated 
recovery of strength, soreness, and the blood marker of muscle damage, but not 
inflammation. Importantly, despite accelerating recovery following the first bout of 
exercise, PCM did not inhibit the RBE.  
The series of investigations encompassing this thesis have established support for 
the use of prolonged PCM cooling in accelerating recovery from exercise of a 
mechanical nature. Further, this thesis provides new additions to the literature on the 
novel application of PCM as a recovery modality for accelerating recovery of strength 
loss without inhibiting the adaptive response to exercise.  
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Exercise can induce damage to the musculoskeletal, metabolic and nervous systems. 
Novel, unaccustomed, or exercise performed in excess can result in exercise-induced 
muscle damage (EIMD). The severity of EIMD is dependent on several factors 
including the exercise type, duration, intensity and the individual’s habituation to the 
exercise. The deleterious effects associated with EIMD have been well documented 
(Armstrong, Warren, & Warren, 1991; Ebbeling & Clarkson, 1989; Pyne, 1994). A 
temporary reduction in muscle force, delayed onset muscle soreness (DOMS), and 
increased inflammation are all associated with EIMD (Tee, Bosch, & Lambert, 2007). 
Ultimately decrements in physical performance can result if the signs and symptoms 
of EIMD are not mitigated appropriately (Burt & Twist, 2011; Twist & Eston, 2008). 
The human body can recover and adapt from exercise when given a sufficient period 
of rest. However, due to limited windows between sessions during training and 
competition phases, full recovery does not occur in most athletes. A chronic 
imbalance between training stress and recovery can ultimately lead to 
underperformance as well as overtraining and burnout (Barnett, 2006; Minett & 
Duffield, 2014). Thus, accelerating recovery from exercise, in order to return the body 
to its pre-exercise state and maximise subsequent performance, has been the focus 
of much research.  
Recovery interventions are touted to decrease the signs and symptoms of EIMD. 
Athletes have turned to an abundance of recovery modalities, such as antioxidant 
supplements, nonsteroidal anti-inflammatory drugs, and cryotherapy, in an attempt to 
improve recovery following exercise (Bishop, Jones, & Woods, 2008; Kovacs & 
Baker, 2014; Nédélec et al., 2012; Robson-Ansley, Gleeson, & Ansley, 2009). Cold 
water immersion (CWI), in temperatures ranging between 10°C and 15°C for 
durations of 12.5 ± 5.6 minutes on average (Bleakley et al., 2010), is one of the most 
popular recovery strategies used following exercise (Leeder, Gissane, van Someren, 
Gregson, & Howatson, 2012). Its popularity has been advocated by research 
implementing its use following isolated eccentric exercise (Machado et al., 2016; 
Vaile, Halson, Gill, & Dawson, 2007), endurance exercise (Brophy-Williams, Landers, 
& Wallman, 2011; Yeargin et al., 2006), resistance exercise (Roberts, Muthalib, et al., 
2015), laboratory cycling protocols (Halson et al., 2008; Lane & Wenger, 2004; 
Peiffer, Abbiss, Watson, Nosaka, & Laursen, 2010; Vaile et al., 2010; Vaile, Halson, 
Gill, & Dawson, 2008) and team-sport exercise (Garcia, da Mota, & Marocolo, 2016; 
Leeder et al., 2019; Montgomery et al., 2008; Rowsell, Coutts, Reaburn, & Hill-Haas, 
2009, 2011; Webb, Harris, Cronin, & Walker, 2013). Recent meta-analyses have 
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demonstrated CWI to be efficacious in alleviating DOMS for up to 96 hours post-
exercise (Bleakley et al., 2010; Leeder et al., 2012; Versey, Halson, & Dawson, 2013). 
Although CWI has received much attention in recent literature, there remains 
variability and disparity in the evidence supporting its use for accelerating the overall 
recovery process, and no consensus exists for optimal treatment criterion. This is, in 
part, due to large variations in temperature and duration of immersion of CWI 
protocols. The underlying mechanisms through which CWI might accelerate recovery 
remain to be elucidated. However, CWI is purported to aid recovery from EIMD 
through a decrease in muscle temperature (Ihsan, Watson, & Abbiss, 2016; White & 
Wells, 2013; Wilcock, Cronin, & Hing, 2006). It has been suggested that a decrease 
in muscle temperature and local circulation reduces cellular metabolism, which 
consequently limits secondary damage (Merrick, Rankin, Andres, & Hinman, 1999). 
Unfortunately, these effects have only been directly demonstrated in animal models 
and remain to be replicated in humans. Investigators have suggested that a more 
aggressive regimen increasing duration, and alternating frequency or temperature of 
the immersions, could be employed with better results (Goodall & Howatson, 2008). 
The duration of cryotherapy can be prolonged by utilising a cooling medium called 
phase change material (PCM). While changing phase from a solid to a liquid, PCM 
absorbs and stores heat while maintaining a constant temperature for the entirety of 
melting. This is known as the latent phase, which correlates with the melting point of 
the PCM. The most commonly utilised PCM is ice, which experiences its latent phase 
at 0°C. Since the latent phase of ice occurs at a relatively low temperature, the 
duration of melting is relatively short. Fortunately, the temperature of the latent phase 
of any PCM can be manipulated. As a result, PCM experiencing its latent phase at a 
temperature greater than 0°C will maintain the latent phase for a longer duration than 
ice, for example. Most research to date has focused on administering PCM, with latent 
phases between 10 to 31°C, in a cooling vest to improve thermal comfort (Barwood, 
Davey, House, & Tipton, 2009; Brade, Dawson, Wallman, & Polglaze, 2010; Purvis & 
Cable, 2000; Tate, Forster, & Mainwaring, 2008). These studies demonstrated that 
PCM with a latent phase of 24°C had a stronger cooling effect on torso skin 
temperature than that with a latent phase of 28°C (Gao, Kuklane, & Holmér, 2011). 
The longest treatment duration in any of these studies was 90 minutes with no 
adverse or negative effects of the skin (Gao, Kuklane, Wang, & Holmér, 2012). 
Consequently, PCM with a latent phase between 10-15°C was suggested to be most 
effective for body cooling (Gao et al., 2011; House et al., 2013). To date, only one 
study has examined the effects of PCM as a recovery method on physiological and 
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thermoregulatory responses (Hausswirth et al., 2012), demonstrating that PCM 
exerts greater benefits on physiological load compared to CWI in the early stage of 
subsequent exercise. 
Wearing a garment fitted with PCM might be more effective and logistically simpler to 
implement than CWI. Given the widespread use and acceptance by athletes of CWI 
as a recovery modality, with limited empirical evidence supporting its use for overall 
functional recovery, it remains important to explore alternative solutions. Further, the 
use of PCM offers a substitute to CWI as it might allow for specific manipulation in 
the frequency, duration, and temperature of treatment. In particular, utilising PCM with 
a phase point of 15°C as an alternative to other cryotherapy modalities would provide 
a solution to prolonging the duration treatment. To date, no literature exists utilising 
PCM to enhance recovery following training and competition in elite athletes or 
recreational populations. The efficacy of PCM cooling for recovery from EIMD has not 
been investigated. Hence, the overarching aim of this thesis was to test the efficacy 
of prolonged cooling using PCM to facilitate accelerated recovery from exercise. 
Specifically, this aim was addressed in 4 experimental chapters: 
1) To establish the efficacy of a novel cooling strategy (PCM) as an intervention 
on indices of strength and soreness from an exercise protocol involving high 
mechanical stress, designed to induce damage.  
2) To establish the efficacy of PCM as a recovery intervention on indices of 
strength, soreness, functional performance, and blood markers of muscle 
damage and inflammation following exercise involving high metabolic stress, 
a marathon run.  
3) To compare the physiological effects (skin, muscle, core temperature and 
cardiovascular measures) of PCM cooling with a temperature matched CWI 
protocol. 
4) i. Determine whether prolonged PCM cooling accelerates recovery from 
exercise involving mechanical stress, in part by inhibiting the inflammatory 
effect compared to a control. 
ii. Examine whether the accelerated recovery from an initial bout of strenuous 
quadriceps exercise would affect the response to a subsequent bout of 
strenuous quadriceps exercise.  
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This literature review is divided into two parts. Part 2.1 discusses the physiological 
response to exercise, with particular focus placed upon muscle damage and 
inflammation. Part 2.2, firstly examines the use of cryotherapy for recovery of the 
exercise-induced responses presented in part 2.1, with a specific focus on cold water 
immersion (CWI). Secondly, the use of a novel cryotherapy recovery strategy, phase 
change material (PCM), is introduced as a supplement to the review of cryotherapy 
literature. Detailed analysis of certain related issues, such as the hemodynamic 
response to exercise, the use of cryotherapy for management of acute soft tissue 
sports injury, the use of cryotherapy for thermoregulation during and from exercise 
performed in the heat, or an in-depth discussion of the molecular inflammatory 
cascade triggered by exercise and the molecular response to cryotherapy (Broatch, 
Petersen, & Bishop, 2018) as well as the influence of cryotherapy on the adaptive 
response to exercise, are beyond the scope of this review.  
2.1 Physiological Response to Exercise 
The processes that transpire within the active muscle during exercise are initiated 
rapidly and occur in several stages (Armstrong et al., 1991; Armstrong, 1990; 
Järvinen, Järvinen, Kääriäinen, Kalimo, & Järvinen, 2005; Lieber, 2018). These 
events can be divided into the initial damage response, followed by a secondary 
damage response, and culminating in a regenerative/repair phase. The initial phase 
encompasses structural damage of the muscle fibre, followed by impaired excitation-
contraction (E‐C) coupling and calcium ion (Ca2+) signalling, and activation of 
degradation pathways (Peake, Nosaka, & Suzuki, 2005). The subsequent secondary 
stage involves a proliferation of the initial muscle injury, coupled with an inflammatory 
response surrounding the damaged muscle. Following the progression of catabolic 
events, the muscle fibre returns to its pre-exercise condition, and cellular homeostasis 
and physiological function are restored. The time course of this cycle is dependent 
on the magnitude of muscle damage and is understood to take several days (Paulsen, 
Mikkelsen, Raastad, & Peake, 2012). The sequence of physiological processes 
occurring as a result of exercise will be detailed in the following sections.  
2.1.1 The Stress Response to Exercise Stimulus 
Three pathways exist that result in exercise-induced structural damage to the muscle 
(Figure 1). In the first pathway, mechanical stress to the muscle directly results from 
unaccustomed exercise of eccentric nature (Fridén & Lieber, 2001; Proske & Morgan, 
2001) involving accelerations/decelerations (Akenhead, Hayes, Thompson, & 
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French, 2013) and/or changes in direction. This type of stress can involve downhill 
running or sports involving cutting motions such as American football, field hockey, 
or rugby. Eccentric muscle actions involve force generation in a lengthening muscle 
(Stauber, 1989) and are associated with a higher force-to-activation ratio (Lieber, 
2018), recruitment of fewer total muscle fibres (Enoka, 1996), and an overall greater 
recruitment of type II muscle fibres which are more susceptible to damage compared 
to type I fibres (Fridén, Sjöström, & Ekblom, 1983; Magal et al., 2010). As a result, 
the net mechanical stress per muscle fibre is increased (Enoka, 1996), and structural 
damage occurs directly due to a failure in the myofibrils during eccentric contractions.  
 
 
Figure 1: Three pathways to exercise-induced structural damage. Mechanical stress 
causes structural damage to the muscle fibre directly. On the other hand, metabolic 
stress and the increase in temperature during exercise cause structural damage 
indirectly through an increase in the metabolic rate and nicotinamide adenine 
dinucleotide phosphate oxidase (NOX) activity, respectively. Both result in an 
increase in mitochondrial reactive oxygen species (ROS) activity. 
 
In the second pathway, exercise of prolonged duration and/or high metabolic intensity 
such as marathon running results in metabolic stress. In the metabolic damage 
model, the initial events resulting in EIMD are caused by metabolic deficiencies (Tee 
et al., 2007). Metabolic stress occurs when the rate of adenosine triphosphate (ATP) 
hydrolysis exceeds that of ATP synthesis (Baird, Graham, Baker, & Bickerstaff, 
2012), due to dysfunction of the Ca2+-ATPase pumps in the sarcoplasmic reticulum 
or sarcolemma, resulting in a reduction in the concentrations of high energy 
phosphates and an increase in cytosolic Ca2+ (see section 2.1.2). Depletion of ATP 
increases the rate of aerobic energy transformation (Clanton, 2007) and the metabolic 
rate at the site of the mitochondria. This triggers an increase in mitochondrial reactive 
oxygen species (ROS; Spiteller, 2006; Supinski & Callahan, 2007), denaturing of 
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proteins, nucleic acids and lipids. The result is the aforementioned structural damage 
that occurs as a direct result of mechanical damage, and concomitantly a change in 
the redox status of the cell, which alters the function of redox-sensitive transcription 
factors. Some of these transcription factors are involved in muscle adaptation, such 
as increasing the antioxidant status and stimulating mitochondrial biogenesis and 
enzymes, while others are involved in the production and secretion of cytokines. 
These metabolic deficiencies ultimately increase the vulnerability of the muscle fibre 
to mechanical stress.  
The third pathway that results in exercise-induced structural damage to the muscle 
occurs independently from the mechanical and/or metabolic stress responses. 
Exercise induces heat generation (Arbogast & Reid, 2004), which increases the 
concentration of nicotinamide adenine dinucleotide phosphate oxidase (NOX) within 
the muscle fibre resulting in an increase in the production of ROS from the 
mitochondria and from the infiltrating inflammatory cells (Powers & Jackson, 2008). 
Concomitantly these effects contribute to the structural damage in the muscle as well 
as to the disruption in the homeostasis of other physiological systems within the body 
(White & Wells, 2013). Importantly, the exercise stimulus can be a combination of 
both metabolic and mechanical stresses. Most team sports, such as football, 
encompass both a metabolic component, due to the prolonged duration of the 
exercise stimulus, and a mechanical component, due to the cutting motions made on 
the field.  
2.1.2 Exercise-Induced Muscle Damage (EIMD) 
Following muscle damage two phases, the initial phase and a delayed secondary 
phase, have been described to transpire (Faulkner, Brooks, & Opiteck, 1993). The 
initial stress response to exercise results in impairment of normal skeletal muscle cell 
function called exercise-induced muscle damage (EIMD; Clarkson, 1992; Clarkson & 
Tremblay, 1988; Clarkson & Hubal, 2002; Fridén & Lieber, 1992). During this primary 
phase of damage, the rapid activation of processes mentioned in the previous section 
(2.1.1) results in structural damage to the skeletal muscle (for review see: Clarkson 
& Sayers, 1999; Proske & Allen, 2005). Specifically, the initial damage response 
involves both disrupted sarcomeres and damage to the E‐C coupling system (Proske 
& Morgan, 2001). Compromised structural integrity at the level of Z line, A band, and 
the contractile system leads to sarcomere disruption in the myofibrils (Armstrong et 
al., 1991; Fridén & Lieber, 1992; Lieber, Thornell, & Fridén, 1996; Nosaka & Clarkson, 
1995; Proske & Morgan, 2001). While a failure in the sequence of events that starts 
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with the release of acetylcholine at the neuromuscular junction and ends with the 
release of Ca2+ from the sarcoplasmic reticulum leads to E‐C uncoupling (Warren, 
Ingalls, Lowe, & Armstrong, 2001).  
 
 
Figure 2: Calcium (Ca2+) activity during the primary phase of exercise-induced 
muscle damage. Structural damage at the level of the muscle fibre makes the 
sarcolemma more permeable to Ca2+, which can then enter the cytosol from external 
sources. Simultaneously, the sarcoplasmic reticulum, which typically stores Ca2+ ions, 
excretes Ca2+ into the cytosol instead of absorbing it. The result is a loss of Ca2+ 
homeostasis. 
 
Ultimately, structural damage of the muscle is induced by a cascade of events 
characterised by a loss of Ca2+ homeostasis (Armstrong et al., 1991; Armstrong, 
1990; Fatouros & Jamurtas, 2016). Destabilisation of the sarcolemma due to both Na-
K-ATPase and Ca2+-ATPase pump dysfunction (Baird et al., 2012) and subsequently 
uncoupling of the E-C coupling system (Ingalls, Warren, Williams, Ward, & 
Armstrong, 1998b; Warren, Ingalls, Lowe, & Armstrong, 2001), makes the muscle 
fibres more permeable to Ca2+ entry (Figure 2; Cho, Woo, Perez, & Lee, 2017). 
Simultaneously, sustained release of Ca2+ from the sarcoplasmic reticulum, which 
typically stores Ca2+ ions, increases cytosolic Ca2+ concentration within the muscle 
fibre, which activates intracellular proteolytic enzyme activity and signalling of 
inflammatory cells (Belcastro, Shewchuk, & Raj, 1998; Fatouros & Jamurtas, 2016; 
McArdle & Jackson, 1997; Peake et al., 2005), increasing intramuscular pressure. 
The result is fragmentation of the sarcoplasmic reticulum which leads to: impaired 
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Ca2+ sequestration (Byrd, 1992), damage to the extracellular matrix and cytoskeleton, 
and/or swollen mitochondria (Armstrong, 1990; Fridén & Lieber, 1992). 
Elevations in intracellular Ca2+ activate several proteolytic and phospholipolytic 
pathways, which respectively degrade structural and contractile proteins and 
membrane phospholipids (Armstrong et al., 1991). Simultaneously, muscle cell 
permeability is reduced while capillary permeability and osmolality are increased, 
resulting in the leakage of these proteins and membrane phospholipids and disruption 
of intracellular homeostasis. For example, the disruption in homeostasis and 
permeability of the sarcolemma enables the diffusion of soluble muscle enzymes, 
such as serum creatine kinase (CK), to leak from the muscle into the interstitial fluid 
and extracellular space, ultimately reaching the circulation (Armstrong et al., 1991; 
Baird et al., 2012; Clarkson, Byrnes, Gillisson, & Harper, 1987b; Magal et al., 2010; 
McLellan, Lovell, & Gass, 2010). Other intramuscular proteins such as myoglobin 
(Lindsay, Carr, Draper, & Gieseg, 2015), metabolites (Ebbeling & Clarkson, 1989), 
cytokines (Robson-Ansley, Milander, Collins, & Noakes, 2004; Vargas & Marino, 
2014), heat shock proteins (demonstrated in animal models; Ingalls, Warren, & 
Armstrong, 1998a), and immune function markers such as C-reactive protein (CRP; 
Cunniffe et al., 2010) are also released. Following exercise, these are routinely 
measured in the circulation to infer the level of homeostatic perturbation indirectly 
associated with EIMD.  
Direct signs such as histological evidence (e.g. muscle-tendon shortening, loss of 
muscle contractile function) during the initial period of disruption of the myofibrillar 
structure (Fridén & Lieber, 1992), and indirect signs such as swelling, inflammation 
(Smith, 1991), and oxidative stress (see Fatouros & Jamurtas, 2016 for review) can 
be used to characterise the severity of EIMD. Symptoms following EIMD such as 
increased passive stiffness, localised soreness, and strength loss (Clarkson & 
Tremblay, 1988; Clarkson & Newham, 1995; Clarkson & Hubal, 2002; Cleak & Eston, 
1992; Eston, Finney, Baker, & Baltzopoulos, 1996; Fridén & Lieber, 2001; 
Hellebrandt, Houtz, Hockman, & Partridge, 1956; Nicol, Avela, & Komi, 2006; Proske 
& Morgan, 2001; Talag, 1973; Warren, Lowe, & Armstrong, 1999; White, Rhind, & 
Wells, 2014; White & Wells, 2013), can also be used to quantify the extent of the 
muscle damage. 
Prolonged strength loss following damaging exercise is considered to be one of the 
most valid and reliable indirect measures of EIMD in humans (Clarkson & Hubal, 
2002; Warren et al., 1999). Following exercise the reduction in strength has been 
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related to an inactivation of the cation pumps within the muscle. In particular, fatigue 
induced by prolonged exercise results in a decline in Na-K-ATPase activity; which is 
most depleted at the cessation of exercise (Leppik et al., 2004). Concomitantly, 
sarcoplasmic reticulum Ca2+-ATPase function has been shown to remain depressed 
for up to 36-48 hours post-exercise (Tupling, Green, Roy, Grant, & Ouyang, 2003). 
Delayed onset muscle soreness (DOMS), the delayed discomfort incurred from the 
EIMD process (Armstrong, 1984; Byrnes et al., 1985; Cheung, Hume, & Maxwell, 
2003; Gulick & Kimura, 1996; Schutte & Lambert, 2001), is the most commonly 
reported symptom of EIMD. However, DOMS might not accurately reflect the 
magnitude of EIMD and inflammation, as changes in indirect markers of muscle 
damage and inflammation are not necessarily accompanied by DOMS (Nosaka, 
Newton, & Sacco, 2002). Hence, it is imperative to mention that DOMS may not 
necessarily correlate with changes in muscle function (Newham et al., 1983; Newham 
et al., 1987; Clarkson & Ebbeling, 1988; Warren et al., 1999). 
Currently, there is no ‘gold standard’ for measuring EIMD. Performing histological 
observations or measuring changes in force-generating capacity seem to be the most 
valid markers of EIMD; however, both have limitations. Muscle biopsy samples might 
not be representative of the whole muscle, and acute muscle damage may occur as 
a result of the biopsy procedure itself. On the other hand, following exercise, the 
muscle can experience a decline in the amount of force or power capacity that a 
muscle can typically exert (Enoka, 2008). Thus, the change in a muscles force-
generating capacity, best measured as a maximal isometric voluntary contraction 
(MIVC), provides a good indication of the status of the whole muscle (Warren et al., 
1999) and can be used to indirectly quantify EIMD. However, MIVC is often measured 
in isolated muscle groups. Therefore, MIVC likely does not reflect the complete 
picture of muscle function associated with activities involving multiple muscle groups 
such as marathon running or a football match (Byrne, Twist, & Eston, 2004). Hence, 
countermovement jump (CMJ) performance, which reflects impairments in stretch-
shortening cycle function (Komi, 2000), may be used concurrently with MIVC to 
provide a more complete picture of dynamic muscle function. Ultimately, tests of 
muscle function are useful because they span the whole period of muscle 
degeneration and regeneration that occurs following EIMD (Warren et al., 1999). 
A combination of methods, including other indirect markers of muscle damage, such 
as DOMS and circulating serum CK, might be the most complete way to quantify the 
magnitude of EIMD. Serum CK is the most commonly measured protein in EIMD 
studies because it is a reliable indicator of muscle membrane permeability found 
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exclusively in muscle tissue (Pyne, 1994). The appearance of CK in blood has been 
generally considered to be an indirect marker of muscle damage (Baird et al., 2012). 
There is controversy in the literature concerning the validity of CK in reflecting muscle 
damage because the magnitude of eccentric contractions involved in the exercise 
and the subsequent extent of muscle disruption both influence serum CK response 
(Baird et al., 2012; Magal et al., 2010). Further, there is a clear discrepancy between 
the time of peak serum CK levels and peak muscle soreness (Clarkson, Apple, 
Byrnes, McCormick, & Triffletti, 1987a; Clarkson & Ebbeling, 1988; Newham, Jones, 
& Edwards, 1983). Thus, CK values should be utilised concomitantly with other blood 
markers when elucidating the degree of muscle damage. 
2.1.2.1 Secondary Damage to Skeletal Muscle 
The initial structural damage occurring within the muscle fibre initiates a positive 
feedback mechanism during which the aforementioned initial damage response is 
exacerbated (Kendall & Eston, 2002; Lapointe, Frémont, & Côté, 2002a). A cascade 
of events is triggered by the initial loss of Ca2+ homeostasis, involving disruption in 
intracellular homeostasis followed by activation of neutrophils resulting in an 
inflammatory response (Howatson & van Someren, 2008; Toumi & Best, 2003; see 
section 2.1.2.2). This phase of muscle damage is referred to as the secondary 
damage response. Due to the increased permeability at the site of damage, the 
concentration of intracellular Ca2+ from extracellular sources is increased (Armstrong 
et al., 1991), further exacerbating the loss of Ca2+ homeostasis within the muscle fibre 
(Duncan, 1987; Gissel & Clausen, 2001). Other events compounding the overall 
structural damage include: endothelial and intramuscular degradation (Howatson & 
van Someren, 2008), initiated by protease activity which degrades cytoskeletal 
proteins within the muscle (Clarkson & Sayers, 1999); an increase in the destructive 
activity of lysosomal enzymes surrounding the primary damaged tissue (Merrick, 
2002); decreased nutritive blood flow, reduced oxygen delivery, and elevated cellular 
metabolism at the site of structural damage (Harris et al., 1986; Hill & Hill, 1998; 
Schaser et al., 1999; Zhang, Bail, Mittlmeier, Haas, & Schaser, 2003); and leukocyte 
invasion at the site of the muscle fibre cell wall (Paulsen et al., 2012) which results in 
potentiation of the inflammatory response. Ultimately, secondary muscle damage 
compounds the symptoms of EIMD and results in accumulation of metabolites, 
increased intramuscular pressure (Ebbeling & Clarkson, 1989) and hypoxic stress on 
the muscle (Andersson, Karlsen, Blomhoff, Raastad, & Kadi, 2010; Armstrong, 1984; 
Ascensão et al., 2008), leading to impaired muscle function in the hours and days 
following exercise (Lapointe et al., 2002a; Merrick et al., 1999). If not managed 
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correctly, these effects can be detrimental to an athlete’s recovery and subsequent 
performance. 
2.1.2.2 Muscle Inflammation from Exercise 
Although inflammation can be induced through mechanical, metabolic, chemical, 
thermal, or microbial stimuli (Hurley, 1983), this section will focus on the inflammatory 
response to EIMD (for thorough review see Clarkson & Sayers, 1999; Kendall & 
Eston, 2002; McArdle & Jackson, 1997; Smith, 1991; Tee et al., 2007; Tidball, 1995). 
Importantly, the underlying aetiology of the inflammatory response following 
mechanical or metabolic stress (described in section 2.1.1) is different (Figure 3; Tee 
et al., 2007; Toumi & Best, 2003; White & Wells, 2013). Briefly, exercise induces an 
increase in the production of ROS by neutrophils, either directly at the site of structural 
damage from mechanical stress or indirectly through the increase in mitochondrial 
ROS from metabolic stress (Figure 1). The result is an increase in the inflammatory 
stress signal resulting in an acute inflammatory response to occur (MacIntyre, Reid, 
Lyster, Szasz, & McKenzie, 1996).  
Muscle fibres contain proteolytic enzymes which initiate the degradation of lipid and 
protein structures following structural damage (Belcastro et al., 1998; Proske & Allen, 
2005; Tidball, 2005). The inflammatory response stimulates leukocyte emigration 
(neutrophil and macrophage invasion) through the endothelial lining to the damaged 
area (Abrams, 1997; Paulsen et al., 2010), which subsequently influence the 
trafficking of inflammatory cells (Adams et al., 2011; Fatouros & Jamurtas, 2016; 
Peake et al., 2005). This process initiates a positive feedback mechanism 
characteristic of the inflammatory response. In this feedback loop leukocytes are 
attracted to the cell to break down and clear away damaged tissue, but might also 
exacerbate the ROS response at the muscle (see Paulsen et al., 2012 for review) 
further contributing to the structural damage and propagating the positive feedback 
pattern of the inflammatory response (Butterfield, Best, & Merrick, 2006). Importantly, 
the direct release of mitochondrial ROS during the metabolic stress pathway 
additionally triggers the inflammatory stress signal through the change in redox status 
of the muscle cell which stimulates the release of cytokines (Brown, Day, & Donnelly, 
1999).  
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Figure 3: Exercise-induced muscle fibre cell signalling resulting in structural damage 
(adapted from White & Wells, 2013); T°: temperature; NOX: nicotinamide adenine 
dinucleotide phosphate oxidase; ROS: reactive oxygen species; IL-6, -8: interleukin-
6, -8; HSPs: heat shock proteins; TF’s: transcription factors. 
 
The inflammatory processes are important in the removal of injured tissue and for 
stimulating regeneration of the damaged fibres (Armstrong et al., 1991; Paulsen et 
al., 2012). Following exercise, the inflammatory process ultimately results in the 
structural and functional repair of damaged tissues (Tidball, 2005). Inflammation can 
also proliferate hypertrophic muscle adaptations (Schoenfeld, 2012) and the 
strengthening of muscle structural elements (Lapointe et al., 2002a). Thus, 
inflammation is necessary for the adaptive response to exercise (Powers & Jackson, 
2008; Tidball & Villalta, 2010). On the other hand, an exacerbated inflammatory 
response can delay muscle regeneration and contribute to secondary muscle 
damage (Brickson et al., 2003; Butterfield et al., 2006; Merrick, 2002; Pizza, Koh, 
McGregor, & Brooks, 2002). Importantly, the overall magnitude of the inflammatory 
response is dependent on the extent of myofibrillar damage, which regulates the 
degree of leucocyte accumulation (Paulsen et al., 2012). For example, eccentric 
exercise, which elicits the greatest extent of structural tissue damage, evokes a 
greater inflammatory response than concentric exercise. The interactions between 
muscle and inflammatory cells as well as the history of previous muscle use also play 
a role in determining the severity of the inflammatory response (Fridén et al., 1983; 
Fridén & Lieber, 2001; Magal et al., 2010; Paulsen et al., 2012; Tidball, 1995).  
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2.1.3 Repeated-Bout Effect (RBE) 
Exercise disrupts homeostasis and induces an adaptive response, dependent on the 
type, duration, and intensity of the exercise and training status of the individual. An 
adaptation called the repeated bout effect (RBE; Clarkson et al., 1987b; Clarkson, 
1992; Clarkson & Tremblay, 1988) occurs following a single bout of unaccustomed 
exercise. However, the magnitude of the RBE is independent of the initial exercise 
volume (Howatson et al., 2007). Various theories exist to explain the mechanisms 
involved in the RBE (Howatson, Someren, & Hortobágyi, 2007; Hyldahl et al., 2017; 
McHugh, 2003; McHugh, Connolly, Eston, Gartman, & Gleim, 2001; McHugh, 
Connolly, Eston, & Gleim, 1999). The adaptive response manifests as an attenuation 
in the physiological response to subsequent exercise (Evans et al., 1986), such as 
influx of CK concentration, myoglobin, symptoms of soreness and decrements in 
performance (Brown, Child, Day, & Donnelly, 1997; Ebbeling & Clarkson, 1989; 
Howatson, Someren, & Hortobágyi, 2007; McHugh, Connolly, Eston, & Gleim, 1999; 
McHugh, Connolly, Eston, Gartman, & Gleim, 2001; Nosaka & Clarkson, 1995; 
Nosaka & Newton, 2002; Nosaka, Sakamoto, Newton, & Sacco, 2001). This 
protective effect is evident from upper limb exercise separated by 1 week (Clarkson, 
Litchfield, Graves, Kirwan, & Byrnes, 1985), after bouts of downhill running separated 
by 6, but not 9, weeks (Byrnes et al., 1985; Jones et al., 1986), and has been 
observed following endurance running, cycling, weightlifting, isometric exercise, 
downhill running and eccentric exercise). Although the duration of the protective effect 
differs between studies, it seems to be greatest within 2 weeks of the preceding bout 
and diminishes over time (Nosaka et al., 2001).  
2.1.4 Summary 
Athletes often experience novel exercise, or exercise of prolonged duration, and are 
regularly exposed to multiple exercise sessions in one day, or repeat exercise 
sessions in a tournament scenario or a season of sport. Such exposures commonly 
cause some degree of EIMD. Sufficient rest will return the cascade of events resulting 
in EIMD to baseline. However, in many circumstances, athletes only experience 
partial recovery due to the performance demand of athletic seasons (Halson et al., 
2002; Montgomery et al., 2008). Thus, when left unabated in athletes, the signs and 
symptoms of EIMD result in reductions in both performance and subsequent training 
(Khan et al., 2016); and the impairments associated with the primary and secondary 
damage responses are often exacerbated. Although the RBE offers an adaptive 
response to exercise and protection against both primary and secondary muscle 
33 
 
damage, muscle damage can be induced in trained individuals, even if the stages of 
muscle damage are shortened and the overall magnitude of EIMD is less in trained 
athletes than in untrained individuals.  
2.2 Cryotherapy for Recovery Following Exercise  
Rapid deployment of a treatment strategy is important for athletes to recover from the 
EIMD described in part 2.1 of this literature review. For this reason, several nutritional, 
pharmaceutical, and physical recovery strategies are currently popular among 
athletes (Howatson & Van Someren, 2008; Peake, 2019). Some of these recovery 
strategies include antioxidant consumption such as tart cherries, nonsteroidal anti-
inflammatories, therapeutic ultrasound, transcutaneous electrical nerve stimulation, 
compression, manual therapy techniques such as massage, and even sleep. These 
techniques are beyond the scope of this review. Part 2.2 investigates the literature 
surrounding the use of cryotherapy for recovery following exercise, paying particular 
attention to the CWI literature. The most thoroughly investigated and most popular 
cryotherapy modality utilised by athletes for recovery is CWI. The efficacy of 
cryotherapy on repeat performances within a short recovery period (same day) will 
not be discussed, as it is contraindicated and the majority of research has 
demonstrated negligible and detrimental effects from this practice. The shortcomings 
of CWI for recovery from exercise provide a rationale for the focus of this thesis, which 
involves prolonging the duration of cooling using PCM as a recovery intervention. 
2.2.1 Introduction to Cryotherapy 
Cryotherapy, the reduction of tissue temperature by the withdrawal of heat from the 
body (Michlovitz, 1990), has been utilised as a medical intervention dating back to 
ancient civilisations. The most common application for cryotherapy at present, in the 
form of ice, is in the management of or rehabilitation from acute soft tissue injury such 
as strains, sprains, contusions, as well as fractures (Bleakley, McDonough, & 
MacAuley, 2004; Knight, 1985; Knight, 1995; Knight, Brucker, Stoneman, & Rubley, 
2000; Swenson, Swärd, & Karlsson, 1996). In the treatment of musculoskeletal 
trauma, the goal for acute management with cryotherapy is to minimise the risk of 
further damage to the musculature by preventing the proliferation of secondary 
damage (Knight, 1995; Knight et al., 2000; Merrick, 2002; Merrick & McBrier, 2010). 
Since cryotherapy can reduce the severity of the initial inflammatory response and 
promote recovery following traumatic injury, it might also facilitate recovery of muscle 
tissue experiencing damage and inflammatory changes associated with exercise 
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(Eston & Peters, 1999; Meeusen & Lievens, 1986; Merrick et al., 1999). For this 
reason, the application of cryotherapy has been adopted as a popular recovery 
modality aimed at limiting and accelerating recovery from exercise-induced 
decrements in performance (Versey et al., 2013). The mechanisms of cooling as they 
pertain to recovery from exercise are reviewed in subsequent sections. 
2.2.2 Cryotherapy in Animal Models 
Animal models have shown that a window of opportunity for intervention with 
cryotherapy lies within the first 30 minutes after injury (Merrick & McBrier, 2010), 
indicating that cryotherapy interventions should be administered before secondary 
damage begins to intensify the signs and symptoms of EIMD. Importantly, animal 
models have demonstrated that cellular metabolic activity (Osterman et al., 1984; 
Sapega et al., 1988) and oxygen demand (Fuhrman, Fuhrman, Farr, & Fail, 1961; 
Fuhrman, 1959) are reduced when muscle temperature is decreased to 10°C-15°C. 
Hence, the rationale for administering cryotherapy treatment following EIMD is that a 
reduction in metabolic rate will suppress the secondary damage response (Merrick et 
al., 1999). Cryotherapy treatment in animal models delivering lesser degrees of 
intramuscular cooling have also demonstrated suppressed metabolic activity (Puntel 
et al., 2012), as well as a reduced inflammatory response (Amon, Menger, & Vollmar, 
2003; Lee et al., 2005; Puntel et al., 2011; Schaser et al., 2006; Vieira Ramos et al., 
2016), oedema formation (Deal, Tipton, Rosencrance, Curl, & Smith, 2002; Dolan, 
Thornton, Fish, & Mendel, 1997; Lee et al., 2005; Schaser et al., 2006; Smith et al., 
1993), and tissue damage (Bleakley & Hopkins, 2010; Merrick et al., 1999; Puntel et 
al., 2012; Schaser et al., 2007). 
Animal models have demonstrated conflicting evidence on the effect of repeat 
cryotherapy exposure on collagen formation. The remodelling phase of muscle 
regeneration involves the deposition of collagen, necessary for the regeneration of 
new myofibres. An excessive collagen response leads to excessive fibrosis. One 
study revealed repeat cryotherapy exposure over 4 weeks led to fibrosis due to 
excessive collagen deposition (Takagi et al., 2011), while one study applying repeat 
cryotherapy treatments over 2 weeks did not (Vieira Ramos et al., 2016). This 
discrepancy could be a result of the different means through which injury was 
induced, especially since the crush injury method as performed by Takagi et al. (2011) 
was likely more destructive than a localised ‘freeze injury’ (Vieira Ramos et al., 2016). 
To date, EIMD has not been induced directly in animal models. As a result, animal 
models involving blunt trauma (Curl et al., 1997; Deal et al., 2002; Dolan et al., 1997; 
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Lee et al., 2005; Puntel et al., 2011; Schaser et al., 2006; Smith et al., 1993), ischemia 
injury (Puntel et al., 2012) or chemically induced muscle damage (Amon et al., 2003) 
result in severe damage responses that are not comparable to human injury or EIMD 
models.  
Importantly, rodent muscle has different metabolic properties and responses to 
environmental stimuli than human skeletal muscle (Kowalski & Bruce, 2014). Thus, 
changes in muscle temperature and blood flow induced by cryotherapy might be more 
extensive in animals compared with human muscles. Additionally, the extent of 
cooling in some of the animal studies demonstrating beneficial results for recovery is 
of longer duration than what is typically used clinically in humans (3-6 hours; Merrick 
et al., 1999; Puntel et al., 2012; Sapega et al., 1988; Schaser et al., 2007). For these 
reasons, direct translation to the clinical setting in humans is limited (Bleakley et al., 
2011), and findings from animal studies cannot be directly applied to form the basis 
of cryotherapy application for exercise recovery in humans.  
2.2.3 Effect of Cryotherapy on Body Temperature 
The effect of tissue cooling during cryotherapy treatment has been well documented 
(Enwemeka et al., 2002; Jutte et al., 2001; Merrick et al., 1993; Myrer et al., 1998; 
Myrer et al., 2001; Yanagisawa et al., 2007). Skin is the first site to respond to cold 
exposure and its temperature decrease linearly (Chesterton, Foster, & Ross, 2002). 
Skin is responsible for initiating thermoregulatory responses in the muscle because 
muscle lacks thermal receptors. Thus, skeletal muscle tissue perfusion is a reflexive 
mechanism from the skin. During skin cooling, based on Fourier's law of heat 
conduction, deep muscle tissue loses heat mainly to the superficial muscle tissue 
(Bleakley & Hopkins, 2010); however, the temperature gradient between these layers 
is minimal, leading to smaller temperature changes than seen at the skin. 
Simultaneously incoming warm blood is diverted to the deeper tissues, thereby 
slowing down the cooling effect of the deep tissues (Pugh et al., 1960). The 
magnitude of change in muscle temperature is not linear. Superficial intramuscular 
temperature cools faster, and to a greater magnitude than deeper muscle tissues 
(Merrick et al., 2003; Yanagisawa et al., 2007). Finally, if the magnitude of cooling is 
sufficient, and not just localised to the skin, a reduction in core temperature will result. 
Importantly, administering cryotherapy to a greater surface area could elicit a 
systemic cooling effect and decrease core temperature to a greater degree than local 
cooling (see Figure 4). 
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Figure 4: Relative pattern of temperature change in different tissues during the 
exercise, cooling, and post-cooling period depicting that the rate of temperature 
change during cooling is not linear across all tissue. Exercise elevates the 
temperature of all tissue, dependant on exercise intensity, duration, and external 
environmental conditions. (Figure adapted from White & Wells, 2013). 
 
In order to optimise effectiveness and induce changes in blood flow, inflammation, 
and tissue metabolism, heat removal must occur at the target muscle and not just at 
the overlying skin. Reducing skin temperature alone without eliciting reductions in the 
deep muscle tissue or core temperature might not be enough to invoke a beneficial 
effect on local muscle recovery or systemic recovery following exercise. This is 
especially important because physiological changes following cryotherapy 
administered after exercise are dependent on the magnitude of tissue cooling 
(Costello et al., 2012a, 2012b; Mawhinney, Jones, Joo, Low, Green, & Gregson, 
2013), rather than a consequence of reduced muscle blood flow, and might be of 
greater importance for muscle recovery than the vascular response (Swenson et al., 
1996).  
During cryotherapy application, the skin and superficial tissues reach significantly 
lower temperatures than the muscle (i.e. skin temperature values of 6.5 ± 3.4°C vs 
muscle temperature values of 27.8 ± 3.5°C 1 cm below subcutaneous level; Merrick 
et al., 2003). Thus, the skin is most prone to irreversible damage. Adverse effects can 
occur from exposures to low temperatures for excessive durations or very low 
temperatures very quickly, especially those that rapidly reduce skin temperature 
before muscle and core temperatures can catch up (for review see Tipton, Collier, 
skin temp 
core temp 
systemic cooling 
core temp 
local cooling 
 muscle temp 
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3cm 
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Massey, Corbett, & Harper, 2017). Some of these effects include nerve damage 
(Costello, McInerney, Bleakley, Selfe, & Donnelly, 2012b), blood acidosis (Wilcock et 
al., 2006), and ice burn/frostbite (Wilke & Weiner, 2003) when the cell is cooled to -
10°C (Gage, 1979; Selfe, Hardaker, Whitaker, & Hayes, 2007). Thus, athletes and 
practitioners should understand the relationship between the patterns of tissue 
cooling and the significance of reducing tissue temperature to dangerous levels.  
The efficacy of cryotherapy is often assessed through skin surface temperature 
measurements when direct measures are unavailable. Early cryotherapy literature 
assumed that changes in intramuscular temperature are strongly related to changes 
in skin temperature; however, skin temperature is a poor predictor of deep tissue 
temperature (Bleakley & Hopkins, 2010). Thus, reductions in skin and intramuscular 
temperature are not strongly correlated because the patterns of tissue cooling differ 
(Figure 4; White & Wells, 2013). The magnitude of change in muscle temperature is 
dependent on the thermal gradient between the muscle and cryotherapy medium 
(Merrick et al., 2003), and is inversely correlated with subcutaneous adiposity (Myrer 
et al., 2001; Otte, Merrick, Ingersoll, & Cordova, 2002). Subcutaneous adiposity has 
low thermal conductivity, creating an insulating effect (Bleakley & Hopkins, 2010). 
Thus, the magnitude of reduction in intramuscular temperature will be less as skin-
fold thickness increases (Selkow et al., 2012; Stephens, Halson, Miller, Slater, & 
Askew, 2017). For this reason athletes and clinicians should take subcutaneous 
tissue thickness into account when aiming to achieve a specific degree of 
intramuscular cooling (Selkow, 2019). For example, to reduce muscle temperature by 
a standard amount in a heterogeneous group, Otte et al. (2002) demonstrated that 
an individual with a 31-40 mm skinfold thickness would have to apply ice for almost 
six times longer than an individual with 0-10 mm skin-fold thickness. Similarly, an 
individual with a 0-10 mm skin-fold thickness will achieve the same degree of 
intramuscular cooling as an individual with a 31-40 mm skin-fold thickness, but the 
cooling duration will take 10 minutes vs 60 minutes respectively (Selkow, 2019).  
The magnitude of change in core temperature is primarily dependent on gender 
(Boehm & Miller, 2019; Kenny & Jay, 2007). In addition to anthropomorphic (body 
surface area, lean body mass), other gender differences exist that will affect the rate 
of core cooling such as the hormonal or sympathetic response. The rate of core 
cooling is secondarily dependent on the cooling stimulus, the amount of body surface 
area exposed to the cryotherapy medium (McDermott et al., 2009), and body 
composition (Bleakley & Hopkins, 2010; Myrer et al., 2001; Otte et al., 2002; 
Stephens, Halson, Miller, Slater, & Askew, 2018). For example, following exercise 
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when cryotherapy treatment temperature and duration were controlled for, core 
temperatures were significantly lower in males with a low body-fat percentage 
(≤12.0%) than in those with high body fat (≥18.0%; Stephens, Halson, Miller, Slater, 
Chapman, et al., 2018). Counterintuitively, it has recently been demonstrated that 
under hyperthermic conditions such as those occurring during maximal exercise, 
females cool faster than males (Boehm & Miller, 2019). Thus, although the 
intramuscular cooling rate is comparable across genders, the rate of core cooling is 
faster in women. For these reasons, cryotherapy application should be tailored 
specifically to the individual. 
2.2.4 Mechanism of Cooling 
The mechanisms of cooling are temperature dependent and reliant on 
vasoconstriction leading to a decrease in blood flow (Bleakley & Davison, 2009; 
Gregson et al., 2011; Mawhinney et al., 2013). Reducing skin temperature induces 
an immediate vasoconstriction reflex at the site adjacent to the cold stimulus 
(Johnson, Yen, Zhao, & Kosiba, 2005). During cryotherapy, vasoconstriction 
contributes to reduced blood flow of the underlying muscle (Ihsan, Watson, Lipski, & 
Abbiss, 2013; Mawhinney et al., 2013; Stanley, Peake, Coombes, & Buchheit, 2014; 
Thorsson, Lilja, Ahlgren, Hemdal, & Westlin, 1985; Vaile et al., 2011). 
Vasoconstriction redistributes blood away from the periphery and toward the core 
(Ihsan et al., 2013; Mawhinney et al., 2013; Song, Chelstrom, Levitt, & Haumschild, 
1989; Vaile et al., 2011) in an effort to maintain core temperature (Bonde-Petersen, 
Schultz-Pedersen, & Dragsted, 1992; Gregson et al., 2011; Knight & Londeree, 1980; 
Mawhinney et al., 2013). The result is a central cascade of venous return (Bonde-
Petersen et al., 1992; Vaile et al., 2011) which increases stroke volume (Stanley et 
al., 2014), central venous pressure (Gabrielsen et al., 1993; Johansen, Jensen, 
Pump, & Norsk, 1997; Mourot et al., 2008; Park, Choi, & Park, 1999), central blood 
volume and flow (Song et al., 1989), and improved cardiac output (Gabrielsen et al., 
1993; Park et al., 1999; for review see Wilcock et al., 2006).  
Cold‐induced reductions in muscle blood flow have traditionally been proposed to limit 
inflammatory signalling (Knight et al., 2000; Swenson et al., 1996), muscle 
metabolism, and subsequent secondary damage to the muscle fibres (Merrick et al., 
1999). Mechanical or metabolic stress causes structural damage which initiates an 
inflammatory cascade (see section 2.1.2.2). Consequently, treatments to facilitate 
recovery have focused on attenuating inflammation. Indeed, artificially repressing the 
inflammatory response triggered by EIMD has been shown to result in a decreased 
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appearance of secondary muscle damage (Lapointe, Frenette, & Côté, 2002b). 
However, there is insufficient data to support the theory that cryotherapy reduces the 
post‐exercise inflammatory cellular stress response. The effects of cryotherapy 
following exercise on inflammation, which can be measured via inflammatory 
cytokines in the blood, are conflicting. Only a few studies have demonstrated a 
positive effect (Guilhem et al., 2013; Pournot et al., 2011; Ziemann et al., 2012). Most 
studies have failed to show a beneficial effect (Fragala et al., 2015; Ingram, Dawson, 
Goodman, Wallman, & Beilby, 2009; Leeder et al., 2015; Peake et al., 2016; Pointon, 
Duffield, Cannon, & Marino, 2011b; Pointon & Duffield, 2012), and some have 
demonstrated a negative effect (Gonzalez et al., 2014; Jajtner et al., 2015; Roberts, 
Nosaka, Coombes, & Peake, 2014; Tseng et al., 2013). 
Similarly, the ability of cryotherapy to reduce muscle metabolism in humans has not 
been established. In theory, reducing the metabolic rate of tissues within and around 
the muscle site experiencing structural damage decreases the oxygen requirement 
of the damaged tissues and reduces secondary tissue hypoxia. In the immediate 
period after EIMD, this effect would protect the healthy neighbouring muscle cells 
from the ischemic environment, thereby reducing the proliferation of secondary 
damage (Knight, 1995; Merrick et al., 1999). Unfortunately, the only direct evidence 
supporting this notion comes from animal studies (Sapega et al., 1988). One study 
indirectly measuring muscle metabolism in humans concluded that post-exercise 
cooling decreases muscle metabolic activity but did not concomitantly report 
intramuscular temperature (Ihsan et al., 2013). According to van’t Hoffs Law, in 
humans, for every 10°C reduction in intramuscular temperature, a 2-3 fold reduction 
in the rate of chemical reaction and a 50% decrement in metabolic activity of the 
tissue has been proposed to occur (Brooks, Hittelman, Faulkner, & Beyer, 1971). 
However, it appears difficult to reduce deep tissue intramuscular temperatures in 
humans by 10°C for a long period of time, and temperatures rarely fall below 20°C 
(Bleakley & Hopkins, 2010; Merrick et al., 1993). Favourable decrements in muscle 
metabolism can be further challenged by the area of muscle damage, and/or by the 
effect of adipose tissue on heat extraction (Bleakley & Hopkins, 2010). Thus, although 
cryotherapy is promoted for its ability to reduce inflammation and muscle metabolism, 
the lack of evidence in the literature for a positive effect on either of these variables 
is likely due to the fact that the cryotherapy stimulus is not sufficiently reducing deep 
muscle temperature at the site of primary injury in the first place. As a result, neither 
inflammation nor muscle metabolism are reduced for a period of time adequately long 
enough to have any beneficial effect on recovery. 
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Cryotherapy is likely more effective in facilitating metabolite removal from and oxygen 
and substrate delivery to the recovering muscle through its ability to reduce oedema 
(Ihsan, Watson, & Abbiss, 2016). Vasoconstriction and blood flow redistribution 
decrease microvascular perfusion in the skeletal muscle, reducing the permeability of 
cellular, lymphatic and capillary vessels, and vessel walls (Cleak & Eston, 1992; 
Fridén & Lieber, 2001; Meeusen & Lievens, 1986; Swenson et al., 1996; Wilcock et 
al., 2006). This causes an osmotic gradient which facilitates the movement of fluids, 
necrotic tissue, and debris from the intracellular and interstitial spaces to the 
extravascular compartments (Enwemeka et al., 2002; Eston & Peters, 1999; 
Gabrielsen et al., 1993; Johansen, Bie, Warberg, Christensen, & Norsk, 1995; Park 
et al., 1999; Stocks et al., 2004) and from the extravascular space into the peripheral 
and central circulation (Ihsan et al., 2016; Wilcock et al., 2006). The result is a 
reduction in the transit distance between the capillaries and muscle fibres which may 
decrease mitochondrial energy production limiting ROS mediated damage.  
2.2.5 Types of Cryotherapy for Exercise Recovery 
Cryotherapy can be administered in a number of different ways. Local cold 
application, using ice, cooling pad or air pulsed cryotherapy, covers small areas and 
might only produce local alterations. Whole-body exposure to a cryotherapy medium, 
such as that occurring from CWI or whole body cryotherapy (WBC), may cause 
effects to the whole body and produce a greater temperature gradient for tissue 
cooling. While CWI is frequently used for exercise recovery, cooling jackets have 
recently gained popularity for their use in mitigating the rise in core temperature in 
warm exercise environments (Brade, Dawson, Wallman, & Polglaze, 2010; Gao, 
Kuklane, & Holmér, 2011; Ross et al., 2011). 
2.2.5.1 Ice 
During rehabilitation from injury, ice is used to relieve pain, reduce inflammation, and 
reduce joint oedema, promoting an earlier return to exercise (Ernst & Fialka, 1994; 
Knight et al., 2000). The physiological effects attributed to ice are a decrease in pain, 
swelling, muscle spasm, and secondary hypoxic injury (Ciolek, 1985; Knight, 1985). 
However, these effects following injury do not directly translate to an exercise 
recovery model. Literature investigating the effect of ice application following exercise 
has shown no effect on soreness (Gulick, Kimura, Sitler, Paolone, & Kelly, 1996; 
Nogueira, Felappi, Lima, & Medeiros, 2019; Yackzan, Adams, & Francis, 1984). A 
recent meta-analysis concluded that local cryotherapy in the form of ice does not 
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improve symptoms of DOMS or strength loss following exercise (Nogueira et al., 
2019). Importantly, strength is decreased immediately following ice treatment (Ruiz, 
Myrer, Durrant, & Fellingham, 1993). Thus, returning athletes to competition 
immediately following cryotherapy could adversely affect their ability to perform. Since 
ice application is limited by duration, and the magnitude of cooling (measured at the 
skin) is dependent on the size of the ice medium (Janwantanakul, 2009), it is likely 
that a single ice treatment over a small area does not provide a sufficient cooling 
stimulus to elicit any beneficial effects on recovery. 
Repeat applications at frequent intervals over several hours are common practice 
following an injury to the muscle (Knight, 1995). However, this protocol is not 
commonly implemented by athletes following exercise. Studies investigating repeat 
applications are limited and inconclusive, with some showing a positive effect at 48 
hours post-exercise on the recovery of soreness (Oakley, Pardeiro, Powell, & Millar, 
2013) and blood markers of muscle damage (Howatson & Van Someren, 2003) 
following exercise. Others have shown no effect (Howatson, Gaze, & van Someren, 
2005) or an adverse effect on adaptation and symptoms of DOMS (Isabell, Durrant, 
Myrer, & Anderson, 1992; Tseng et al., 2013). Interestingly, one of the studies 
demonstrating a positive effect (Oakley et al., 2013) employed a treatment frequency 
that most closely resembled clinically recommended guidelines (application as soon 
as possible, several times a day for 15-20 minutes throughout the 72-hour recovery 
period; Michlovitz, 1990). The other study demonstrating a positive effect exhibited a 
significant decrease in CK levels at 72 hours compared with control in resistance-
trained participants (Howatson & Van Someren, 2003). In contrast, the participants in 
a follow-up study utilising the same treatment parameters but showing no difference 
in CK levels, were untrained individuals (Howatson et al., 2005). Thus, ice is generally 
not effective in the treatment of EIMD induced by unaccustomed eccentric exercise. 
A more frequent application administered over a longer time period may prove 
beneficial. Unfortunately, athletes are not likely to comply with such a demanding 
treatment schedule. 
2.2.5.2 Whole Body Cryotherapy 
Exposing the whole body or part of the body to very cold air (-110°C to -140°C) for 
durations of 2-4 minutes is defined as whole body cryotherapy (WBC) or partial body 
cryotherapy (PBC), respectively (Banfi, Lombardi, Colombini, & Melegati, 2010; 
Costello et al., 2015). This cryotherapy modality is especially popular for treating 
symptoms such as pain, oedema, and inflammation in various chronic pathological 
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conditions (Hirvonen, Kautiainen, Moilanen, Mikkelsson, & Leirisalo-Repo, 2017; 
Missmann, Himsl, Mur, Ulmer, & Marschang, 2016). Accelerated subjective recovery 
of soreness following EIMD using WBC has recently been demonstrated (Bleakley, 
Bieuzen, Davison, & Costello, 2014; Costello et al., 2015) and the use of WBC for 
this purpose has gained some traction in athletic populations. Following exercise, 
WBC and PBC have demonstrated beneficial effects on inflammatory biomarkers 
(Banfi et al., 2010, 2009; Guilhem et al., 2013; Pournot et al., 2011; Ziemann et al., 
2012), muscle damage (Banfi et al., 2009; Ferreira-Junior et al., 2015; Hausswirth et 
al., 2011; Ziemann et al., 2012), and soreness (Fonda & Sarabon, 2013; Hausswirth 
et al., 2011; Pournot et al., 2011; Ziemann et al., 2012). Evidence for an effect on 
functional recovery is mixed, with some studies concluding that WBC positively 
influenced muscle function or performance capacities that are otherwise detrimentally 
affected by exercise (Ferreira-Junior et al., 2015; Fonda & Sarabon, 2013; Hausswirth 
et al., 2011; Krüger, de Mareés, Dittmar, Sperlich, & Mester, 2015; Ziemann et al., 
2012), while others have shown no effect (Costello et al., 2012a; Vieira et al., 2015). 
However, the two studies showing no effect administered treatment 24 hours after 
the exercise protocol (Costello et al., 2012a) or performed the functional testing too 
soon following WBC, at which point reduced muscle temperatures would have limited 
performance in the subsequent exercise (Vieira et al., 2015). Two more recent studies 
have shown no effect on inflammation, muscle damage or hormonal response 
(Krueger, Costello, Achtzehn, Dittmar, & Mester, 2019), or the ability of WBC to 
augment training-induced aerobic adaptations and performance (Broatch, Poignard, 
Hausswirth, Bishop, & Bieuzen, 2019). Overall, studies indicate that WBC may be 
successful in reducing soreness following exercise and returning athletes to pre-
exercise strength at a faster rate than control conditions (Rose, Edwards, Siegler, 
Graham, & Caillaud, 2017), but there remains little evidence of clinically relevant 
improvements in functional recovery (Bleakley et al., 2014). 
2.2.5.3 Cold Water Immersion 
The majority of research investigating cryotherapy for recovery from exercise has 
utilised CWI. The mechanisms associated with CWI for recovery following exercise 
have been thoroughly investigated (Bailey et al., 2007; Bleakley et al., 2010; Broatch, 
Petersen, & Bishop, 2014; Cochrane, 2004; Glasgow, Ferris, & Bleakley, 2014; Ihsan 
et al., 2016; Poppendieck, Faude, Wegmann, & Meyer, 2013; Wilcock et al., 2006), 
and are believed to be associated with reduced temperature (Gregson et al., 2013, 
2011; Mawhinney et al., 2013; Mawhinney et al., 2017; Peiffer, Abbiss, Watson, 
Nosaka, & Laursen, 2010; Peiffer, Abbiss, Nosaka, Peake, & Laursen, 2009; Roberts, 
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Muthalib, et al., 2015; Roberts et al., 2014), and reduced blood flow (Bleakley & 
Davison, 2009; Gregson et al., 2011; Mawhinney et al., 2013; Meeusen & Lievens, 
1986) in the skeletal muscle. These physiological responses are heavily dependent 
on exercise mode, intensity, and duration. The magnitude of these effects are further 
understood to be dependent on water temperature, immersion duration, frequency of 
immersions, and mode of immersion (continuous vs intermittent; Hohenauer, 
Taeymans, Baeyens, Clarys, & Clijsen, 2015; Machado et al., 2016; Vieira et al., 
2016; White et al., 2014). However, the variables mentioned above are inconsistently 
manipulated throughout the literature. Although CWI differs from other forms of 
cryotherapy due to the added effect of hydrostatic pressure (see Wilcock et al., 2006 
for review), which augments the effects of cold-induced vasoconstriction, blood flow 
(Gabrielsen et al., 1993; Gregson et al., 2011; Ihsan et al., 2013; Johansen et al., 
1997; Mawhinney et al., 2013; Park et al., 1999; Stocks et al., 2004), and 
parasympathetic control (Mourot et al., 2008), hydrostatic pressure has no additional 
recovery benefit in reducing symptoms of EIMD (Leeder et al., 2015). 
Immersion temperatures between 10-15°C are most beneficial for the recovery of 
soreness and functional recovery (Versey, Halson, & Dawson, 2013). However, 
immersion temperature has been a poorly controlled variable in the literature, ranging 
between 5-20°C (Bleakley et al., 2010; Versey et al., 2013). Some have shown no 
effect (Corbett, Barwood, Lunt, Milner, & Tipton, 2012; Poppendieck et al., 2013; 
Sellwood, Brukner, Williams, Nicol, & Hinman, 2007), or a positive effect (Anderson, 
Nunn, & Tyler, 2018; Dupuy, Douzi, Theurot, Bosquet, & Dugué, 2018; Rowsell et al., 
2009, 2011) of varying immersion temperatures on variables associated with recovery 
following exercise. Dupuy and colleagues (2018) reported that only immersion in 
water temperatures below 15°C had a positive impact on muscle damage and 
inflammation as measured by changes in CK, IL-6, and CRP. Ultimately, reduced 
water temperature is not likely to produce additional recovery benefits (Poppendieck 
et al., 2013), and results in increased discomfort (Bailey et al., 2007; Heyman, De 
Geus, Mertens, & Meeusen, 2009; Vaile et al., 2008; Versey, Halson, & Dawson, 
2011). Immersion duration is of greater importance because it is correlated with the 
magnitude of change in tissue temperature (Peiffer, Abbiss, Watson, Nosaka, & 
Laursen, 2009). Immersions of at least 10 minutes are most common in the literature 
(Banfi et al., 2010; Bleakley et al., 2010; Versey et al., 2013) but range between 3-24 
minutes (Bleakley et al., 2010) and 3-20 minutes (Versey et al., 2013). Studies that 
have found a positive effect of CWI on soreness and functional recovery have utilised 
immersion durations of 5-15 minutes (Versey et al., 2013), 10-20 minutes (Bleakley 
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et al., 2010), or 10-15 minutes (Machado et al., 2015). Only one study has examined 
the effect of different CWI durations on the recovery of strength following cycling 
exercise (Peiffer, Abbiss, Watson, et al., 2009). However, no duration was found to 
accelerate recovery, likely because follow-up testing was performed very shortly 
following immersion during which time participants were too cold to optimally perform 
anaerobic tests. The effect of prolonged immersion duration on indices of recovery 
on the days following exercise in humans has not been studied. Importantly, in 
addition to the cold shock response associated with the initial immersion, prolonging 
immersion duration could result in cold incapacitation ensuing in rapid loss of fine and 
gross motor skills primarily in the hands and fingers as well as a loss of power and 
muscle coordination. If immersion duration is too long, hypothermia can occur.  
Similar to ice application, a single CWI dose is likely insufficient to influence the 
mechanisms responsible for accelerating recovery. The most practical way to prolong 
immersion duration is to employ repeat exposures following a single exercise bout. 
Initially, repeat exposures were localised to one body part (e.g. the arm) submerged 
in water for 15 minutes (Eston & Peters, 1999; Meeusen & Lievens, 1986). Following 
eccentric exercise, repeat local immersion reduced muscle stiffness and muscle 
damage (as measured using CK) but did not affect soreness and strength loss (Eston 
& Peters, 1999). More recently, immersion of the entire body has been commonly 
implemented, since the thermal and physiological responses to water immersion are 
influenced by the amount of surface area exposed to the water (Stephens et al., 
2017). Thus, full-body immersion is likely to have superior recovery effects than 
localised limb submersion. Intermittent whole body CWI results in a greater mean 
decrease in core temperature than a single session of continuous CWI (Stephens et 
al., 2017). However, studies on recovery indices following repeat whole body 
immersions have demonstrated conflicting results. Some have demonstrated 
improved recovery of performance (Vaile et al., 2008) and reduced soreness 
(Machado et al., 2017; Montgomery et al., 2008; Rowsell et al., 2009; Skurvydas et 
al., 2006; Vaile et al., 2008), while others have demonstrated no effect on systemic 
inflammation or functional recovery (Goodall & Howatson, 2008; Higgins, 
Heazlewood, & Climstein, 2011; Siqueira et al., 2018).  
Limited research exists comparing the application of ice with CWI following exercise. 
Only one study demonstrated that CWI was more effective than ice at enhancing 
lactate recovery following exercise (Adamczyk, Krasowska, Boguszewski, & 
Reaburn, 2016). On the other hand, literature comparing PBC or WBC with CWI has 
shown that CWI is more effective than PBC or WBC in decreasing limb blood flow 
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(Hohenauer et al., 2018; Mawhinney et al., 2017) and accelerating recovery of muscle 
soreness (Abaïdia et al., 2017). Research has evaluated the efficacy of CWI and 
WBC on performance following endurance exercise and found that WBC negatively 
impacted the recovery of muscle function compared to CWI, but neither intervention 
was more effective than a placebo (Wilson et al., 2018). In contrast, WBC was more 
effective than CWI at attenuating soreness and strength following resistance training, 
but neither cryotherapy intervention was more effective than the placebo treatment at 
accelerating recovery (Wilson, Dimitriou, Hills, Gondek, & Cockburn, 2019). These 
two studies are perfect examples of the variabilities in immersion protocols that exist 
throughout the literature. Although the two studies mentioned above employed 
varying exercise stimuli in order to examine the effects of CWI and WBC on metabolic 
(Wilson et al., 2018) and mechanical stress (Wilson et al., 2019), immersion 
temperature varied, even though both studies were completed by the same research 
lab. Ultimately any evidence in favour of CWI is likely due to the fact that temperature 
reductions from CWI are maintained for longer than from WBC (Costello et al., 2015; 
Costello et al., 2012a; Hohenauer et al., 2018; Mawhinney et al., 2017). Further, the 
thermal input associated with cooling between the two modalities is different (i.e. 
convective vs conductive cooling; Mawhinney et al., 2017). The relatively poor 
thermal conductivity of air compared to the greater conductance of tissue heat 
transfer/loss in water (Wakabayashi, Kaneda, Sato, Tochihara, & Nomura, 2008; 
Westerlund, Oksa, Smolander, & Mikkelsson, 2003), limits subcutaneous and core 
body cooling during WBC, and enhances these variables during CWI (Bleakley et al., 
2014). 
2.2.5.3.1 Effect of CWI on Blood Markers 
A reduction in cellular, lymphatic, capillary and membrane permeability caused by 
vasoconstriction following CWI is believed to attenuate the efflux of CK. Alterations of 
tissue clearance due to blood-flow or function can affect the CK concentration in the 
blood. However, reviews have demonstrated only a small effect (Hohenauer et al., 
2015; Leeder et al., 2012), or no effect (Anderson et al., 2018; Bailey et al., 2007; 
Bleakley et al., 2010; Fonseca et al., 2016; Halson et al., 2008; Leeder et al., 2015; 
Pointon et al., 2011b; Rowsell et al., 2009) of CWI on CK efflux on the days after 
exercise. Further still, some have reported an increase after cooling compared with 
the control condition (Pointon et al., 2011b; Tseng et al., 2013). Interestingly, the 
effect of CWI on reducing CK might be temperature-dependent, as post-exercise 
immersion in 15°C reduced CK at 72 hours post-exercise, whereas immersion in 5°C 
did not (Vieira Ramos et al., 2016). Ultimately, the weight of evidence suggests that 
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CWI has greater efficacy than WBC at attenuating CK following exercise (Abaïdia et 
al., 2017; Wilson et al., 2018).  
Interleukin 6 (IL-6) is a cell signalling myokine that is released from contracting 
muscles into the circulatory system during exercise, is present during muscle 
regeneration and recovery, and has both pro- and anti-inflammatory properties 
(Tidball, 1995). Traditionally IL-6 has been used as a marker of acute inflammation 
after exercise but it has not consistently been associated with greater EIMD (Paulsen 
et al., 2012). Exercise-induced elevations in IL-6 are more apparent after exercise 
involving high metabolic stress of a large muscle mass than following single-joint 
exercise. No effect (Broatch et al., 2014; Montgomery et al., 2008; Vaile et al., 2007) 
or a moderate effect in attenuating increases in IL-6 (Peake et al., 2008; Pournot et 
al., 2010; Stacey, Gibala, Martin Ginis, & Timmons, 2010; Tavares et al., 2019) have 
been reported following CWI. A rise following CWI has also been demonstrated 
(Peake et al., 2016; Roberts et al., 2014), but may reflect the sustained release of IL-
6 from skeletal muscle in response to glycogenolysis (Keller et al., 2001).  
C-reactive protein (CRP) is hepatocyte-derived acute phase protein stimulated by 
increases in systemic IL-6 (Pepys & Hirschfield, 2003; Petersen & Pedersen, 2005) 
and utilised as a non-specific marker of inflammation (Pepys & Hirschfield, 2003; 
Ross, 1999). For this reason, CRP is commonly used to quantify inflammation 
following exercise when access to quantification of cytokine expression is 
unavailable. However, studies using CRP to quantify the inflammatory response 
following CWI have reported no effect (Banfi, Melegati, & Valentini, 2007; Halson et 
al., 2008; Ingram et al., 2009). Others suggest that CWI might enhance both the pro-
inflammatory and anti-inflammatory responses responsible for muscle remodelling 
(Jajtner et al., 2015). 
2.2.5.3.2 Effect of CWI on Recovery of Soreness  
The most consistent effect of CWI is a reduction in the degree of perceived muscle 
soreness (Bailey et al., 2007; Barnett, 2006; Elias, Wyckelsma, Varley, McKenna, & 
Aughey, 2013; Hohenauer et al., 2015; Ingram et al., 2009; Machado et al., 2015; 
Minett, Duffield, Kellett, & Portus, 2012; Montgomery et al., 2008; Pointon et al., 
2011b; Pointon & Duffield, 2012; Pournot et al., 2010; Siqueira et al., 2018; 
Yanagisawa et al., 2003). CWI has a positive effect on alleviating acute muscle 
soreness (Poppendieck et al., 2013). Meta-analyses have concluded that CWI had a 
moderate beneficial effect on alleviating DOMS at 24 hours (Hedges' g = 0.4–0.7), 48 
hours (Hedges' g = 0.6), 72 hours (Hedges' g = 0.2–0.6), and 96 hours (Hedges' g = 
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0.6–0.7) following exercise (Bleakley et al., 2012; Hohenauer et al., 2015; Leeder et 
al., 2012; Machado et al., 2015). However, the overall effect of CWI on soreness is 
dependent on exercise mode, the degree of muscle damage, or the training status of 
the individual. For example, Leeder et al. (2011) demonstrated that CWI was effective 
in alleviating DOMS at 24 and 48 hours following high-intensity exercise but was only 
moderately effective at 48 hours following eccentric exercise. Similarly, Ihsan et al. 
(2016) concluded that CWI is limited in accelerating recovery from EIMD induced by 
single-joint eccentrically biased contractions and that CWI seems more effective in 
ameliorating effects of EIMD induced by prolonged endurance exercise or prolonged 
intermittent based exercise. Eccentric exercise elicits greater tissue damage and 
evokes a superior inflammatory response than concentric exercise. As a result, 
perceived soreness is likely to be greater following eccentric exercise. Thus, one can 
expect to experience a lesser overall effect from CWI on soreness following eccentric 
exercise than following concentric exercise. However, the physiological effects of 
CWI following different exercise types have yet to be elucidated. 
Given the subjective nature of soreness, the efficacy of post-exercise CWI could be 
confounded by a placebo effect. Indeed, a recovery placebo administered after an 
acute high-intensity interval training session was proven to be as effective as CWI in 
the recovery of muscle strength over 48 h (Broatch et al., 2014). Further, training 
status is often not considered in the literature but is significant because 
unaccustomed exercise results in greater amounts of soreness. Studies showing a 
negligible effect of CWI on soreness all reported having utilised trained participants 
(Anderson et al., 2018; Delextrat, Calleja-González, Hippocrate, & Clarke, 2013; King 
& Duffield, 2009; Pointon et al., 2011a; Stanley, Peake, & Buchheit, 2012). This 
finding suggests that CWI is likely to have a lesser effect on reducing soreness in 
athletes as opposed to untrained individuals.  
2.2.5.3.3 Effect of CWI on Recovery of Muscle Function 
A major functional consequence resulting from EIMD is an immediate and prolonged 
loss of muscle strength, which is not necessarily accompanied by soreness (Cleak & 
Eston, 1992). The ultimate indicator of post-exercise recovery is the ability of the 
muscle to produce force (Minett & Duffield, 2014). Therefore, alleviating strength at a 
rate faster than normal could allow athletes to achieve better performance, giving 
them a competitive advantage over their peers. However, athletes have been 
unsuccessful in finding a modality to accelerate recovery of muscle strength following 
exercise. The ultimate goal of using CWI as a recovery modality is to enhance 
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subsequent performance; however, performance benefits following CWI are not 
consistently demonstrated across current research. Few studies have shown 
accelerated return to baseline strength following CWI compared with control 24-48 
hours following exhaustive simulated team sports exercise (Bailey et al., 2007; 
Broatch et al., 2014; Ingram et al., 2009; Pournot et al., 2010), 48 hours following 
eccentric quadriceps contractions (Vaile et al., 2007), or 24-72 hours following drop 
jump exercise (Skurvydas et al., 2006). Others have shown no difference in the 
recovery of strength loss from CWI compared with control using the same drop jump 
protocol (Howatson, Goodall, & van Someren, 2009b; Siqueira et al., 2018). Similarly, 
Jakeman, Macrae, & Eston (2009) showed no difference in the recovery of torque 
from a single session of CWI compared with control performed following a plyometric 
jumping protocol. Importantly, the CWI protocols between the drop jump studies 
differed. Skurvydas et al. (2006) administered CWI (2 x 15 minutes at 15°C) 
immediately, 4, 8 and 24 hours following exercise; while, Howatson et al. (2008) and 
Siqueira et al. (2018) administered CWI (12 minutes at 15°C, 20 minutes at 10°C, 
respectively) immediately, 24, 48 and 72 hours post-exercise. A combination of 
multiple immersions within the first 24 hours as well as the prolonged duration of CWI 
exposure in Skurvydas et al. (2006) study was more effective in accelerating recovery 
of strength than the CWI protocols implemented by Howatson et al. (2008) and 
Siqueira et al. (2018).  
The method of measuring strength throughout the literature investigating the effects 
of CWI varies greatly, which might further explain the discrepancy in the findings of 
the studies mentioned above. For example, Vaile et al. (2007) utilised peak force 
during an isometric squat as their strength measure, while Skurvydas et al. (2006) 
used a modified strain gauge to quantify strength. There are inconsistencies in the 
muscle groups and contraction types used for establishing an effect of CWI on the 
recovery of strength within the literature. One of the most informative criteria of 
muscle damage is a decrease in muscle force (MIVC), yet studies examining the 
effect of CWI on the recovery of strength have generally failed to utilise this measure. 
Of the few studies administering CWI and measuring recovery of muscle strength 
post-exercise (Bailey et al., 2007; Broatch et al., 2014; Ingram et al., 2009; Pournot 
et al., 2011; Skurvydas et al., 2006; Vaile et al., 2007), only two utilised MIVC (Broatch 
et al., 2014; Ingram et al., 2009). One administered CWI for 15 minutes in 10°C water 
following an acute high-intensity interval training session (Broatch et al., 2014) and 
found MIVC returned to baseline 48 hours following exercise in the CWI treatment 
group, but not in the control group; however, strength between the two groups was 
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not statistically different at any time point. Similarly, the other study applied two 5 
minute immersions in 10°C water following 80 minutes of simulated team sports 
exercise and a 20-metre shuttle run test to exhaustion (Ingram et al., 2009), and found 
that while CWI resulted in lower decrements in strength and a near return of strength 
to baseline at 48 hours following exercise, there were no differences between 
recovery conditions for the isometric strength measures. In a meta-analysis including 
only tests of isometric/isokinetic knee extension or elbow flexion, CWI was not 
effective in improving the rate of recovery of muscle strength post-exercise (Leeder 
et al., 2012). Interestingly, it has recently been suggested that CWI mediated recovery 
of MIVC following exercise in the heat might not reflect recovery exclusively from 
EIMD (Ihsan et al., 2016), but might also include recovery from central fatigue (Minett 
et al., 2014; Pointon et al., 2011b).  
Functional performance, such as sprint or cycling test performance and vertical jump 
assessment, are more indicative of overall muscular function and recovery from EIMD 
than MIVC. A handful of studies have demonstrated CWI induced improvements in 
functional performance in the post-exercise period following team sports and interval-
based endurance exercise (Ascensão, Leite, Rebelo, Magalhäes, & Magalhäes, 
2011; Elias et al., 2013; Ingram et al., 2009; Minett et al., 2014; Pointon et al., 2011b), 
but not after eccentric strength loadings (Goodall & Howatson, 2008; Sellwood et al., 
2007). Similar to the effect of CWI on soreness, a single application of CWI might be 
insufficient to induce accelerated recovery of strength following damage to muscle 
contractile properties. Studies showing no effect on functional recovery did not 
monitor the recovery of strength beyond the first 24 hours (King & Duffield, 2009; 
Peiffer, Abbiss, Watson, et al., 2009; Pointon & Duffield, 2012). One study 
demonstrated impaired peak power (Anderson et al., 2018), but utilised trained 
participants and a cross-over design, separating exercise sessions by 7 days. A 
cross-over design should not be applied to avoid the influence of the RBE on the 
magnitude of muscle damage between conditions. The RBE experienced by the 
participants in the study (Anderson et al., 2018) was not accounted for by the authors 
when interpreting their results. In general, studies investigating the efficacy of CWI 
following repeat exercise events have not taken the potential protective effect of the 
RBE into account. 
CWI might be effective at restoring muscle function as evident during CMJ 
performance. The effect of CWI on jump performance seems to be temperature-
dependent as only immersion in 15°C but not 5°C improved recovery of jump height 
while having no accelerated effect on the recovery of strength (Vieira et al., 2016). 
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Others have shown no effect on jump performance using the same EIMD and CWI 
protocol, although there was a tendency for CWI to increase CMJ performance post-
exercise, this did not reach statistical significance (Siqueira et al., 2018). Jump 
performance is highly dependent on the myotendinous capacity to generate power, 
indicating that CWI could be more effective for the recovery of stretch-shortening 
cycle movements to a greater extent than the recovery of isometric strength. Whether 
CWI has specificity to restore muscle power over strength requires further research 
but may be explained by the ability of CWI to reduce venous blood oxygen saturation 
and availability and aid in the recovery of type II muscle fibres specifically (Roberts et 
al., 2014), which may be preferentially damaged following eccentric exercise and are 
the predominant fibre type in high-velocity muscle contractions involving elevated 
power production (Fridén & Lieber, 2001). This is assuming that CWI specifically 
effects the excitation-relaxation kinetics (Favero, 1999) of skeletal muscle involved in 
muscle power generation.  
2.2.5.4 Phase Change Material 
The magnitude of change in tissue temperature is greater with cryotherapy methods 
that undergo a phase change (Merrick et al., 2003; Dykstra et al., 2009). Specifically, 
Merrick et al. (2003) demonstrated that modalities that undergo a phase change 
caused lower skin and intramuscular temperatures than cold modalities that did not 
possess these properties (ice bag: 6.5°C, skin temperature; 27.8°C, 1 cm 
intramuscular temperature; vs gel pack: 9.9°C, skin temperature; 29.5°C, 1 cm 
intramuscular temperature). Unfortunately, CWI, WBC, and ice are all limited in 
duration of treatment application. Further, neither CWI nor WBC undergoes a phase 
change. A phase change is important because it relates to a property called ‘enthalpy 
(heat) of fusion’, which is the quantity of heat required to make the material change 
phase (Merrick et al., 2003). Enthalpy of fusion greatly enhances the ability of a cold 
modality that changes phase to absorb heat. For example, even though a gel pack 
may be initially colder than a bag of ice, the gel pack does not change phase meaning 
it only experiences sensible heat loss. On the contrary, a modality that changes phase 
such as ice experiences a latent heat phase during the phase change (see Figure 5). 
Therefore, modalities experiencing the latent heat phase have an advantage over 
modalities capable of experiencing only a sensible heat phase by providing greater 
thermal storage density because during the latent phase the temperature remains 
constant. Thus, over time the ice will elicit a greater cooling potential than a gel pack 
(Knight, 1995; Merrick et al., 2003).  
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The duration of treatment application can be prolonged utilising phase change 
material (PCM) that changes phase at a temperature greater than the standard gel 
pack (e.g. 15°C PCM vs 0°C gel pack). The cooling effect of PCM depends on the 
capacity to absorb heat during periods when external heat load or body heat 
production exceeds heat loss. When PCM is heated (by exposure to the human 
body), its temperature increases and reaches the point at which it changes from solid 
to liquid called the phase point. The phase point will dictate the duration that the PCM 
can hold a given temperature. When PCMs reach their phase point, they continue to 
absorb heat at a constant temperature until all the material is transformed into the 
melted liquid phase. The duration of this process, called the latent phase of melting, 
is variable and dependent on the temperature gradient between skin and PCM, the 
PCM phase point, the area covered by PCM and the volume of the PCM (Hassabo, 
2014; Tiest, Kosters, Kappers, & Daanen, 2012). For example, PCMs will melt faster 
if the skin is warmer, PCM with a phase point of 10°C will not hold that temperature 
as long as PCMs with a set point of 15°C, and a small volume of PCM will melt faster 
than a larger volume of PCM. Ice is the most commonly utilised PCM for exercise 
recovery, but it a phase point of 0°C limits it from sustaining its cooling capacity for 
prolonged periods. Ultimately, the latent phase for a 15°C PCM is significantly longer 
than for a 0°C ice bag (Figure 5). Importantly, before reaching the temperature at 
which the latent phase of melting occurs, while PCM is in its solid ‘frozen’ state, it will 
experience temperature change defined as sensible heat. Once PCM has changed 
phase entirely to its melted state, it will again continue to experience temperature 
change (sensible heat) until it equilibrates with the environmental temperature. 
Cryotherapy modalities that do not experience phase change, such as a gel pack or 
CWI, only exhibit sensible heat loss (Figure 5).  
PCM was developed by NASA in 1975, based on prototype work using liquid cooling 
garments by Bill Elkins, as a method for the passive control of spacesuit temperature 
in which severe temperatures are encountered. Since then, much of the previous 
human research on PCM cooling has focused on the temperature-regulating effect 
(Gao, Kuklane, & Holmer, 2010; Gao et al., 2011) and the cooling effect to elicit 
thermal comfort from heat strain (Bennett, Hagan, Huey, Minson, & Cain, 1995; Chou, 
Tochihara, & Kim, 2008; House et al., 2013; Kenny et al., 2011; Reinertsen et al., 
2008; Zhang, 2003), and from heat strain specifically following exercise (Barwood et 
al., 2009; Brade et al., 2010; Purvis & Cable, 2000; Tate, Forster, & Mainwaring, 
2008). Most of the research has applied PCM through pockets in vests at phase 
points ranging between 10-31°C, for treatment durations longer than from CWI. The 
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longest reported treatment duration was 90 minutes at 21°C, with no adverse or 
negative effects at the skin (Gao, Kuklane, Wang, & Holmér, 2012). PCM vests (24°C) 
are more effective at cooling the skin temperatures than 28°C vests but do not affect 
core temperature after exercise (Gao et al., 2011). PCM with a lower melting point 
might reduce core temperature more effectively.  
 
 
Figure 5: Sample melting pattern of PCM with a phase point of 15°C, or 0°C for 
comparison, as well as a material with only sensible heat properties. Latent heat 
period demonstrates a change in phase while maintaining a constant temperature. 
Latent heat phase is longer for 15°C PCM than for 0°C PCM, which is generic ice 
changing from solid to liquid. The 15°C PCM is compared with a reference that does 
not change phase (experiencing only sensible heat). For example, this can be a gel 
pack or CWI that initially starts at 10°C but warms up to 20°C as it equilibrates with 
room temperature. Melting duration is arbitrary since it is dependent on the 
temperature gradient between skin and PCM, the PCM phase point, the area covered 
by PCM and the volume of the PCM. 
Applying PCM directly to the skin fitted under a garment might be more effective, less 
time consuming, and logistically simpler for cooling large muscles masses compared 
with CWI or other cryotherapy modalities, particularly if large numbers or entire 
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squads are seeking concurrent recovery treatment. Only one study has investigated 
the use of a PCM cooling vest for recovery from a metabolic challenge measuring 
ventilatory parameters (Hausswirth et al., 2012). They found that compared to CWI, 
PCM reduced physiological load in the early stage of subsequent exercise. No study 
has examined the effects of PCM cooling on indices of recovery from EIMD on the 
days after exercise. Single applications of PCM with a phase point of 15°C can 
provide up to 3 hours of cooling, which might improve the recovery process compared 
with conventional cryotherapy interventions like CWI. The ability to exploit the latent 
heat phase of PCM in order to maintain a steady temperature for a prolonged duration 
could enhance the effects of cooling on recovery and could be a practical and portable 
substitute to CWI.  
2.2.6 Conclusion 
The effectiveness of cryotherapy for the treatment of EIMD remains inconclusive. The 
most popular modality, CWI, offers some benefits for reducing soreness and 
accelerating the restoration of muscle function. However, in the literature, treatment 
duration and temperature vary greatly, which explains the overall equivocal evidence 
supporting its use for accelerating the recovery process. Further, the best available 
evidence supporting the use of cryotherapy for recovery stems from animal models. 
However, the magnitude of reduction in metabolic rate and muscle temperature 
achieved in animal models has not been replicated in humans. Ultimately, popular 
cryotherapy modalities are all limited by the duration of application. For this reason, 
the literature suggests that reductions in tissue temperature should be prolonged 
(Casa et al., 2007; Goodall & Howatson, 2008; Peiffer et al., 2009; Proulx, Ducharme, 
& Kenny, 2003) in order to sufficiently influence an inflammatory process that goes 
on for several hours (Armstrong et al., 1991), and a cascade of events that continues 
for several days (Lieber, 2018). Prolonging the magnitude of tissue cooling could be 
the missing link in mitigating the overall extent of tissue damage (Bleakley et al., 2012; 
Enwemeka et al., 2002; Ihsan et al., 2013; Knight, 1995; Merrick, 2002), reducing 
secondary muscle damage (Merrick et al., 1999; Swenson et al., 1996), and 
enhancing the regenerative response (Dykstra et al., 2009; Järvinen et al., 2005) 
following exercise. A recovery intervention capable of prolonging the cooling duration 
might accelerate the recovery of the signs and symptoms associated with EIMD.   
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3.1 General Methods 
This chapter describes the methodological procedures common to the four 
experimental studies encompassing this thesis. The general methods outlined below 
act as a reference point for the upcoming experimental chapters. Descriptions of 
measures that were unique to individual studies can be found in the methods section 
of the relevant chapter. Institutional ethical approval was sought and granted by the 
Northwell Health Institutional Review Board for all investigations, while the Faculty 
Ethics Committee at Northumbria University granted additional ethical approval for 
the investigations in chapter 5 and 6. Ethical approval was granted prior to data 
collection for each investigation and written informed consent was sought after verbal 
and written detailed instructions regarding the study requirements were provided to 
all participants (see Appendix 9.1 and 9.2 for an example of 1. Northumbria and 2. 
Northwell Health informed consent, respectively). 
3.2 Participant Recruitment 
Recruitment was initiated through word of mouth or poster advertisement aimed at 
the populations described within each chapter. Healthy participants between the ages 
of 18-56 years were recruited for all studies. The investigations encompassing 
chapters 4 and 5 of this thesis recruited healthy recreationally trained female and 
male participants. Chapter 6 and 7 recruited only male participants, in an attempt to 
reduce the influence of differences in body composition on the response to 
cryotherapy and the hormonal response on the adaptive mechanism to exercise. The 
inclusion criteria for chapters 4 and 7 required participants to be acutely 
unaccustomed to eccentric exercise in the quadriceps, with the exception that 
participants in chapter 7 were required to be regularly participating in team-sport or 
other forms of physical exercise. Participants in chapter 5 were recruited from a pool 
of runners registered to complete a road marathon. Participants were familiarised with 
the study protocols and procedures prior to the initiation of any data collection, which 
are outlined in detail within each experimental chapter. 
3.3 Exclusion Criteria  
Participants were excluded if they had any known sensitivity to cold, allergy to cold or 
ice, compromised circulation or vascular disease in the legs, or had a history of 
musculoskeletal injury of the lower extremity within the 6 months of study 
participation. The use of any recovery treatments unrelated to study participation 
(e.g., cryotherapy, foam rolling, compression garments), nutritional supplements 
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(e.g., protein, antioxidants), or anti-inflammatory drugs (NSAIDS) were prohibited for 
the duration of each study.  
3.4 Controls 
Participants were instructed to limit their physical activity in the 48 hours prior to, and 
for the duration of the data collection period in all studies. Those participating in 
chapter 7 were additionally instructed to refrain from partaking in any novel eccentric 
exercise involving the lower limbs in the week between the two exercise bouts. 
Participants were not placed on any dietary restrictions and were instructed to 
maintain their regular eating habits. Participants were allowed to consume water ad 
libitum throughout each session of data collection; except not in chapter 6. 
3.5 Phase Change Material Application 
The experimental cryotherapy modality used throughout the course of this thesis were 
commercially available Phase Change Material (PCM; Glacier Tek USDA 
BioPreferred PureTemp PCM, Plymouth, MN, USA) packs that ‘freeze’ (have a latent 
phase) at 15°C. The Glacier Tek PCM are filled with a proprietary blend of fully 
hydrogenated natural fats certified by the U.S. Food and Drug Administration as food-
grade chemicals such as palm oil, palm kernel oil, rapeseed oil, coconut oil and 
soybean oil, mixed with sodium chloride, and encapsulated in flexible plastic. This is 
specifically referred to as microencapsulated PCM. The PCM look like wax when in a 
frozen solid state and like vegetable oil when in their melted liquid state (Figure 6).  
 
 
Figure 6: Two Glacier Tek PCM packs in the frozen state (left), and in their melted 
state (right).  
57 
 
Two PCM blocks (864 cm2 area; 32.4 × 2 × 13.3 cm) fitted directly on the skin over 
the quadriceps on each leg were administered to each leg (Figure 7) in participants 
receiving the treatment condition. Participants in the control group (chapter 7), and 
in the group defined as indirect cooling in chapter 4, received melted room 
temperature PCM packs and applied them identically to the treatment condition. In 
chapter 5, participants in the control condition did not receive any intervention. The 
PCM utilised in the series of investigations in this thesis were all prepared for 
treatment by being frozen solid in a generic refrigerator. Preliminary testing in the 
lab established that the temperature gradient between the surface of the thigh skin 
temperature (~33°C) and the 15°C PCM results in a phase change duration of 3 
hours. Additionally, the manufacturer and an independent quality association (PCM, 
RAL, Stuttgart, Germany), have verified that the PCM packs can maintain a 
constant temperature of 15°C for at least 3 hours in a thermoneutral environment 
until the substance is fully melted. This prompted the PCM in the treatment 
condition to be changed for a fresh frozen set after the initial 3 hours of wear in 
chapters 4 and 7. When the first set of packs had to be replaced by the participant 
while away from the lab, the frozen state of the second set of packs was verbally 
confirmed by the investigator on the second day of data collection. For participants 
receiving the treatment condition in chapters 4 and 7 skin temperature data were 
also manually inspected by the investigator to verify the cooling status throughout 
the entire duration of treatment. Snug-fitting athletic shorts (Eastbay brand) were 
worn over top of the PCM in order to hold them in place.  
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Figure 7: Participant in chapter 4 wearing two PCM packs per leg, with the 
participant’s right leg being treated with the frozen state PCM and the left leg being 
treated with melted PCM, and displaying the medially positioned PCM pack on each 
leg. The participant’s right leg is receiving two frozen PCM packs applied directly to 
the skin over the quadriceps, which was defined as the direct cooling condition. The 
participants left leg is receiving two melted PCM packs applied directly to the skin 
over the quadriceps which was defined as the indirect cooling condition (refer to 
chapter 4: section 4.2.2 for further clarification, and section 4.4 for an explanation for 
indirect cooling). In all other chapters, participants in the treatment group received 
two frozen PCM packs to each leg. 
 
3.6 Skin Temperature (Chapters 4, 6 & 7) 
Before application of PCM, in chapter 4, a thermistor probe programmed to acquire 
data at 1-minute intervals was taped directly to the surface of the skin over each of 
the thighs at approximately mid-femoral length (OMEGA Engineering, INC., 
Stamford, CT, USA). Before application of PCM, in chapters 6 and 7, a telemetric 
dermal patch skin temperature sensor sticker (VitalSense Dermal Patch, Respironics 
Inc., Murrysville, PA, USA) was applied directly to the surface of the skin over one 
thigh at approximately mid-femoral length. Data from the dermal patch was 
transmitted wirelessly to a data recorder found on the Sensor Electronics Module 
(SEM; Hidalgo Ltd, Cambridge, UK). The Respironics Sensor Electronics Module, 
and specifically the VitalSense dermal patch, are considered a valid and reliable tool 
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for the ambulatory monitoring of multiple physiological parameters such as skin 
temperature (Liu, Zhu, Wang, Ye, & Li, 2013). A reliability trial conducted before data 
collection revealed that the inter-day coefficient of variation (CV) for this protocol was 
2.7%. Quadriceps skin temperature was recorded continually for the entirety of the 
PCM application in chapters 4, 6, and 7.  
3.7 Compression Pressure (Chapters 4 & 7) 
Following application of PCM, compression of one leg was measured by a pressure 
measuring device (Kikuhime; TT, 160 Medi Trade, Søleddet, Denmark) by placing 
the pressure sensor between the PCM and the anterior surface of the thigh skin (mid-
point between the superior aspect of the patella and the inguinal crease). 
Compression was measured in both seated and standing positions. Measurements 
were repeated three times with the mean value recorded. The Kikuhime pressure-
measuring device has previously been validated for use with compression clothing 
(Brophy-Williams et al., 2014). A reliability trial conducted before data collection 
revealed that the inter-day CV for this protocol was 11.4%. Compression pressure 
was recorded following application of PCM in chapters 4 and 7. 
3.8 Strength: Maximal Isometric Voluntary Contraction 
[MIVC] (Chapters 4, 5 & 7) 
Strength of the knee extensors was assessed unilaterally on both legs. The strength 
testing was completed on one leg and then immediately repeated on the contralateral 
leg. Strength was determined using an isokinetic dynamometer (chapter 4: Biodex 
System 2; chapters 5, 7: Biodex System 3, Shirley, NY, USA) with a leg extension 
attachment. Participants were seated with the trunk at approximately 90° of flexion, 
and a joint angle equivalent to 90° knee flexion, as assessed by a goniometer within 
the Biodex software and verified visually using a generic level. The lateral femoral 
condyle was aligned to the centre of rotation of the dynamometer. Participants were 
positioned for testing knee flexion according to the Biodex Multi-Joint System 
Setup/Operation Manual. Extraneous movement of the upper body was limited by two 
harnesses across the chest and the abdomen.  
During the familiarisation session, participants completed the strength testing protocol 
twice. During the first run through of the strength testing protocol, participants were 
instructed to ‘apply pressure’ to the pad attached to the strap of the leg extension 
attachment but ‘not to hold the contraction’, in order to understand which direction 
they would be pushing in as well as to understand the timing of the breaks between 
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repetitions. This was repeated at each angle of knee flexion to be tested. During the 
second run through, the verbal cues were described to the participants and 
participants were asked to perform each isometric contraction at what they believed 
to be 50% of their maximal intensity for the full 5 seconds. 
At each knee flexion angle being assessed, the strength testing procedure included 
one repetition deemed the ‘warm-up’, followed by two maximum isometric voluntary 
contractions (MIVCs). For the warm-up, participants performed one isometric 
contraction of the knee extensors at a self-selected intensity, but not at what they 
believed at the time was their maximal intensity. After a 30 second rest period, this 
was followed by two MIVCs, held for 5 seconds each with rests of 15 seconds 
between each contraction. Participants were given strong, standardised verbal 
encouragement for the duration of each contraction. The average of the two peak 
force efforts at each joint angle was recorded as the measure of MIVC (units: Newton 
meters [Nm]) and used for data analysis. Reliability of the MIVC torque measurement 
is generally high (intraclass correlation coefficients ≥ 0.85; Abernethy, Wilson, & 
Logan, 1995; Kellis & Baltzopoulos, 1995). Howatson et al. (2009a) previously 
analysed the inter-day test-retest reliability of MIVC measured on a fixed isokinetic 
dynamometer over 5 days and found MIVC to be highly reliable (intra-class correlation 
coefficient = 0.99; CV = 1.0%). A reliability trial conducted before data collection 
revealed that the inter-day CV for this protocol was 7.5%. Measures of MIVC were 
completed in chapters 4, 5, and 7.  
3.9 Eccentric Muscle Damage Protocol (Chapters 4 & 7) 
The exercise protocol was performed on the same isokinetic dynamometer that was 
used to measure strength. The eccentric exercise protocol was always performed 
immediately following strength testing without adjusting any of the settings 
established prior to strength testing. The exercise protocol consisted of 120 eccentric 
quadriceps contractions with 60 seconds of rest between sets (chapter 4: 12 sets, 10 
repetitions; chapter 7: 10 sets, 12 repetitions). Target intensity was determined as 
90% of previously measured MIVC at 80° of knee flexion. The range of motion was 
5° (0° = full extension) to 95° knee flexion in chapter 4, and 40° to 100° knee flexion 
in chapter 7. Contractions were performed at 1.05 rad s−1 (60° s−1). Based on 
previous work (McHugh & Pasiakos, 2004; McHugh & Tetro, 2003), it was expected 
that an angular velocity of 1.05 rad s−1 was sufficiently slow enough to allow 
participants to produce the target torque accurately and would result in significant 
strength loss and soreness on subsequent days following exercise. The protocol was 
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immediately repeated on the contralateral leg. Both legs performed the eccentric 
exercise, one at a time, in order to increase the likelihood of elevating the 
inflammatory response (Margaritelis et al., 2015). During the familiarisation session, 
participants completed only two sets of the eccentric exercise protocol one time, and 
only at an intensity that allowed the participant to understand the motion necessary 
to perform the exercise (< 50& of participants expected MIVC). 
3.10 Muscle Soreness [DOMS] (Chapters 4, 5 & 7) 
Delayed onset of muscle soreness (DOMS) in the lower limbs was assessed by 
having participants perform a two-legged squat to 90° knee flexion and verbally report 
the discomfort level for each leg using a 0 to 10-point visual analogue scale (VAS; 
0=no discomfort, 10=too painful to squat to 90°). 
3.11 Blood Sampling and Analysis (Chapters 5 & 7) 
In chapters obtaining blood samples, blood was drawn by way of a finger prick. Blood 
samples were always performed prior to any activity being initiated by the participants. 
The fingertip was cleaned with 95% ethanol before an automatic lancet device was 
used to puncture the skin to draw capillary blood. The first drop of blood was removed 
to prevent possible contamination. A 30 μL sample of capillary blood was obtained 
using a 30 μL pipette (Microsafe Tubule, Safe-Tec Clinical Products, Pennsylvania, 
USA) for the enzymatic measurement of CK concentration. The sample was then 
immediately analysed (Reflotron® Plus System, Roche Diagnostics, Basel, 
Switzerland) using a CK test strip (Reflotron CK, Roche Diagnostics, Mannheim, 
Germany). A 10 μL sample was obtained in a 10 μL pipette for the immune-
chromatographic assay of hsCRP (Nano-Checker 710, Nano-Ditech Corporation, 
Cranbury, NJ, USA) using a hsCRP test strip (Nano-Check hs-CRP, Nano-Ditech 
Corporation, Cranbury, NJ, USA) and following the manufacturer's guidelines. The 
intra-sample coefficient of variation is 3.1% for the CK analyser (Horder et al., 1991), 
and a reliability trial conducted before data collection revealed that the inter-day CV 
for analysis of CK was 7.9%. The intra-sample coefficient of variation is 15% for 
hsCRP (Nano-Ditech Corporation, Cranbury, NJ, USA), and a reliability trial 
conducted before data collection revealed that the inter-day CV for analysis of hsCRP 
was 17.7%. Blood samples for determining the concentration of CK and hsCRP were 
drawn and recorded in chapters 5 and 7. 
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4.0 THE EFFICACY OF COOLING 
WITH PHASE CHANGE MATERIAL 
FOR THE TREATMENT OF 
EXERCISE-INDUCED MUSCLE 
DAMAGE: PILOT STUDY 
 
 
 
 
 
 
 
 
 
This chapter has been accepted for publication: 
Kwiecien SY, McHugh MP, Howatson G. (2018). The efficacy of cooling with phase 
change material for the treatment of exercise-induced muscle damage: pilot study. J 
Sports Sci. 36(4):407-413. 
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4.1 Introduction 
The deleterious effects of EIMD following a bout of unaccustomed exercise, 
particularly when the exercise is eccentric-based, are well documented (see section 
2.1.2). The magnitude and duration of the EIMD response can depend on the exercise 
mode, duration, and intensity of the exercise and is characterised by a reduction in 
strength and increased muscle soreness on the days after exercise (Clarkson & 
Newham, 1995; Miles & Clarkson, 1994). Timely recovery from these symptoms is 
therefore critical to maintain readiness to train and compete on subsequent sessions 
and days. 
Given that EIMD is a multifaceted process, an intervention strategy for its prevention 
does not yet exists. The alternative is to administer an intervention to effectively treat 
the symptoms of EIMD after they manifest in an attempt to reduce the extent of 
secondary muscle damage.  The most popular strategy used to facilitate recovery 
after exercise resulting in EIMD is cryotherapy (see section 2.2). Cryotherapy relates 
to the cooling of an area in the attempt to induce clinically relevant reductions in body 
temperature (see section 2.2.3). The reductions in skin, muscle, and core 
temperature associated with cryotherapy are purported to alleviate some of the 
physiologic and functional deficits associated with EIMD (see section 2.2.4). 
Ultimately the precise mechanisms through which cryotherapy might accelerate 
recovery following exercise are not well understood. Recently, using a contralateral 
cryotherapy model, Allan et al. (2017) demonstrated that administering cryotherapy 
to a single limb exerted adrenergic control, resulting in a systemic response evident 
in the untreated limb. This evidence established the basis for bilateral research 
designs with true control conditions when investigating the cold-induced post-
exercise response. 
The most popular cryotherapy strategy used to facilitate recovery after strenuous 
exercise resulting in EIMD is CWI (see section 2.2.5.3) because it offers a quick, 
simple, and if required, whole body intervention. Previously a moderate effect on 
soreness, and no effect on strength, with some benefit for power restoration has been 
demonstrated following CWI (Bleakley et al., 2012; Leeder et al., 2012; Versey et al., 
2013). Although the average immersion duration across studies was 12.5 ± 5.6 
minutes within a temperature range of 10-15°C (Bleakley et al., 2012), there remains 
great variability in the duration and temperature of immersion protocols (Bleakley et 
al., 2012; Leeder et al., 2012; Poppendieck et al., 2013; Versey et al., 2013), and no 
consensus for optimal treatment criteria. Ultimately CWI is limited by its treatment 
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duration as it can only be applied for short periods due to contraindications from 
spending extended periods immersed in cold water, athlete tolerance to the 
intervention and logistical issues surrounding delivering such an intervention in 
applied scenarios. 
To date, following exercise, prolonging the duration of cryotherapy has only been 
achieved through repeated exposures (Skurvydas et al., 2006). A cryotherapy 
modality capable of delivering cooling for one period of a prolonged duration might 
overcome the limitations associated with other cryotherapy modalities outlined in 
section 2.2. The duration of cryotherapy application can be prolonged using PCM 
because PCM has the capability to maintain a constant temperature for a prolonged 
duration (see section 2.2.5.4). Conceptually, the recovery process could be enhanced 
using PCM given that the cold application time would be longer than conventional 
cryotherapy methods, like CWI, allowing for cooler temperatures to be maintained for 
a longer period. When applied to exercise paradigms, several studies have reported 
that PCM with a melting point ≥0°C administered to the core in the form of a vest 
resulted in a reduction in core temperature (Tate et al., 2008) and skin temperature 
(Barwood et al., 2009; Brade et al., 2010; Purvis & Cable, 2000), compared to control 
conditions. However, the local application of PCM set to melt at 15°C in an exercise 
recovery paradigm has not been investigated.  
As a first step to understanding the potential of prolonging the duration of cooling this 
chapter aimed to establish the efficacy of 6 consecutive hours of PCM cooling, while 
being mindful of the evidence that implicates a systemic response from unilateral 
cryotherapy treatment (Allan et al., 2017), by administering direct- and indirect- PCM 
cooling to a single muscle group as compared to control in the recovery from EIMD. 
Consequently, the purpose of this pilot study was to establish the efficacy of a novel 
cooling strategy (15°C PCM) as a recovery intervention following a bout of isolated 
eccentric exercise. The overall aim of this thesis is to investigate the efficacy of PCM, 
capable of prolonging the duration of cryotherapy exposure, as an alternative 
cryotherapy modality for accelerating recovery following strenuous exercise. 
Therefore the findings of this chapter will address the specific aim of this thesis by 
establishing whether prolonging the duration of cooling is capable of accelerating 
recovery of indices associated with EIMD induced through mechanical stress. The 
findings might also provide further evidence as to whether local unilateral cooling 
exhibits a similar systemic effect as was evident in the model implemented by Allan 
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et al. (2017). It was hypothesised that prolonged PCM cooling would alleviate strength 
loss and soreness on the days following the eccentric exercise. 
4.2 Methods 
4.2.1 Participants 
A power calculation was conducted to determine an adequate sample size for this 
investigation. Using the findings of previous work documenting strength loss and pain 
following similar bouts of eccentric exercise of the quadriceps (McHugh & Pasiakos, 
2004; McHugh & Tetro, 2003) and hamstrings (McHugh & Nesse, 2008), it was 
estimated that in order to detect significant changes strength loss would average 20% 
over the 3 days after exercise in the control leg. Thus, it was estimated that there 
would be 80% power to detect a 14% difference in strength loss between treatments 
at an alpha level of 0.05 with a total of 12 participants. 
Consequently, six males and two females (mean ± SD; age, 37 ± 12 years; height, 
177.1 ± 9.3 cm; body mass, 76.4 ± 9.7 kg) volunteered to participate. Participant 
recruitment was based on the details described in section 3.2 and the exclusion 
criteria described in section 3.3. Participants adhered to the controls described in 
section 3.4 throughout the duration of data collection. The institutional research ethics 
committee, in line with the Declaration of Helsinki, approved all procedures.  
4.2.2 Experimental design 
Participants reported to the laboratory for a total of six days; one familiarisation 
session, one baseline testing session which included the eccentric exercise protocol, 
and four consecutive days following the exercise to assess quadriceps strength and 
muscle soreness. On the first visit, participants were familiarised with all testing 
procedures. Familiarisation occurred 7 days prior to baseline testing. On the day of 
baseline testing, participants had their quadriceps strength, and soreness assessed 
of both limbs prior to performing an eccentric exercise protocol of the knee extensors. 
The same examiner conducted the tests of MIVC and the exercise protocol, using 
standardised verbal commands to ensure consistency. Participants were randomised 
in a counterbalanced order to initiate the eccentric exercise on either the dominant or 
non-dominant leg. The exercise protocol was immediately followed by the application 
of frozen (direct cooling) PCM to the quadriceps of one leg and room temperature 
(indirect cooling) PCM to the other leg (see section 4.2.3). Five months later the 
participants returned to the laboratory and the protocol was repeated bilaterally with 
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room temperature PCM applied to both legs. The 5-month delay was implemented in 
order to ensure that the RBE did not impact the damage response (Nosaka, Newton, 
& Sacco, 2005). Strength and soreness values for the control treatment were 
averaged across both legs. The experimental design is summarised in Figure 8. 
 
 
 
Figure 8: Schematic representation of the experimental protocol on both legs 
showing the sequence of events from baseline strength measures, to the eccentric 
exercise, to frozen PCM application on one leg (direct cooling) and room temperature 
PCM on the contralateral leg (indirect ‘systemic’ cooling), to strength and soreness 
assessments for 4 days after the isolated quadriceps eccentric exercise; followed by 
repeating the protocol with melted PCM on both legs (control) 5 months later. This 
was followed by a 5-month break to remove the effect of the RBE. The experimental 
protocol was then repeated with room temperature PCM applied to both legs after 
eccentric exercise (control). 
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4.2.3 Phase Change Material Application 
Upon initial completion of the eccentric exercise protocol, participants immediately 
applied frozen 15°C PCM to the quadriceps of one leg (direct cooling), and room 
temperature PCM to the other leg (indirect cooling) for a total of 6 hours. The direct 
cooling frozen (15°C) PCM was always applied to the limb that completed the 
exercise protocol second in order to minimize the time between exercise cessation 
and the direct cooling treatment condition. Upon completion of the exercise protocol 
5 months later, participants applied room temperature PCM to both legs (control) for 
a total of 6 hours. Thus, there were three treatments: leg directly treated with 15°C 
PCM packs (defined as direct cooling), leg receiving indirect cooling treated with room 
temperature PCM packs (defined as indirect ‘systemic’ cooling) contralateral to the 
leg receiving 15°C PCM packs, and legs tested 5 months later and both treated with 
room temperature PCM packs (defined as control). For complete PCM application 
procedures, please refer to section 3.5 and Figure 7. 
4.2.4 Strength Assessment 
Strength was tested at each of 30°, 50° and 70° knee flexion. For complete strength 
testing procedures, please refer to section 3.8.  
4.2.5 Eccentric Exercise Protocol 
The eccentric exercise protocol consisted of 120 eccentric quadriceps contractions 
(12 sets, 10 repetitions), with the range of motion set at 5° (0° = full extension) to 95° 
knee flexion. For thorough detail of the eccentric exercise protocol, please refer to 
section 3.9.  
4.2.6 Soreness Assessment 
For procedures to assess muscle soreness, please refer to section 3.10.  
4.2.7 Skin Temperature  
For procedures to assess skin temperature, please refer to section 3.6.  
4.2.8 Statistical Analysis  
All data are presented as mean ± SD. Strength at each of the three test angles was 
expressed as a percentage of pre-exercise strength to remove the effect of inter-
individual variation in knee extension strength. Strength prior to the initial eccentric 
exercise bout was compared to strength prior to the eccentric exercise performed 5 
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months later to ensure there was no systematic change over time that might have 
affected susceptibility to EIMD. The effect of PCM cooling on strength loss on the 
days after eccentric exercise was assessed using 3 × 3 × 4 treatment by angle by 
time repeated measures analyses of variance (ANOVA). The three levels for the 
treatment factor were direct cooling, indirect cooling and control. The three levels for 
the angle factor were 30°, 50° and 70° knee flexion. The four levels for the time factor 
were day 1, day 2, day 3, and day 4 after the eccentric exercise. The effect of PCM 
cooling on soreness on the days after eccentric exercise was assessed using 3 × 4 
treatment by time repeated measures ANOVA. Since it was possible that cooling one 
leg might have affected the damage response in the contralateral leg, it was 
hypothesised that the magnitude of strength loss and soreness for the indirect cooling 
treatment would lie between the responses for the direct cooling and control 
treatments. Therefore, the linear contrast for the treatment effects was reported in 
addition to the main treatment effect as recommended by Atkinson (2002). The 
average skin temperature during the 6 hour PCM treatment was compared between 
treatments using a repeated measures ANOVA.  
Normality of all data sets was examined using the Shapiro-Wilk test. Mauchly’s test 
was used to assess assumptions of sphericity and, where necessary, Greenhouse–
Geisser corrections were used. Significant interactions of temperature, soreness or 
strength loss between the three treatments were followed up using Fisher’s least 
significant difference test for pairwise comparisons. Where appropriate, Cohen’s d 
ES were calculated to provide magnitude of effects; with the magnitude of effects 
considered either small (0.20-0.49), medium (0.50-0.79), and large (>0.80; Durlak, 
2009). The upper and lower limit of 95% confidence intervals (CI) for least significant 
difference are reported where relevant. Statistical analyses were performed using 
SPSS v.21 (IBM, Armonk, NY, USA) and a P-value of less than 0.05 was considered 
statistically significant.  
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4.3 Results 
4.3.1 Skin Temperature 
There was no drift in temperature over the 6 hour cooling period. There was a 
treatment effect for skin temperature (Table 1; F = 280.5, P < 0.0001, ES = 13.66, 
direct cooling CI: 21-23°C, indirect cooling CI: 30-32°C, control CI: 30-32°C).  
 
Table 1: Average skin temperature over 6 hours and temperature at hour 6 post-
exercise intervention for each treatment condition. Values are mean ± SD. 
 6 Hour Average (°C) Temperature @ 6 Hours (°C) 
Direct Cooling 21.9 ± 1.0 21.7 ± 0.7 
Indirect Cooling 31.7 ± 1.4 31.2 ± 1.4 
Control 31.3 ± 1.3 31.3 ± 1.8 
 
 
4.3.2 Strength  
Average quadriceps strength expressed as a percentage change from baseline for 
the 4 days following the exercise intervention showed a main effect of time (F = 7.0, 
P = 0.017, ES = 1.99; Figure 9), indicating the presence of muscle damage following 
the isolated eccentric exercise. Overall recovery of MIVC was independent of 
treatment with no group (P = 0.089) or interaction effect observed (P = 0.645). 
However, the overall treatment effect showed a significant linear trend (F = 26.1, P = 
0.018, ES = 3.86); indicating a quicker reduction in the force loss in the direct cooling 
PCM treatment group vs the control group (F = 9.4, P = 0.018, ES = 2.32, direct 
cooling CI: 94.9-107.3%, control CI: 86.4-98.7%), but not vs the indirect cooling group 
(P = 0.086). Over time, the treatment effect was not different between test angles (P 
= 0.589) with no interaction effect observed (P = 0.537). Additionally, strength loss 
(averaged across all treatments) was not different between test angles (P = 0.272). 
Although there was a significant angle*time interaction (F = 3.5, P = 0.006, ES = 1.42) 
because strength at 30° appeared to be less than strength at 50 and 70° on day 3, 
post hoc analysis revealed these differences were not significant (P = 0.282). 
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Figure 9: Isometric strength loss of the quadriceps (averaged across all three test 
angles and presented as a percentage change from baseline strength loss) at 
baseline and over the 4 days following the isolated quadriceps eccentric exercise in 
the direct cooling, indirect cooling and control conditions. Values are mean ± SD. 
Strength was reduced over the 4 days following exercise (P = 0.017), with a significant 
linear treatment effect (P = 0.018) indicating accelerated recovery of strength in the 
direct cooling PCM treatment group vs the control group.  
 
Baseline knee extension strength in the direct and indirect cooling legs was well 
reproduced 5 months later (Table 2; treatment effect: P = 0.475; direct cooling vs 
control: P = 0.854; indirect cooling vs control: P = 0.994). At baseline, there was a 
significant main angle effect (F = 117.8, P < 0.0001, ES = 8.21); peak knee extension 
strength occurred at 70° (281 ± 69 Nm) with lower torques at 50° (230 ± 58 Nm; F = 
67.7, P < 0.0001, ES = 6.21) and 30° (162 ± 44 Nm; F = 125.2, P < 0.0001, ES = 
8.45), but this was not different between treatments (P = 0.475). Average torque 
during the eccentric exercise was not different between the direct cooling (241 ± 53 
Nm), indirect cooling (240 ± 52 Nm) and control conditions (251 ± 41 Nm; P = 0.165) 
conditions. Net torque data for each day of data collection are presented in Table 2 
to demonstrate the return of function following the exercise protocol. 
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Table 2: Isometric strength (MIVC) of the quadriceps averaged across all 3 test 
angles for each treatment (direct cooling, indirect cooling, control) reported as net 
torque values (Nm) on each day after eccentric exercise. Values are mean ± SD. 
 
 Direct Cooling (Nm) Indirect Cooling (Nm) Control (Nm) 
Baseline 220 ± 60 228 ± 60 223 ± 51 
Day 1 205 ± 67 197 ± 46 189 ± 54 
Day 2 223 ± 64 212 ± 61 208 ± 57 
Day 3 228 ± 62 216 ± 58 213 ± 54 
Day 4 226 ± 62 214 ± 50 220 ± 64 
Time Effect P < 0.0001 P = 0.113 P = 0.157 
 
4.3.3 Soreness 
Soreness was elevated following the eccentric exercise (F = 24.9, P < 0.0001, ES = 
3.78), but recovery of soreness was independent of treatment with no group (P = 
0.071) or interaction effect observed (P = 0.245). However, the overall treatment 
effect showed a significant linear trend for soreness (F = 7.5, P = 0.029, ES = 2.07; 
Figure 10); indicating a more rapid recovery of soreness in the direct cooling PCM 
treatment group vs the control group (F = 7.5, P = 0.029, ES = 2.07, direct cooling CI: 
0.025-1.6, control CI: 1.3-2.3), but not vs the indirect cooling group (P = 0.116). 
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Figure 10: Subjective reports of quadriceps soreness on a 0-10 visual analogue scale 
(VAS; 0 = no discomfort, 10 = too painful to squat to 90°) in the direct cooling, indirect 
cooling and control conditions at baseline and over the 4 days following the isolated 
quadriceps eccentric exercise. Values are mean ± SD. Soreness was increased 
following the exercise in all treatment groups (P < 0.0001). However, a significant 
linear treatment effect was evident (P = 0.029) indicating a more rapid recovery of 
soreness in the direct cooling PCM treatment group vs the control group.  
 
4.4 Discussion 
The primary purpose of this study was to test the efficacy of PCM cooling for 
improving recovery from exercise resulting in EIMD, in order to establish a proof of 
concept for future studies. The present study was the first to administer a single 
cryotherapy treatment for a prolonged duration. The results indicate that 6 hours of 
continuous direct cooling using 15°C PCM mitigated strength loss and soreness on 
the days following the eccentric exercise compared with a control condition. Despite 
greater reductions in quadriceps strength loss and muscle soreness in the direct 
cooling condition, no significant differences in the magnitude of effect on strength and 
soreness were observed between direct and indirect cooling conditions. However, the 
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strength and soreness values for the indirect cooling condition fell between the direct 
cooling and control conditions, and there was a significant linear trend for both 
strength and soreness. These findings suggest that the direct application of PCM 
cooling to one leg will systemically influence the contralateral limb receiving no 
cooling (indirect cooling). 
This is the first study to have successfully administered a local cryotherapy modality 
for a prolonged duration. Previously, the longest total treatment duration included in 
the systematic review by Bleakley et al. (2012) involved a total treatment duration of 
120 minutes (2 x 15-minute immersions in 15°C separated by 10 minutes, performed 
immediately post-exercise, and repeated at 4, 8 and 24 hours; Skurvydas et al., 
2006). Skurvydas et al. (2006) demonstrated beneficial effects from CWI vs control 
for recovery of both soreness and strength on the days after performing 100 drop 
jumps. Their findings support the need for an increased cryotherapy duration in order 
to improve effectiveness on indices of recovery. However, the practicality of delivering 
multiple repeat CWI treatments in the initial 24 hour window after exercise can be 
challenging. By contrast, the present study demonstrated that wearing a pair of shorts 
fitted with PCM packs successfully provided a prolonged duration of targeted cooling 
while accelerating recovery of strength and soreness on the days following eccentric 
exercise. Thus, PCM cooling might be a practical alternative to other forms of 
cryotherapy. 
The intended purpose of a prolonged period of PCM cooling was to intervene during 
the period of injury proliferation. The benefits of cryotherapy for accelerating recovery 
after EIMD are purported to be due to a reduction in temperature at the muscle 
susceptible to secondary damage, which might lower metabolic demand and limit the 
proliferation of muscle damage following exercise (see section 2.2.4 for review). In 
the present study, the application of 15°C PCM to the quadriceps reduced skin 
temperature to 22°C for the entire treatment duration. By comparison, post-exercise 
CWI at 10°C for 20 minutes reduced skin temperature to 22°C immediately upon 
cessation of immersion (Minett et al., 2014). In the same study the CWI intervention 
hastened the recovery of MIVC 24 hours post‐exercise compared to control. Thus it 
is possible that reducing skin temperature for the 6 hours of cooling in the present 
study limited the proliferation of EIMD to a greater degree compared with 20 minutes 
of immersion in the Minett et al. (2014) study. Similarly, Mawhinney et al. (2013) 
immersed athletes in 8 or 10°C water for 10 minutes post-exercise. The reduction in 
skin temperature upon cessation of immersion, taken halfway between the two 
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immersion conditions, was ~23°C in their study. The authors also measured femoral 
artery blood flow (duplex ultrasound) and concluded that no differences were 
observed between cooling conditions in terms of the magnitude of effect on blood 
flow. Hence they concluded that the effectiveness of cryotherapy in the treatment of 
EIMD is dependent on its ability to reduce muscle temperature and not muscle blood 
flow. Although it cannot be inferred directly in the present chapter, reduced skin 
temperature during cryotherapy treatment might reflect reduced blood flow within the 
limb (Ihsan et al., 2013). Thus it is possible that the reduction in skin temperature in 
the present study might have translated to a reduction in blood flow, but ultimately the 
mechanisms through which PCM mitigated EIMD are likely related to the prolonged 
reduction in temperature of the exercised limb.   
In the present study, the findings for the direct PCM cooling condition, that strength 
over the 4 days after eccentric exercise averaged 101% of baseline and soreness 
averaged 1.0 on a 10-point scale, indicate that direct PCM cooling minimised the 
extent of muscle damage. Importantly, although not significant, there was an overall 
trend for a significant main effect of treatment on both strength loss (P = 0.089) and 
soreness (P = 0.071). Furthermore, there was a significant linear trend for both 
strength and soreness and the corresponding strength and soreness values were 
94% and 93% for strength and 1.7 and 2.3 for soreness, respectively, for the 
contralateral leg (indirect cooling) and control (5 months later) treatments. These 
results support the findings of Allan et al. (2017), who implemented a contralateral 
CWI study design, immersing only one leg, and demonstrated that a systemic 
response was evident in the skeletal muscle of the non-immersed limb. Similarly, 
Wolf, (1971) previously suggested that a centrally induced effect occurs as evident 
by a decrease in the intramuscular temperature of the contralateral extremity after 
cooling the ipsilateral side to 10°C for 15 min. The contralateral design of the present 
study allowed us to assess the potential systemic impact of the direct PCM cooling 
leg on the indirect cooling leg. However, this design overlooked the possibility of the 
RBE in the control condition when the exercise was repeated 5 months later. 
Ultimately the use of the control treatment was not a limitation as symptoms of EIMD 
are consistent within participants when a damage protocol was repeated a few 
months later (Nosaka et al., 2005).  
A recent meta-analysis indicated that compression garments worn for recovery 
purposes can facilitate the return of strength and power following exercise (Hill, 
Howatson, van Someren, Leeder, & Pedlar, 2014b). Since this study has indicated 
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potential efficacy, the lack of measurement of compression in this study was a 
confounding factor. Although the same shorts fitted with PCM packs were worn on all 
test occasions, in the initial session, the direct cooling condition required the PCM to 
be frozen while the indirect cooling condition required the PCM to be melted. This 
difference between the frozen and melted state could have affected the degree of 
compression on the thigh. In order to determine the effect of compression during PCM 
application, chapter 7 will utilise a pressure monitoring device to measure the degree 
of pressure exerted by the garments. Additionally, in the present study, room 
temperature PCM was not applied to the leg receiving indirect cooling until the direct 
cooling leg completed the eccentric exercise. Thus, the direct cooling leg received 
PCM treatment and compression immediately after the eccentric exercise while the 
indirect cooling leg did not receive compression until approximately 35 minutes 
following exercise. The possibility that this delay in the application of compression 
affected subsequent symptoms was assessed by comparing strength loss and 
soreness between both legs after the control session (5 months later). In the control 
session, when room temperature PCM packs were applied to both thighs, the 
application of compression shorts was also delayed by 30 to 40 minutes in one leg 
compared with the contralateral leg. However, there was no difference in soreness (P 
= 0.227) or strength loss (P = 0.787) between legs on the days after the eccentric 
exercise in the control condition. Hence, the delay in the application of compression 
caused by the study design was not a confounding factor.  
While the present study sets the stage for larger studies on the potential benefit of 
PCM cooling, it was not without limitations. Firstly, although a sample of eight 
participants was sufficient to indicate a benefit of PCM in accelerating recovery of 
strength and soreness, there was insufficient power to detect a difference between 
the control and indirect cooling treatments. Hence the sample size was insufficient to 
determine whether the direct PCM cooling condition caused a systemic effect in the 
indirect cooling limb and it was not possible to conclude whether direct cooling to one 
leg had a systemic effect in the contralateral leg; but the treatment effect on strength 
and soreness evident in the indirect cooling group indicates that this was a possibility. 
Secondly, quadriceps strength in the present study was measured at 30, 50, and 70°, 
since peak knee extension torque occurs at around 70°, with lower values occurring 
at 50° and 30°. In the present study, strength loss was not different between 70°, 50° 
and 30° (P = 0.272), and the effect of PCM cooling on strength loss was not different 
between test angles (P = 0.537). However, Child, Saxton, & Donnelly, (1998) had 
previously demonstrated greater strength loss at short muscle lengths (20° compared 
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with 100°) after 75 maximal eccentric contractions of the knee extensors. Lower knee 
extension strength has also been demonstrated at 110° (McHugh & Tetro, 2003). 
Therefore, strength measures at angles less than 30° or greater than 100° may be 
necessary to see a clear effect of muscle length on strength loss following eccentric 
exercise. Thirdly, familiarisation is established as being a potential contributing 
source of error to the testing of muscle function. Despite the participants being 
familiarised to the strength testing protocol in the present study, it was possible that 
participants could have experienced improvements in their baseline strength between 
the initial treatments and the control data collection periods. However, this was not 
the case as strength prior to the initial eccentric exercise bout was compared to 
strength prior to the eccentric exercise performed 5 months later, and there was no 
difference in absolute baseline strength values between exercise sessions. Finally, 
since both males and females were included, the group was not fully homogenous. 
In order to address these limitations, the subsequent chapter will aim to establish the 
efficacy of PCM cooling in a larger sample of participants, with a between-groups 
design to negate the potential confounding influence of a systemic effect.  
This study demonstrated that direct PCM cooling was effective in accelerating 
recovery of soreness and strength in a single muscle group EIMD model of 
mechanical nature. The results further indicate that 6 hours of direct PCM cooling was 
well tolerated and that the prolonged PCM cooling duration was a practical and 
portable cryotherapy method. However, the mechanisms through which PCM might 
mitigate EIMD were not examined in the present study and the results cannot be 
directly applied to a metabolic stress model or to a training environment where 
multiple muscle groups are stressed. In this regard, the chapter 5 will administer 
cryotherapy following the completion of a marathon run. 
4.5 Conclusion 
This was the first examination of the prolonged application of PCM as a recovery 
modality from the signs and symptoms of EIMD. These data suggest that direct PCM 
cooling accelerated recovery of muscle function after EIMD of mechanical nature and 
reduced the soreness associated with muscle damage. These data also indirectly 
provided some evidence to support cryotherapy exhibiting both local and systemic 
effects; however, further direct evidence is required to support this finding. In 
conclusion, the data from the current study provide evidence that PCM can be utilised 
effectively as a recovery modality following eccentric exercise understood to elicit 
mechanical stress of the muscle. Given this evidence, and the practical utility of a 
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wearable garment to deliver prolonged cooling to muscles following exercise, a larger 
study to address the effect of PCM cooling on additional markers of EIMD in a larger 
sample, encompassing a between participant’s design and using a passive recovery 
control group will be conducted in the subsequent chapters. 
4.6 Perspectives 
This chapter aimed to establish the efficacy of cooling the quadriceps for a prolonged 
duration (6 hours) using PCM following eccentric exercise performed by the 
quadriceps involving high mechanical stress. This chapter administered direct PCM 
cooling to the quadriceps of one leg, while a placebo condition of room temperature 
PCM were simultaneously applied to the contralateral leg during the 6 hour recovery 
period. Since following the initial exercise session it became apparent that the 
placebo condition might have benefited from a systemic effect of cooling, the study 
protocol was repeated 5 months later, and both legs received the control condition. 
Thus, recovery of strength and soreness were assessed following application of the 
3 treatment conditions identified as: direct cooling, indirect cooling, and control. In this 
chapter, prolonging the duration of cooling using PCM effectively accelerated 
recovery of strength loss and soreness in the quadriceps compared to control. 
Importantly, the prolonged duration of cooling in this study was well tolerated by all 
participants, and no adverse events were reported. These findings addressed the first 
aim of the thesis, which was to establish the efficacy of PCM as an alternative 
cryotherapy intervention for recovery from EIMD.  
This study supports the findings of previous investigations that utilised CWI to 
successfully reduce muscle soreness following exercise (see section 2.2.5.3.2 for 
review). However, unlike previous work investigating the effects of cryotherapy on the 
recovery of strength that generally have failed to demonstrate a beneficial effect (see 
section 2.2.5.3.3 for review), this study demonstrated that prolonged PCM cooling 
was effective in accelerating recovery of muscle strength following exercise of 
mechanical nature. Although this chapter demonstrated that recovery of both strength 
and soreness were accelerated by PCM treatment following exercise of mechanical 
nature, these findings must be investigated in an EIMD model induced primarily by 
metabolic stress. Especially since it has been proposed that CWI may be more 
effective for recovery from metabolically stressful exercise, as opposed to 
mechanically stressful exercise (Ihsan et al., 2016; Leeder et al., 2012). Thus, chapter 
5 will administer 3 hours of PCM cooling to both quadriceps in the treatment condition 
following a marathon run. 
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Interestingly, the findings of the present chapter indicate that local PCM application 
might have acted systemically in the contralateral limb since the soreness and 
strength loss reported for the direct cooling and indirect cooling conditions were not 
different. Since the results of this chapter indicate that direct cooling one leg might 
have influenced the recovery of strength and soreness of the contralateral leg (indirect 
cooling), chapter 6 will aim to establish the degree of temperature reduction achieved 
in the muscle and within the core of the body from 3 hours of PCM cooling, in order 
to ascertain whether the response observed in the limb contralateral to the direct 
cooling was indeed a true systemic effect.  
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5.0 THE EFFICACY OF 
PROLONGED PHASE CHANGE 
MATERIAL COOLING FOR 
ENHANCING RECOVERY 
FOLLOWING MARATHON 
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5.1 Introduction 
Although muscle damage can be induced by either mechanical or metabolic stress 
(Tee et al., 2007), the events occurring during exercise with a large metabolic 
component such as a marathon differ from those occurring from exercise 
encompassing primarily mechanical components such as the isolated eccentric 
exercise performed in chapter 4. The processes occurring during and following a 
marathon are multifactorial relating to not only peripheral factors within the skeletal 
muscles associated with EIMD, but also an increase in the magnitude of thermal load 
(Deschenes et al., 1998; Mortensen et al., 2008), as well as central nervous system 
fatigue (Petersen et al., 2007). Functional performance, strength loss, soreness, 
muscle damage, inflammation and oxidative stress have all been reported following 
marathon length runs (Davies & Thompson, 1986; Kratz et al., 2002; Maron et al., 
1977; Millet et al., 2002, 2003; Nicol et al., 1991; Petersen et al., 2007; Place et al., 
2004; Starkie et al., 2001; Suzuki et al., 2003). These symptoms can persist for 
extended periods following a marathon even in experienced runners (Maron et al., 
1977; Petersen et al., 2007). Indeed, following a marathon, the repair of focal muscle 
fibre damage has been reported to take up to 8 weeks (Warhol et al., 1985). As a 
result, marathon runners have turned to a range of recovery strategies to mitigate 
their symptoms after training and competitive runs in an attempt to speed up the 
regenerative process. Some popular strategies include cryotherapy (Wilson et al., 
2018), compression garments (Hill et al., 2014a), or nutritional interventions (Clifford 
et al., 2016; Howatson et al., 2010).  
Cryotherapy interventions, used to mitigate symptoms of EIMD and to accelerate 
recovery, have become increasingly popular amongst athletes. One of the most 
popular cryotherapy modalities among athletes is CWI (see section 2.2.5.3). 
However, it has recently been suggested that the efficacy of CWI for attenuating the 
effects associated with EIMD might be dependent on the mode of exercise utilised. 
In a review of the literature, CWI was found to be more effective in ameliorating effects 
of EIMD induced by metabolically stressful whole body exercise, such as prolonged 
running, than following mechanically stressful single joint exercise, such as high 
intensity isolated eccentric contractions (Ihsan et al., 2016). Similarly, in a meta-
analysis Leeder et al. (2011) determined that CWI was effective in alleviating 
soreness at 24 and 48 hours after high intensity whole body exercise but only 
moderately effective at 48 hours following isolated eccentric exercise. Thus, CWI may 
be more successful in accelerating recovery following a marathon than following 
isolated eccentric exercise.  
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Unfortunately, the only study to have previously investigated the effectiveness of 
cryotherapy for recovery from a marathon concluded that cryotherapy was no more 
effective than a placebo intervention at improving functional recovery or perceptions 
of training stress (Wilson et al., 2018). The authors administered a CWI protocol of 
8°C for 10 minutes immediately following completion of the marathon run. It is likely 
that this duration of immersion did not sufficiently reduce muscle temperature for a 
period long enough to diminish the extensive secondary phase of muscle damage 
that occurs following a marathon run. Indeed, in studies administering one continuous 
immersion, the average immersion duration was 12.6 minutes at a mean temperature 
of 13°C (Bleakley et al., 2010; Versey, Halson, & Dawson, 2013). Although an optimal 
dose for cryotherapy application has yet to be established, Vromans, Thorpe, Viroux, 
& Tiemessen (2019) have recently suggested that the most optimal dose-response 
relationship for CWI protocols using full-body immersion occurs when a minimum 
CWI dose of 1.1 is applied. This corresponds with an immersion duration of 11 
minutes in a water temperature of 10°C. Unfortunately their study did not account for 
any differences in the elevated thermal load that occurs from prolonged endurance 
exercise, as opposed to the relatively smaller overall thermal load occurring during 
resistance exercise. Therefore, it seems counterintuitive to expect a recovery 
intervention, administered for only 13 minutes following a marathon run lasting on 
average 4 hours, to have significant effects on the signs and symptoms associated 
with EIMD resulting from an exercise of such magnitude. Increasing the cryotherapy 
dose following endurance exercise, to account for elevations in muscle and core 
temperature, might be necessary for the cryotherapy modality to elicit a similar 
response following endurance exercise than following resistance exercise. 
A longer duration of cooling can be safely achieved by using PCM packs that freeze 
at 15°C (see section 2.2.5.4). The efficacy of 6 hours of PCM cooling for recovery of 
strength and soreness following eccentric exercise was demonstrated in chapter 4. 
Whilst 3 hours of PCM cooling has also been shown to accelerate recovery of strength 
(Brownstein et al., 2019; Clifford et al., 2018) and soreness (Clifford et al., 2018) 
following soccer match play. Although the previous chapter demonstrated that PCM 
was capable of accelerating recovery following isolated eccentric exercise, it remains 
unknown whether PCM will do the same following exercise with a large metabolic 
component. As the overall aim of this thesis is to determine the efficacy of prolonged 
PCM cooling for recovery from exercise, this chapter examined the effects of 
prolonged PCM cooling on recovery of strength, soreness, functional performance, 
and blood markers of muscle damage (CK) and inflammation (hsCRP) following the 
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completion of a marathon run. It was hypothesized that 3 hours of prolonged PCM 
cooling would accelerate recovery of strength loss, soreness, CMJ height, and blood 
markers of muscle damage and inflammation on the days following the marathon run. 
Therefore, this chapter will contribute to the overall aims of this thesis by providing 
insight into the efficacy of prolonged PCM cooling following exercise with a major 
metabolic component. The results of this chapter will be contrasted and compared 
with the results of the previous chapter to determine whether PCM cooling is similarly 
effective for accelerating recovery following exercise of both metabolic and 
mechanical nature. 
5.2 Methods 
5.2.1 Participants 
A power calculation was conducted based on the available literature on marathon 
running to determine an adequate sample size for this study. Estimates were made 
of the expected change, and the inter-subject variation in change for each marker of 
muscle damage (Howatson et al., 2010; Duthie et al., 1990; Kratz et al., 2002; Suzuki 
et al., 2003; Smith et al., 2004). Assuming that the control group would have the 
expected responses, estimates were made on how much lower that response would 
need to be in the PCM treatment group. Thus, it was estimated that there would be 
80% power to detect a 10% difference in strength loss between treatments (SD: 8.0%, 
based on % change from baseline data for muscle damage) at an alpha level of 0.05 
using a one-sided t-test with a total of 15 participants per group. 
As such, thirty healthy volunteers, 11 male and 19 female, participated in the study 
(mean ± SD; age, 34 ± 8 years; height, 169.4 ± 10.7 cm; body mass, 68.1 ± 12.9 kg). 
Participants were runners with varying degrees of marathon experience (number of 
previous marathons: 5 ± 6) whose expected completion times were 4:10 ± 0:42 hours. 
Female participants verbally confirmed that they were premenopausal. In the 5 days 
prior to the marathon run, and for the duration of the study, participants adhered to 
the controls described in section 3.4. The institutional research ethics committee, in 
line with the Declaration of Helsinki, approved all procedures.  
5.2.2 Experimental Design 
Participants reported to the laboratory for a total of four days. On the first day of data 
collection (baseline testing) participants completed an elite performance readiness 
questionnaire, before being randomly assigned into either the PCM treatment group 
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(n = 15; 6 male, 9 female) or the control group (n = 15; 5 male, 10 female). Participants 
were paired and equally assigned to either group based upon both predicted finish 
time and sex in a pseudorandomised fashion, in an attempt to account for possible 
sex differences in response to marathon running. Participants were then familiarised 
with all of the testing procedures prior to baseline data collection of all dependent 
variables. Measurements of all outcome variables were also recorded one, two and 
three days following completion of the marathon run. The following marathons were 
completed by study participants: New York City (n = 26), Philadelphia (n = 1), 
Brooklyn (n = 1), London (n = 1), and Cape Cod (n = 1). All marathons were road 
routes. The terrains for these marathons were similar with the courses being 38-43% 
downhill and 37-41% uphill, with a total elevation of 894.5 ± 281.4 feet. Participants 
ran at a self-selected pace, and were allowed to consume fluids, electrolytes and/or 
food ad libitum during the marathon but were asked to avoid consuming any 
supplements containing BCAAs, protein, antioxidants or caffeine. 
5.2.3 Phase Change Material Application 
Participants in the PCM treatment group wore the frozen (15°C) PCM over the 
quadriceps of both legs for a total of 3 hours. Participants receiving PCM treatment 
began the intervention within 1:20 ± 0:34 hours of finishing the marathon. For 
complete PCM application procedures, please refer to section 3.5.  
5.2.4 Strength Assessment 
Strength was tested at 80° knee flexion. For complete strength testing procedures, 
please refer to section 3.8.  
5.2.5 Soreness Assessment 
For procedures to assess muscle soreness, please refer to section 3.10.  
5.2.6 Countermovement Jump  
Countermovement jumps were performed using the Optojump optoelectric system 
(Bolzano, Italy). This optical measurement system is considered a valid and reliable 
tool to evaluate CMJ performance (Glatthorn et al., 2011). A reliability trial conducted 
before data collection revealed that the inter-day CV for this protocol was 3.6%. Prior 
to data collection, participants were given an unlimited number of trial sessions to be 
performed at ~50% maximal effort, until their jumping technique was performed 
correctly according to the following instructions. Participants started the movement 
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upright with their hands fixed to their hips and after a verbal cue, descended into a 
self-selected squat position prior to performing a maximal effort vertical jump. 
Participants were instructed to maintain no bend in their knees at the peak of the 
jump. If a participant bent their knees at the peak of the jump, the jump did not count 
towards a maximal effort. Once the participant’s technique was correct, participants 
performed 3 maximal efforts, separated by approximately 60 seconds of standing 
recovery; the mean of the 3 jumps was used for analysis. Jump heights were recorded 
in centimetres. CMJs were performed prior to strength testing.  
5.2.7 Blood Sampling and Analysis  
For blood sampling procedures and analysis, please refer to section 3.11.  
5.2.8 Statistical Analysis 
All data are presented as mean ± SD. The effect of PCM cooling or control on strength 
loss, soreness, CMJ height, CK, and hsCRP on the three days following the marathon 
was assessed using 2 × 4 treatment by time mixed-model ANOVA. The two levels for 
the treatment factor were PCM cooling and control. The four levels for the time factor 
were baseline and day 1, day 2, day 3, after the marathon. Baseline values were 
compared between treatment groups using independent t-test. There were technical 
issues with measuring CMJ for 7 participants throughout the duration of the study. 
Thus, only 12 and 11 participants in the control and PCM treatment groups, 
respectively, were included in the treatment by time analysis of the CMJ data. 
Normality of all data sets was examined using the Shapiro-Wilk test. Mauchly’s test 
was used to assess assumptions of sphericity and, where necessary, Greenhouse–
Geisser corrections were used. Differences between treatments at any particular time 
interval were assessed with independent t-tests using Bonferroni corrections for 
planned pairwise comparisons. Where appropriate, Cohen’s d ES statistics were 
calculated to provide magnitude of effects; with the magnitude of effects considered 
either small (0.20-0.49), medium (0.50-0.79), and large (>0.80). The upper and lower 
limit of 95% confidence intervals (CI) for least significant difference are reported 
where relevant. Statistical analyses were performed using SPSS v.21 (IBM, Armonk, 
NY, USA) and a P-value of less than 0.05 was considered statistically significant.  
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5.3 Results 
A summary of participant characteristics and completion times are presented in Table 
3. 
 
Table 3: Participant characteristics and marathon completion times. Values are mean 
± SD. 
Treatment n 
Age 
(years) 
Height 
(cm) 
Weight 
(kg) 
# Previous 
Marathons 
Expected 
Finish 
Time 
Actual 
Finish 
Time 
PCM 
15 36±8.1 170.9±10.0 67.1±11.5 3±6 4:21±0:42 4:23±0:53 
Female 
9 35±8.6 164.6±6.7 60.5±6.7 4±6 4:16±0:43 4:29±0:51 
Male 6 37±7.7 180.3±5.8 77.1±10.1 10±7 3:34±0:22 3:40±0:20 
Control 
15 33±8.8 167.9±11.5 69.1±14.4 6±7 3:59±0:40 4:11±0:48 
Female 
10 31±8.2 162.3±7.4 62.8±12.3 3±7 4:26±0:46 4:29±0:58 
Male 5 36.6±9.3 179.0±10.4 81.7±9.5 2±2 4:11±0:36 4:13±0:47 
Total 30 34±8.4 169.4±10.7 68.1±12.9 5±6 4:10±0:42 4:17±0:50 
Between group 
comparisons 
P = 0.338 P = 0.454 P = 0.689 P = 0.143 P = 0.169 P = 0.543 
Note: Finish times are reported as h:mm. 
 
5.3.1 Strength 
At baseline average knee extension peak torque was not different between groups (P 
= 0.771; PCM treatment: 157.9 ± 36.6 Nm, control: 154.0 ± 35.3 Nm). Average 
quadriceps strength expressed as a percentage change from baseline for the 3 days 
following the marathon showed a main effect of time (F = 15.0, P < 0.0001, ES = 1.46; 
Figure 11). However, overall recovery of MIVC was independent of treatment with no 
group (P = 0.535) or interaction effect observed (P = 0.828), indicating that the 
recovery of strength over the 3 days following the marathon was comparable in both 
treatment and control conditions. For illustrative purposes, torque data for each day 
of data collection of each bout are presented in Table 4 to demonstrate the return of 
function following the exercise protocol. 
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Figure 11: Isometric strength loss of the quadriceps (presented as a percentage 
change from baseline strength loss) for the PCM treatment and control groups before 
and on the three days following the marathon. Values are mean ± SD. Strength was 
reduced over the 4 days after the marathon (P < 0.0001), with no difference between 
groups.  
 
Table 4: Isometric strength (MIVC) of the quadriceps for the PCM treatment and 
control conditions reported as net torque values (Nm) on each day after the marathon.  
 
 PCM (Nm) Control (Nm) 
Baseline 156 ± 34 154 ± 34 
Day 1 137 ± 32 133 ± 32 
Day 2 149 ± 33 141 ± 33 
Day 3 156 ± 35 148 ± 35 
Time Effect P = 0.002 P < 0.0001 
Note: Values are mean ± SD. 
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5.3.2 Soreness 
At baseline, quadriceps soreness was not different between groups (P = 0.254; PCM 
treatment: 0.2 ± 0.8, control: 0.0 ± 0.0, VAS 0-10). Following the marathon, 
perceptions of soreness increased over time (Figure 12; F = 76.4, P < 0.0001, ES = 
3.31). Overall recovery of soreness was independent of treatment with no treatment 
(P = 0.264) or interaction effect observed (P = 0.195). Interestingly, peak soreness 
was inversely correlated with number of prior marathons (P = 0.005, r = -0.497), but 
this effect was not different across treatments (P = 0.544).  
 
 
 
Figure 12: Subjective reports of quadriceps soreness on a 0-10 scale (0 = no 
discomfort, 10 = too painful to squat to 90°) for the PCM treatment and control groups 
before and for three days following the marathon. Values are mean ± SD. Soreness 
following the marathon was increased in both groups (P < 0.0001). 
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5.3.3 Countermovement Jump Height 
Jump height was not different between groups at baseline (P = 0.764; PCM treatment: 
21.2 ± 4.4 cm, control: 21.9 ± 5.5cm). Jump height decreased following the marathon 
(Figure 13; F = 15.9, P < 0.0001, ES = 1.74). There was no difference between 
treatments in the recovery of CMJ, with no treatment (P = 0.273) or interaction effect 
observed (P = 0.198).  
 
 
Figure 13: Percentage change from baseline in countermovement jump (CMJ) height 
for the PCM treatment and control groups before and for three days following the 
marathon. Values are mean ± SD. Following the marathon, CMJ height was impaired 
in both groups (P < 0.0001), but was not different between treatments. 
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5.3.4 Blood Markers 
At baseline, CK values were not different between groups (P = 0.224; PCM treatment: 
119.0 ± 71.0 U·L−1, control: 169.2 ± 139.0 U·L−1). At baseline, CRP values were not 
different between groups (P = 0.267; PCM treatment: 1.03 ± 0.82 ug/ml, control: 0.77 
± 0.34 ug/ml). Following the marathon, CK and hsCRP increased over time in both 
groups (Table 5), with no difference between the PCM treatment and control 
conditions (CK: P = 0.623; hsCRP: P = 0.655) and no interaction effects (CK: P = 
0.309; hsCRP: P = 0.412). 
 
Table 5: Response of indices of muscle damage (serum Creatine Kinase; CK) and 
inflammation (high sensitivity C-Reactive Protein; hsCRP) in the blood before 
(baseline) and for 3 days (Day 1, 2, and 3) after the marathon run in the PCM and 
Control groups. Values are mean ± SD. 
 
 CK (U·L−1) hcCRP (ug/ml) 
 PCM Control PCM Control 
Baseline 
119 ± 70  
(2.00 ± 0.28) 
169 ± 138 
(2.11 ± 0.31) 
1.03 ± 0.82   
(-0.07 ± 0.26) 
0.77 ± 0.34   
(-0.15 ± 0.17) 
Day 1 
893 ± 471 
(2.87 ± 0.30) 
841 ± 372 
(2.87 ± 0.24) 
7.72 ± 5.28 
(0.79 ± 0.31) 
7.38 ± 4.56 
(0.80 ± 0.27) 
Day 2 
419 ± 289 
(2.51 ± 0.35) 
547 ± 363 
(2.64 ± 0.31) 
3.63 ± 1.89 
(0.51 ± 0.22) 
4.27 ± 2.29 
(0.56 ± 0.28) 
Day 3 
328 ± 193 
(2.42 ± 0.32) 
378 ± 416 
(2.36 ± 0.47) 
2.26 ± 1.12 
(0.30 ± 0.24) 
4.23 ± 5.80 
(0.43 ± 0.39) 
Time Effect P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 
Note: Values are presented as absolute value (log transformed value).  
 
5.4 Discussion  
This study investigated whether administering 3 hours of PCM cooling would 
accelerate recovery following a marathon run. The marathon resulted in reduced 
muscle function, increased perceptions of soreness, and increased concentrations in 
the blood markers of muscle damage (CK) and inflammation (hsCRP). Contrary to 
the hypothesis, and unlike the findings of the previous chapter, there was no 
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difference in the rate of recovery between the PCM treatment and control groups. The 
results of the present chapter indicate that prolonged PCM cooling was not an 
effective recovery strategy when administered after running a marathon.  
The findings of the present study are in agreement with the only other previous study 
to have investigated the effectiveness of cryotherapy for recovery from a marathon 
(Wilson et al., 2018). Wilson et al. (2018) demonstrated that compared with control 
neither CWI nor WBC accelerated recovery of strength loss, soreness, muscle 
function, and blood markers of muscle damage and inflammation after a marathon 
run. Importantly the marathon run in their study did not elicit any strength loss, making 
it difficult to determine whether the cryotherapy interventions were effective. 
Furthermore, Wilson et al. (2018) reported that their participants were trained 
endurance runners and that the course of their marathon consisted of an outdoor 
route comprised of predominantly grass and unpaved footpaths, with some short 
concrete sections run at a self-selected pace. Since muscle soreness was largely 
absent by the second day following the marathon, coupled with no effect from the 
marathon on strength loss, their findings indicate that the marathon run was not 
strenuous enough to elicit a damage response. Comparably, the participants in the 
present study were less trained, had longer marathon completion times (4:17 vs 3:48 
hours), elevated soreness on the second day that had not recovered in either group 
by the third day following the marathon, and increased blood markers of muscle 
damage and inflammation. Additionally, participants in the present study experienced 
a 12% and 13% reduction in MIVC one day following the marathon in the PCM and 
control groups respectively, with strength returning to baseline in the PCM treatment 
group by day 2 but not until day 3 in the control group. Hence, the damage response 
in the present study was greater than that reported by Wilson et al. (2018). The 13% 
strength loss and 5 out of 10 pain on day 1 in the control group of the present study 
are comparable to values reported by Howatson et al. (2010; 18% strength loss and 
4 out of 10 pain on day 1). Thus, in the present study, there was sufficient damage 
from the marathon to detect a benefit from the PCM cooling intervention.  
There was also no benefit from PCM treatment, compared to control, for accelerating 
CMJ height following the marathon. However, it is notable that, compared to baseline,  
the PCM treatment group did not exhibit compromised jump height on any of the three 
days following the marathon (Day 1: 87% of baseline, Day 2: 98%, Day 3: 99%). On 
the other hand, jump height was impaired for two days after the marathon in the 
control group (Day 1: 84%, Day 2: 88%). This finding has some value considering 
that CMJ may be a better indicator of overall muscle function than isolated strength 
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measures. Significant decrements in CMJ height have previously been reported for 2 
days following marathon running (Petersen et al., 2007). One previous study 
measured CMJ height following a marathon and showed a 10% and 5% reduction in 
jump height on day 1 and 2, respectively; with no benefit from a nutritional intervention 
in accelerating recovery of CMJ height (Clifford et al., 2016). Comparably, only one 
previous study has examined the effects of CWI on CMJ height following a half-
marathon, reporting minimal impairment of CMJ height and subsequently no effect of 
CWI in accelerating recovery of CMJ height after the half-marathon (4% reduction; 
Wiewelhove et al., 2018).  
There are limited studies investigating the potential effectiveness of recovery 
strategies in road running. Further, few of these studies have successfully 
implemented a recovery intervention to ameliorate any of the signs and symptoms 
following marathon running (Clifford et al., 2016; Hill et al., 2014a; Howatson et al., 
2010). One study successfully administered a lower limb compression garment which 
reduced perceived muscle soreness one day after the marathon but did not affect 
strength (Hill et al., 2014a). One study implemented a pre- and post-marathon 
nutritional intervention which successfully accelerated recovery of strength but did not 
affect soreness (Howatson et al., 2010). In the third study, there was insufficient 
muscle damage from the marathon to determine an effect of the nutritional 
intervention (Clifford et al., 2016). Interestingly, the nutritional intervention 
investigated by Clifford et al. (2016) was provided only on the 3 days after the 
marathon, while runners in the treatment group of Howatson's (2010) study received 
the nutritional intervention for 5 days prior to the marathon, as well as on the 2 days 
after the marathon. Hence it was possible that consuming a nutritional intervention 
prior to the exercise stimulus acted systemically as a pre-recovery modality to mitigate 
some part of the metabolic response that occurred during a marathon run. Indeed, 
the inflammatory response was blunted in the runners receiving a nutritional 
intervention prior to running a marathon (Howatson et al., 2010), and this may have 
limited the subsequent exacerbation of secondary damage. Since administering 
cryotherapy prior to exercise is generally contraindicated, the PCM packs were not 
implemented as a pre-recovery strategy in the present study, and ultimately the 
inflammatory response was not reduced by the PCM treatment.  
The previous chapter indicated that PCM cooling successfully accelerated recovery 
following eccentric exercise encompassing a mechanical component of muscle 
damage. Unlike the findings of the previous chapter, this study indicated that PCM 
did not accelerate recovery following a marathon, which involves a large metabolic 
92 
 
component. It is possible that the cooling effect from the PCM packs applied locally 
to the quadriceps was not large enough to act systemically on a damage response 
occurring across several muscle groups. This is especially likely when considering 
that endurance type protocols typically produce a greater level of systemic 
hyperthermia and different metabolic perturbations, compared with isolated exercise 
such as resistance exercise (Deschenes et al., 1998; Mortensen et al., 2008). 
Therefore a larger magnitude of cooling would be necessary to elicit the same 
response following a marathon than following isolated eccentric exercise. 
Alternatively, the PCM cooling treatment in the present study might have been 
administered too late into the muscle damage cycle, once secondary damage had 
already occurred. Lastly, it is possible that the mechanisms through which 
cryotherapy accelerates recovery are effective following exercise involving primarily 
mechanical muscle damage, but not following exercise involving prolonged exposure 
to metabolic stress. A few theories exist to explain the difference in response to 
metabolic and mechanical stress (Tee et al., 2007). One of the more pronounced 
features of endurance exercise is an elevation in systemic inflammation (see section 
2.1.2.2; Shin & Lee, 2013; Suzuki et al., 2003), which is independent of the training 
status of the runner (Santos et al., 2016). Indeed, the marathon run markedly elevated 
hsCRP in the present study, but PCM did not effectively accelerate the recovery of 
this response. However, overall there is insufficient data to support the theory that 
cryotherapy reduces the post-exercise inflammatory response. Ultimately it is most 
likely that magnitude of the cryotherapy dose was insufficient in the present study. 
It is important to acknowledge the other limitations of this study. Due to the nature of 
marathon environments with large numbers of runners, retrieving one's belongings 
following the race was delayed, as a result the PCM were not applied until on average 
80 minutes following completion of the marathon. Adding to this delay in PCM 
application, during such a long-distance run, muscle damage is likely induced before 
the marathon run is concluded; thus, an overlap exists between the individual 
exercising and muscle damage occurring. This overlap was likely significantly smaller 
in previous studies showing a beneficial effect from PCM where the exercise took 
between 40 minutes (chapter 4) to 90 minutes (Brownstein et al., 2019; Clifford et al., 
2018) to complete and PCM were applied within 10 (chapter 4), 30 (Clifford et al., 
2018), and 45 minutes (Brownstein et al., 2019) of exercise cessation. Animal models 
have previously shown that a window of opportunity for intervention with cryotherapy 
lies within the first 30 minutes after injury (Merrick & McBrier, 2010). Thus, in the 
present study, a combination of exercise that had high metabolic stress for a 
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prolonged duration (on average exceeded four hours) and a delay in the application 
of PCM cooling might have limited the potential of the intervention to accelerate 
recovery. In an ideal scenario, PCM cooling would be administered as soon as 
possible upon cessation of exercise. This timing was likely more successfully 
achieved in chapter 4 following 40 minutes of isolated eccentric contractions or a 90-
minute soccer game (Brownstein et al., 2019; Clifford et al., 2018).  
5.5 Conclusion 
The present study expands upon the findings of chapter 4, as well as previous studies 
administering PCM for 3 and 6 hours following isolated eccentric knee extensions and 
a soccer match attenuated strength loss (chapter 4 and 7; Brownstein et al., 2019 
and Clifford et al., 2018, respectively) and/or soreness (chapter 4 and 7; Clifford et 
al., 2018, respectively). Chapter 4 indicated that PCM can successfully accelerate 
recovery following EIMD comprised of a large mechanical stress component. 
However, the present study demonstrated that prolonged PCM cooling was not 
effective in accelerating recovery following exercise encompassing a large metabolic 
stress component. Therefore, the lack of effect in the present study might be due to 
the mechanisms of PCM acting differently following high-intensity exercise with a 
significant eccentric component than following a marathon. However, it remains 
unknown whether the physiological responses to prolonged PCM cooling following 
exercise of primarily metabolic or mechanical nature are different. Based on these 
data, local PCM cooling might not provide a sufficient cooling stimulus to elicit a 
systemic response in order to accelerate recovery following prolonged endurance 
exercise, although this should be confirmed with a tightly controlled experimental 
paradigm. 
5.6 Perspectives  
The overall aim of this thesis is to establish the efficacy of prolonged cooling using 
PCM for attenuating muscle damage and accelerating recovery from exercise. In the 
previous chapter, PCM cooling hastened the recovery of strength and soreness 
following eccentric exercise of the quadriceps. Subsequently, it was expected that 
PCM cooling would also accelerate recovery following a marathon. Especially since 
marathon running is associated with a large muscle damage response and 
inflammatory response. However, the results of the present chapter demonstrated 
that prolonged PCM cooling was not effective for accelerating recovery of muscle 
function, perceptions of soreness, and blood markers of muscle damage and 
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inflammation following marathon running. Although there was no difference between 
the PCM treatment and control groups in any of these variables, strength was only 
significantly reduced below baseline on day 1 and returned to baseline by day 3 in 
the PCM treatment group, while in the control group strength was significantly 
reduced below baseline on days 1 and 2 and did not and return to baseline by day 3. 
Comparably, CMJ height was not significantly reduced below baseline on any of the 
days following the marathon in the PCM treatment group but remained compromised 
on days 1 and 2 in the control group. Although not significantly different between 
treatments, upon visual inspection soreness, muscle damage and inflammation 
(hsCRP) were lower in the PCM treatment group than in control. Although the results 
from this study do not support the use of PCM to alleviate muscle damage and 
accelerate recovery following a marathon run, it is possible that a larger cooling 
stimulus such as PCM applied to the entire leg and not just the quadriceps might have 
elicited a more favourable result. 
Apart from the difference in duration of PCM cooling in the previous chapter (6 hours) 
and the present chapter (3 hours), the major factor that might explain the discrepancy 
in the results between the two studies is that the muscle damage models were 
different. The study in the previous chapter employed isolated eccentric exercise to 
induce muscle damage. In that instance, muscle damage was induced solely through 
direct mechanical disruption. On the contrary, although marathon running involves a 
large number of stretch-shortening cycles, structural damage occurs due to the 
continued demand in the face of substrate depletion. Furthermore, the muscle 
damage in chapter 4 was localised to one muscle group (quadriceps), and it was the 
quadriceps that were directly cooled following the eccentric exercise. In the present 
study, during the marathon run, muscle damage was not localised to a single muscle 
group and occurred in more than just the quadriceps, but only the quadriceps were 
cooled. Thus, the localised cooling stimulus was likely insufficient to elicit any 
beneficial effects to the peripheral musculature that was also likely experiencing a 
damage response and was clearly experiencing a systemic inflammatory response 
(see hsCRP data in Table 5).  
The results from this chapter compared with those of the previous chapter, that PCM 
cooling was not effective following a marathon but accelerated recovery following 
eccentric exercise, address the overall aims of this thesis by indicating that prolonged 
PCM cooling can be effectively utilised as a recovery modality following exercise 
encompassing mechanical stress but not metabolic stress. The following chapter of 
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this thesis will attempt to isolate the effects of 3 hours of PCM cooling at the 
quadriceps, in non-exercising rested individuals, in order to determine the 
physiological effects of cooling at the quadriceps muscle and the core. The effect of 
local PCM cooling on core temperature will answer some of the questions arising from 
this chapter and the previous chapter, because an effect on core temperature will 
indicate that PCM cooling acts both locally and systemically. This result would explain 
the systemic effect evident in chapter 4 and would further indicate that the local PCM 
cooling following the marathon run in the present chapter was too little of a cooling 
stimulus to elicit a systemic effect on recovery. Further, although the PCM intervention 
was not successful in accelerating recovery in this chapter, it was evident that the 
marathon induced elevations in blood markers of muscle damage and inflammation 
over the 3 days after the run. However, blood markers of muscle damage or 
inflammation were not measured following the mechanically induced muscle damage 
in the previous chapter. Therefore, in order to compare the effects of PCM cooling on 
muscle damage and inflammation occurring from metabolic stress vs mechanical 
stress, chapter 7 will aim to quantify the degree of muscle damage and inflammation 
evident in the blood following isolated eccentric exercise.  
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6.1 Introduction 
The previous chapters established the efficacy of prolonged cooling using PCM for 
accelerating recovery following mechanically stressful eccentric exercise (chapter 4), 
but not following marathon running which is an exercise with a significant 
metabolically stressful component (chapter 5). Further, PCM cooling has also been 
used effectively for accelerating recovery following match play in professional soccer 
players (Brownstein et al., 2019; Clifford et al., 2018), which encompasses 
components of both mechanical and metabolic stress. Therefore, it would appear that 
either the mechanisms through which PCM accelerated recovery in the previous two 
chapters varied or that the magnitude of the cooling dose was sufficient following the 
mechanically stressful exercise in chapter 4 but not following the metabolically 
stressful exercise in chapter 5.  
Many of the physiological changes suspected to be integral to the therapeutic effects 
of cryotherapy are thought to be temperature-dependent (White & Wells, 2013) and 
dependant on the intensity of the cold stimulus (Crowe et al., 2007) and how it affects 
the body (García-Manso et al., 2011). The thermal and cardiovascular responses to 
CWI have recently been reviewed by Stephens (2017). Briefly, recovery following 
exercise is purported to be enhanced by CWI primarily due to its ability to reduce 
muscle temperature (Mawhinney et al., 2013; 2017; Roberts et al., 2014; 2015); with 
the skin temperature playing a relatively minor role (Vargas et al., 2018). Core 
temperature can also been reduced by CWI if the immersion duration is long enough 
to sufficiently elicit a systemic response (Costello et al., 2012a; Gregson et al., 2011; 
Stephens et al., 2018). Additionally, CWI has also been demonstrated to restore the 
cardiovascular response following exercise as measured using indices of heart rate 
variability (HRV; Al Haddad et al., 2010; Almeida et al., 2016; Bastos et al., 2012).  
Since typical CWI protocols involve a single post-exercise treatment for 10-15 
minutes in water temperatures between 10-15°C (Bleakley et al., 2012; Leeder et al., 
2012), limited effectiveness might be a result of inadequate treatment duration, 
temperature, or both. Although lower immersion temperatures might be more 
effective in the treatment of EIMD by virtue of greater reductions in muscle 
temperature (Mawhinney et al., 2013), protocols of excessive cooling capacity (colder 
temperatures) may result in sympathetic activation (Datta & Tipton, 2006), or may 
exacerbate the pro-inflammatory response (White et al., 2014). Concurrently, 
prolonging the treatment duration of cryotherapy at very low temperatures puts the 
superficial tissues at risk of developing cold-related injury (Enwemeka et al., 2002; 
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Nadler et al., 2003; Swenson et al., 1996), may lead to excessive thermal discomfort 
and, if prolonged, is not well tolerated (Howatson et al., 2016). In practice, if the goal 
is to increase the period for which the aforementioned physiological effects are 
maintained (decreased muscle and core temperature), repeat treatments may be 
necessary but are impractical and present logistical challenges. A longer duration of 
targeted post-exercise cooling can be achieved using PCM; however, the cooling 
efficacy of PCM was not investigated in the previous chapters.  
Prolonging the duration of tissue cooling has previously been suggested as a critical 
component in reducing the secondary muscle damage response (Merrick et al., 1999; 
Swenson et al., 1996) and mitigating the overall extent of tissue damage (Bleakley et 
al., 2012; Enwemeka et al., 2002; Ihsan et al., 2013; Knight, 1995). Merrick et al. 
(1999) were the first to provide empirical evidence that a prolonged dose of 
cryotherapy was effective in retarding secondary injury. The authors concluded that 
the 5 hours of continuous cold application maximized the injury-reducing effect of 
cryotherapy and suggested that the prolonged duration of application may be 
advantageous. Bleakley et al. (2012) suggested that prolonging the cooling duration 
would be necessary in humans in order to achieve similar magnitudes of 
intramuscular cooling evident in animal models. Enwemeka et al. (2002) 
demonstrated that 20 minutes of cooling was insufficient to reduce intramuscular 
temperature at the deep tissue. Similarly, Ihsan et al. (2013) concluded that the 
magnitude of reduction in muscle perfusion and metabolic activity from 15 minutes of 
CWI was insufficient to promote noticeable physiologic changes associated with 
minimizing muscle damage or preserving muscle function. With these 
recommendations in mind, it is logical that prolonging the dose of cryotherapy may 
overcome some of the aforementioned limitations.  
The overall aim of this thesis is to assess the efficacy of prolonged PCM cooling as a 
recovery modality following exercise. As was evident in chapter 4, 6 hours of PCM 
cooling accelerated indices of recovery following eccentric exercise; while 3 hours of 
cooling in chapter 5 were unsuccessful in enhancing recovery following marathon 
running. Thus, it was possible that the 6 hours of PCM cooling in chapter 4, but not 
the 3 hours of cooling in chapter 5, attenuated some mechanism occurring during the 
stage of secondary damage following isolated eccentric exercise but not following a 
marathon run encompassing prolonged metabolic stress. However, in the previous 
two chapters it was unknown to what extent prolonged PCM cooling might have 
exerted effects on body temperature and cardiovascular measures, similar to those 
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occurring from CWI. Additionally, it was unknown whether muscle and core 
temperatures remained reduced throughout the duration of PCM treatment. For this 
reason, this chapter aimed to understand the physiological effects (muscle, core, skin 
temperature and HRV) that occur during 3 hours of PCM cooling and to compare 
them with a CWI treatment of matched temperature. It was hypothesised that both 
PCM and CWI would decrease intramuscular and core temperature during treatment 
but with a prolonged effect from PCM due to its ability to deliver a longer cooling 
duration. 
6.2 Methods 
6.2.1 Participants 
Using the findings of previous studies that examined the change in intramuscular 
temperature during CWI administered at rest (Gregson et al., 2011) a power 
calculation was conducted to detect a practically significant decline in intramuscular 
temperature from CWI or PCM in order to determine an adequate sample size for this 
study. Since the CWI temperature to be used in the present study was 15°C, it was 
estimated that the effects would lie somewhere between those seen at 8°C or 22°C 
(Gregson et al., 2011). Based on the inter-subject variability in the decline in 
intramuscular temperature at 1 cm of the vastus lateralis with CWI at 8°C and 22°C it 
was estimated that 10 subjects per group would provide 80% power to detect a 1°C 
change in temperature at an alpha level of 0.05 (0.88°C using SD of 0.94; 1.01°C 
using an SD of 1.07). Furthermore, there will be sufficient power to detect a 
meaningful difference in temperature between CWI and PCM with the proposed 
sample size because in a subsequent study the difference between the decline in 
temperature at 1 cm 30 minutes post CWI at 8°C vs. 22°C was 2.26 ± 0.98°C 
(Mawhinney et al., 2017).  
Eleven physically active males (mean ± SD; age, 27 ± 6 years; height, 183.6 ± 8.5 
cm; body mass, 81.5 ± 12.4 kg) volunteered to participate in this study. Participant 
recruitment was based on the details described in section 3.2. All participants were 
free from lower leg injury for at least 1 month prior to study completion and had no 
known vascular disease in the lower limbs, compromised circulation, allergy or 
hypersensitivity to cold. Participants were instructed to refrain from strenuous 
exercise for 72 hours prior to, and for the duration of the study period. The institutional 
research ethics committee, in line with the Declaration of Helsinki, approved all 
procedures.  
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6.2.2 Experimental Design  
In this repeated measures, crossover design study participants visited the laboratory 
on 3 consecutive days. Firstly for a familiarisation session before data collection 
commenced, followed by two separate treatment sessions, all separated by 24 hours. 
Participants were randomised to receive one treatment on day 1 and the other 
treatment on day 2. During PCM treatment, frozen 15°C PCM were applied to the 
skin over the quadriceps of both legs for 3 hours (Figure 14a). During CWI treatment, 
participants sat immersed to the umbilicus in an inflatable, temperature-controlled (15 
± 1°C) cold-water bath (iCool Sport, Australia) for 15 minutes (Figure 14b). Upon 
completion of PCM treatment, the dry shorts remained on the participant, while rolled 
up so that the skin remained exposed, for the duration of the recovery period. Upon 
completion of the CWI, participants were allowed to dry off by patting dry with a towel 
and change into a new pair of dry shorts which were then rolled up so that the skin 
remained exposed for the duration of the recovery period. The duration of changing 
during the CWI session lasted no longer than 5 minutes for each participant. 
 
 
Figure 14: a) Participant fully instrumented during PCM treatment; and b) during CWI 
treatment 
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Vastus lateralis muscle temperature at 1, and 3 cm, skin temperature, core 
temperature, HR, blood pressure (BP) and thermal comfort were recorded 
continuously throughout baseline, treatment (15 minutes  CWI vs 3 hours PCM) and 
recovery (2 hours CWI vs 1 hour PCM) during both treatment conditions. Data 
collection during CWI treatment and recovery consisted of a shorter overall collection 
period compared to the PCM trial. Since both treatments were matched for 
temperature, it was impractical for participants to remain instrumented for the 
additional 1 hour of recovery following CWI treatment, in order to match the duration 
of PCM treatment and recovery. Thus, recovery of all variables was monitored for 1 
hour following completion of PCM treatment (4 hours total time), and for 2 hours 
following immersion (2 hours 15 minutes total time; see Figure 15). During data 
collection, participants remained in a semi-reclined seated position with legs 
outstretched on a bed except during the CWI treatment. All testing was performed in 
a temperature-controlled laboratory (24.9 ± 3.4°C). 
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6.2.3 Phase Change Material Application 
For complete PCM application procedures, please refer to section 3.5. 
6.2.4 Intramuscular Temperature 
To account for subcutaneous fat, skinfold at the exact site of thermocouple insertion 
on the quadriceps was measured using Skinfold Calipers (Harpenden, Baty 
International, West Sussex, UK) by the same individual and divided by 2 to determine 
the thickness of the thigh subcutaneous fat layer over each participant’s vastus 
lateralis (Enwemeka et al., 2002). The vastus lateralis was then marked 
approximately 6 cm lateral to the mid-point between the superior pole of the patella 
and the anterior-superior iliac crest using a sterile pen. Additional markings were 
placed 1 cm inferior and superior to this point, one for each insertion depth. The area 
was cleaned with a povidone-iodine surgical scrub solution. Insertion depth was 
based upon halving the skinfold measure and adding this to the required depth (1 or 
3 cm). 
A 45 and 32 mm sterile intravenous 20 gauge needle catheter was used for the 3 and 
1 cm insertion, respectively. Insertion depth was verified by subtracting the total 
insertion depth (1 cm or 3cm plus half the skinfold) from the corresponding length of 
the needle. The difference (length of needle minus calculated insertion depth) was 
verified with a sterile ruler. Once at the correct insertion depth, the needle was 
removed, and the flexible catheter remained inserted. A sterile flexible intramuscular 
Thermocouple Probe (Type T, IT-21; Physitemp Instruments, Clifton, NJ) was 
threaded through the barrel of the catheter. The catheter was removed from the 
muscle while the thermocouple remained inserted (Figure 16). The thermocouple 
insertion site was secured in place with sterile tegaderm by bending the thermocouple 
flush with the skin. The procedure was then repeated for the 1 cm deep thermocouple. 
Once fully instrumented, the thermocouples were connected to a digital monitor 
(Bailey Instruments BAT-12, Physitemp Instruments, Inc.) for continuous recording. 
Thermocouples remained inserted throughout the duration of treatment and recovery. 
At the conclusion of data collection, thermocouples were removed, and ‘actual’ 
insertion depth was verified by measuring the inserted portion of the thermocouple 
against a sterile ruler. The left leg of each participant was instrumented with 
thermocouples for CWI, while the right leg was instrumented for PCM treatment. 
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Figure 16: One thermocouple inserted into vastus lateralis showing flexible catheter 
(pink) threaded over the thermocouple towards the thermocouple ‘head’ away from 
the insertion site. The thermocouple head was later plugged into an extension cable 
and connected to the digital monitor once fully instrumented. A second thermocouple 
was subsequently inserted as described above (section 6.2.3), and both insertion 
sites were secured with sterile tegaderm prior to initiation of both treatments.  
 
6.2.5 Core Temperature 
Participants were provided with an activated ingestible core temperature sensor 
(VitalSense, Respironic Inc, Murrysville, PA, USA) during familiarisation. Participants 
were instructed to ingest the capsule with water ~8 hours prior to initial testing. 
Participants were given a second core temperature sensor following completion of 
testing on day 1 to ingest at the same time of day as done prior to the first visit. The 
ingestible core temperature sensor wirelessly transmits core body temperature as it 
travels through the digestive tract. The sensor’s signal passes through the body to 
the data recorder found on the SEM also used for recording skin temperature data 
(Hidalgo Ltd, Cambridge, UK). The core temperature sensor passes through the body 
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at the subject’s normal rate of motility. Since core temperature might be influenced 
by the temperature of ingested material, participants were prohibited from consuming 
any food or beverage throughout the duration of data collection. Numerous studies 
have measured core temperature via a telemetric pill and have previously reported 
this method to be a valid estimate of core body temperature and highly reliable in a 
sports medicine setting (Byrne & Lim, 2007; Gant, Atkinson, & Williams, 2006; Ganio 
et al., 2009)  
6.2.6 Skin Temperature 
On arrival to the lab for the treatments, the skin temperature sensor was applied to 
the quadriceps of the leg that was not being instrumented with intramuscular 
thermocouples. For detailed procedures to assess skin temperature, please refer to 
section 3.6. 
6.2.7 Cardiovascular Measures 
Participants were fitted with a wireless ambulatory chest strap HR monitor (EQ02 
LifeMonitor, Hidalgo Ltd, Cambridge, UK) that continuously recorded HR. The chest 
strap housed the SEM data recorder which collected core and skin temperature data. 
HR data were analysed using Vivosense (Vivonoetics, San Diego, USA). An 
automatic artefact-marking algorithm was applied to the raw electrocardiogram 
(sensitivity level: medium noise filtering; minimal and maximal allowable HR limits: 30 
and 220 beats per minutes, respectively). R-wave markings were generated for HRV 
calculations. The square root of the mean squared differences of successive intervals 
(RMSSD) was reported because RMSSD provides the most reliable and practically 
applicable measure for day-to-day monitoring (Al Haddad, Laursen, Chollet, Ahmaidi, 
& Buchheit, 2011). Five minutes rolling averages were calculated for RMSSD, with 
the baseline measure taken prior to insertion of the intramuscular thermocouples. An 
automated blood pressure cuff was placed on the participant’s right arm (M10-IT; 
Omron Healthcare). 
6.2.8 Thermal Comfort 
Ratings of thermal comfort were recorded every 15 min. During CWI, thermal comfort 
was asked at the first and last minute of immersion. Participants were asked to rate 
their thermal comfort on a nine-point standard scale (Davey, Reilly, Newton, & Tipton, 
2007). 
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6.2.9 Statistical Analysis 
All data are presented as mean ± SD. Within each treatment, the changes in 
dependent variables over time were assessed by a one factor ANOVA with 
differences vs baseline assessed using Bonferroni corrections. Over time, the 
comparison of treatments was assessed using a 2 × 10 treatment by time repeated 
measures ANOVA. The two levels for the treatment factor were CWI or PCM. The ten 
levels for the time factor were baseline [0 minutes], and every 15 minutes up to 2 
hours 15 minutes. For these analyses, the entire duration of CWI treatment (15 
minutes) and recovery (2 hours) was compared to the first 2 hours 15 minutes of PCM 
treatment. Recovery effect (return to baseline) from both treatments over time was 
assessed using a 2 × 5 treatment by time repeated measures ANOVA. The five levels 
for the time factor were baseline (0 hours), 15, 30, 45 minutes, 1 hour, and 1 hour 15 
minutes for CWI and baseline (0 hours), 3 hours, 3 hours 15 minutes, 3 hours 30 
minutes, 3 hours 45 minutes, and 4 hours for PCM. The first 1-hour duration of 
recovery following each treatment was compared for these analyses. Where there 
was a significant treatment effect or treatment by time interaction, differences 
between treatments at any particular time interval were assessed using Bonferroni 
corrections for planned pairwise comparisons. Additionally, Pearson product-moment 
correlation coefficients were used to assess the relationship between thigh skinfold 
thickness and intramuscular temperature. 
To estimate the magnitude of the treatment effects, Cohen’s d effect sizes (ES) were 
calculated with the magnitude of effects considered either small (0.20-0.49), medium 
(0.50-0.79), and large (>0.80). Prior to employing ANOVAs, normality of distribution 
of all data sets were verified using the Shapiro-Wilk test. Mauchly’s test of sphericity 
was used to assess assumptions of sphericity and, where necessary, Greenhouse-
Geisser corrections were applied to tests of within-participant effects. Statistical 
analyses were performed using SPSS v.21 (IBM, Armonk, NY, USA) and a P-value 
of less than 0.05 was considered statistically significant. 
6.3 Results 
6.3.1 Thermocouple Depth and Skinfold 
Average skinfolds were not different between legs (P = 0.377; right leg: 10.1 ± 5.2 
mm, left leg: 9.7 ± 5.5 mm). Thermocouple depths, corrected for skinfolds were 3.0 ± 
0.4 cm and 1.0 ± 0.3 cm for PCM and 3.1 ± 0.3 cm and 1.1 ± 0.3 cm for CWI, and 
were not different between treatments at 3 cm (P = 0.416) or 1 cm (P = 0.688). 
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Decreases in intramuscular temperature were correlated with skinfold thickness, with 
stronger effects at 1 cm (CWI P < 0.001, r = 0.912; PCM P < 0.001, r = 0.853) vs. at 
3 cm (CWI P < 0.01, r = 0.727; PCM P = 0.05, r = 0.594). 
6.3.2 Intramuscular Temperature 
Intramuscular temperature declined progressively at both depths during both 
treatments (Table 6; time effect: all P < 0.0001). At the conclusion of the recovery 
period intramuscular temperature remained below baseline at both depths in both 
treatments (time effect: all P < 0.0001).  
 
Table 6: Comparison of vastus lateralis intramuscular temperatures (1cm and 3cm) 
during baseline, treatment, and recovery of the two cryotherapy treatments (CWI vs 
PCM). 
 
 CWI 1cm (°C) CWI 3cm (°C) PCM 1cm (°C) PCM 3cm (°C) 
Baseline 34.0 ± 1.1 35.6 ± 0.6 33.9 ± 1.5 35.8 ± 0.5 
End of Treatment 26.2 ± 2.9 28.4 ± 2.7 26.0 ± 2.2 28.2 ± 2.8 
End of Recovery 30.5 ± 1.0 31.0 ± 1.0 29.0 ± 1.6 30.1 ± 2.1 
Average 29.4 ± 1.1 30.2 ± 1.2 27.4 ± 2.1$ 29.8 ± 2.4 
Note: Values are mean ± SD. Average intramuscular temperature at 1cm was lower 
from PCM treatment than CWI (F = 12.4, $P = 0.006, ES = 2.23; PCM CI: 26.6-
29.8°C, CWI CI: 29.1-30.6°C), but there was no difference at 3cm (P = 0.545). 
 
Overall intramuscular temperature at both depths was lower from PCM treatment 
(Figure 17; F = 113.5, P < 0.0001, ES = 6.74; PCM CI: 28.3-30.9°C, CWI CI: 29.6-
31.0°C). At the end of CWI treatment intramuscular temperature decreased more 
rapidly and was 14.0% lower at 1cm and 16.1% lower at 3cm vs 15 minutes into PCM 
treatment (mean difference at 1 cm: 4.3 ± 1.7°C, P < 0.0001, ES = 2.48, CI: 3.1-5.4°C; 
at 3 cm: 5.5 ± 2.1°C, P < 0.0001, ES = 2.61, CI: 4.1-6.9°C). At 3 cm, intramuscular 
temperature remained 10.6% lower 15 minutes into recovery following CWI vs 30 
minutes into PCM treatment (difference: 3.4 ± 1.6°C, P = 0.01, ES = 2.10, CI: 2.3-
4.5°C), but no longer at 1 cm (2.1%; difference: 0.6 ± 1.8°C, P = 0.99). Upon 
conclusion of CWI recovery (2 hours 15 minutes total time), intramuscular 
temperature at 3 cm was 7.5% higher compared with 2 hours 15 minutes into PCM 
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treatment (difference: 2.4 ± 2.3°C, P = 0.045, ES = 0.82, CI: 3.4-0.3°C), while 
intramuscular temperature at 1 cm was on average 12.5% higher during CWI 
recovery vs PCM treatment from 1 hour to 2 hours 15 minutes (F = 91.4, P < 0.0001, 
ES = 6.03, CI: 4.6-2.1°C).  
 
 
Figure 17: Vastus lateralis intramuscular temperature at 1cm and 3cm during both 
PCM and CWI treatments and for the full duration of recovery from both treatments. 
Values are mean ± SD. Intramuscular temperature declined progressively during the 
PCM treatment (P < 0.0001) and remained below baseline after 1:00 of recovery at 
both depths (1cm: P < 0.0001; 3cm: P < 0.0001). Intramuscular temperature 
decreased from baseline immediately following CWI (P < 0.0001) and remained 
below baseline after 2 hours of recovery at both depths (1cm: P < 0.0001; 3cm: P < 
0.0001). Intramuscular temperature was lower with CWI vs PCM at 3 cm from 0:00 to 
0:30 (0:15 *P < 0.0001; 0:30 *P < 0.0001) but only from 0:00 to 0:15 at 1 cm (*P < 
0.0001). At 3 cm intramuscular temperature was lower with PCM vs CWI at 2:15 (‡P 
= 0.045), while at 1 cm intramuscular temperature was lower from 1:00 to 2:15 
(treatment by time ‡P < 0.0001; time effect 1:00 P = 0.018; 1:15 P = 0.001; 1:30 P = 
0.001; 1:45 P = 0.001; 2:00 P = 0.001; 2:15 P = 0.001). 
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When comparing intramuscular temperature for the first 1 hour of recovery from both 
treatments, the intramuscular temperature at 1 cm was 4.1% higher from CWI 
averaging 28.6 ± 1.4°C than from PCM averaging 27.7 ± 1.7°C (Figure 18; F = 9.1, P 
= 0.013, ES = 1.91; PCM CI: 25.6-28.8°C, CWI CI: 27.7-29.6°C). However, there was 
no difference at 3 cm (2.2%; P = 0.350). 
 
 
Figure 18: Change in vastus lateralis intramuscular temperature from baseline during 
the first hour immediately following the conclusion of both PCM and CWI treatments 
(absolute time displayed for CWI is 0:15 through 1:15, and for PCM is 3:00 through 
4:00). Values are mean ± SD. Overall intramuscular temperature during recovery was 
lower from PCM than CWI at 1 cm (P = 0.013). This difference was specifically evident 
at 0:15 (*P = 0.03, CI: -2.1 to -0.4°C), 0:30 (*P = 0.005, CI: -2.1 to -0.7), and 0:45 
minutes (*P = 0.01, CI: -1.8 to -0.5).  
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6.3.3 Core Temperature 
Core temperature declined during both PCM and CWI treatments (Figure 19; F = 9.7, 
P < 0.0001, ES = 1.98). Overall the change in core temperature was independent of 
treatment with no group (P = 0.741) or interaction effect observed (P = 0.100). The 
nadir of core temperature from PCM treatment occurred 45 minutes into the recovery 
period (absolute time: 3 hours 45 min; 0.28 ± 0.27°C below baseline) while the nadir 
of core temperature from CWI treatment occurred 1 hour 30 minutes into the recovery 
period (absolute time: 1 hour 45 min; 0.25 ± 0.32°C below baseline). 
 
 
Figure 19: Mean change from baseline in core temperature during treatment and 
recovery from both PCM and CWI. Values are mean ± SD. Core temperature declined 
during the PCM and CWI treatments (P < 0.0001). 
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6.3.4 Skin Temperature 
The effect of both treatments on skin temperature at baseline, treatment and recovery 
are detailed in Table 7. Skin temperature declined during both PCM and CWI 
treatments (F = 233.9, P < 0.0001, ES = 9.67). CWI decreased skin temperature more 
rapidly than PCM (F = 174.4, P < 0.0001, ES = 8.37), but the skin temperature was 
overall lower from PCM treatment than CWI (F = 124.2, P < 0.0001, ES = 7.02; PCM 
CI: 24.3-25.5°C, CWI CI: 27.8-29.2°C). Skin temperature immediately after CWI was 
2.4 ± 1.7°C lower than 15 minutes into the PCM treatment (P = 0.01, ES = 1.41, CI: 
1.3-3.6°C), however, at all subsequent time points, skin temperature was lower during 
the PCM treatment (0:30 P = 0.01, ES = 1.50; 0:45 P = 0.001, ES = 2.65; 1:00 P = 
0.001, ES = 3.74; 1:15 P = 0.001, ES = 4.18; 1:30 P = 0.001, ES = 4.54; 1:45 P = 
0.001, ES = 4.78; 2:00 P = 0.001, ES = 4.73; 2:15 P = 0.001, ES = 4.77).  
 
Table 7: A comparison of skin temperatures during baseline, treatment, and recovery 
of the two cryotherapy treatments (CWI vs PCM). 
 CWI (°C) PCM (°C) 
Baseline 31.3 ± 1.1 31.1 ± 0.6 
End of Treatment 23.6 ± 0.8 23.8 ± 1.0 
End of Recovery 29.5 ± 1.2 27.7 ± 1.1 
Treatment Average ------------------ 24.1 ± 0.3 
Note: Values are mean ± SD. CWI does not have a treatment average since data 
were collected every 15 minutes.  
 
6.3.5 Perceived Thermal Comfort 
Overall, thermal comfort was lower for CWI than for PCM (F = 5.6, P = 0.002, ES = 
1.50) with greater thermal discomfort reported immediately upon the conclusion of 
CWI treatment (2.7 ± 0.8 vs. 4.5 ± 0.8 15 minutes into the PCM treatment; P < 0.0001, 
ES = 1.63, CI: 1.1-2.6°C). This time point is also where thermal comfort reached its 
nadir for both treatments. Comparably, thermal comfort was 4.9 ± 1.0 upon conclusion 
of PCM treatment. Although not different from baseline at any time point during the 
recovery period, thermal comfort returned to baseline values 30 minutes following 
PCM treatment (baseline: 5.4 ± 0.8 vs 0:30 recovery: 5.5 ± 1.0). Comparably, thermal 
112 
 
comfort remained below baseline through the first 15 minutes of recovery after CWI 
(P = 0.012, ES = 3.23, CI: 0.2-1.3°C), and did not return to baseline values upon 
conclusion of data collection (baseline: 5.0 ± 0.8 vs 2:00 recovery: 4.9 ± 1.1). 
6.3.6 Cardiovascular Measures 
There were technical issues with HR signals for 2 participants during the entire PCM 
treatment and for one participant after 2 hours of the PCM treatment. Thus, only 9 
participants were included in the analysis of HR data, and the analysis only included 
data for up to 2 hours. HR declined during both treatments (Figure 20; F = 10.4, P < 
0.0001, ES = 2.04) with no difference between treatments (P = 0.151; Table 8). 
Overall there was an increase in RMSSD during both treatments (F = 5.8, P < 0.0001, 
ES = 0.65) with no interaction effect (P = 0.155; Table 8). For the PCM treatment 
there was a trend for an increase in RMSSD (F = 3.0, P = 0.069, ES = 1.22), while 
for the CWI treatment there was a clear increase in RMSSD (F = 4.2, P < 0.0001, ES 
= 1.45). Blood pressure was unaffected by either treatment (systolic P = 0.139, 
diastolic P = 0.904) and there were no differences between treatments (systolic P = 
0.166, diastolic P = 0.101). 
 
Table 8: Fifteen minute rolling average HR and RMSSD data during 2 hours of PCM 
application and 15 minutes of CWI followed by 1 hour 45 minutes of recovery. 
 
 Heart Rate (bpm) RMSSD (ms) 
 PCM CWI PCM CWI 
Baseline 68 ± 7 68 ± 8 60 ± 22 62 ± 30 
0:15 62 ± 9 61 ± 11 63 ± 24 67 ± 28 
0:30 63 ± 7 61 ± 8 61 ± 24 79 ± 25 
0:45 64 ± 6 57 ± 8 65 ± 22 74 ± 26 
1:00 61 ± 7 59 ± 8 65 ± 26 70 ± 31 
1:15 62 ± 9 57 ± 8 70 ± 26 71 ± 27 
1:30 60 ± 5 59 ± 11 75 ± 25 75 ± 31 
1:45 59 ± 7 56 ± 9 70 ± 25 79 ± 32 
2:00 61 ± 9 57 ± 8 73 ± 23 84 ± 33 
Note: Values are mean ± SD. HR was reduced over time during both treatments (P < 
0.0001). There was an increase in RMSSD from CWI (P < 0.0001) and a trend for an 
increase from PCM treatment (P = 0.069). 
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Figure 20: Absolute heart rate during treatment and recovery from both PCM and 
CWI (in 5 minute intervals). Values are mean ± SD. Although HR visibly increased 
during CWI treatment, over time HR declined during both the PCM and CWI 
treatments and recovery (P < 0.0001) with no difference between treatments (P = 
0.151). 
 
6.4 Discussion 
The main finding in this study was that 15 minutes of CWI was comparable to PCM 
packs applied directly to the skin overlying the quadriceps for 3 hours in terms of the 
magnitude of reduction in vastus lateralis intramuscular temperature. Ultimately 
prolonged PCM cooling provided a sustained decrease in intramuscular temperature 
that was maintained for the 3 hours of application (Figure 17), and a more gradual 
recovery (Figure 18). However, the initial reduction in intramuscular temperature was 
more rapid during the CWI treatment. In addition to the local effects on muscle 
temperature, both treatments delivered local and systemic effects by decreasing core 
temperature, decreasing HR and increasing HRV. Importantly, the systemic effects 
were observed despite there being no exercise intervention to induce cardiovascular 
stress prior to the treatments. The combined local and systemic effects explain in part 
the accelerated recovery from PCM following exercise of primarily mechanical nature 
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in chapter 4 as well as in supplementary work (Brownstein et al., 2019; Clifford et al., 
2018). Further, the clear systemic effects demonstrated in this study support the 
response observed in the limb contralateral to the direct cooling limb in chapter 4. 
This study provides the first evidence that the application of PCM elicits systemic 
effects, as well as local effects at the musculature comparable to those occurring from 
CWI treatment. 
Current best evidence suggests that to optimise the clinical effectiveness of 
cryotherapy, a critical level of muscle cooling must be achieved (Bleakley & Hopkins, 
2010). Reducing muscle temperature will reduce cellular metabolism which would 
decrease the proliferation of secondary injury, thereby limiting the overall extent of 
tissue damage (Knight, 1995; Merrick, 2002). Previously, muscle metabolism was 
favourably minimised at a temperature range of 10-15°C in animal models (Sapega 
et al., 1988). Studies in humans have demonstrated reductions in muscle temperature 
immediately following CWI performed after exercise that range between ~31°C at 1 
cm (Mawhinney et al., 2013; Mawhinney et al., 2017), ~28°C at an unknown 
intramuscular insertion depth (Roberts, Muthalib, et al., 2015), and ~24°C at 1 cm 
(Roberts et al., 2014). Comparably the lowest absolute intramuscular temperature 
achieved in this study was 26.0°C at 1 cm from both PCM cooling and CWI. However, 
in the present study, average vastus lateralis temperature at 1 cm for the total PCM 
trial period (4 hours) was 7% lower than the average temperature at 1 cm for the total 
CWI trial (2 hours 15 minutes). Thus, not only can PCM provide prolonged cooling, 
but it can also provide a greater magnitude of cooling to the peripheral musculature. 
This may have implications for the preferential use of PCM over CWI in exercise 
recovery. Especially since the damage that occurs following strenuous exercise is 
bimodal, involving both the initial mechanical and/or metabolic muscle injury and a 
secondary phase that involves a disruption in intracellular homeostasis followed by 
an inflammatory response which initiates 2-6 hours post damaging exercise 
(Armstrong et al., 1991). Thus a prolonged cooling intervention during this timeframe 
has potential to blunt the harmful processes that occur during the phase of secondary 
damage, limiting further haemorrhage and cell death (Schaser et al., 2007). In support 
of this rationale, it has previously been demonstrated in an animal models that local 
cooling for prolonged durations limited secondary damage (3-6 hours; Merrick et al., 
1999; Puntel et al., 2012; Sapega et al., 1988; Schaser et al., 2007). 
Few studies have examined the impact of CWI on resting core temperature where 
there was no exercise-induced temperature elevation prior to CWI treatment (Costello 
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et al., 2012a; Gregson et al., 2011). Costello et al. (2012) reported a 0.4 ± 0.2°C 
reduction following 4 minutes of CWI at 8°C while Gregson et al. (2011) reported a 
0.2 ± 0.1°C drop in core temperature following two 5 minute treatments in 8°C water. 
Comparable reductions in core temperature were evident from both treatments in the 
present study. This finding was surprising considering that PCM was applied locally, 
while CWI involved submerging a large part of the body. However, the longer 
treatment duration during PCM cooling delivered a continued decrease in muscle 
temperature which provided a temperature gradient for heat removal from the central 
core resulting in a progressive decline in core temperature. It is well understood that 
the pattern and magnitude of change between peripheral tissue temperature and core 
temperature differs due to the increased reliance of core temperature change on 
convective cooling as opposed to conductive cooling (Taylor, Caldwell, van den 
Heuvel, & Patterson, 2008). CWI is associated with vasoconstriction which 
suppresses peripheral blood flow and the consequential reduction in convective heat 
delivery from the core to the periphery which causes a substantial reduction in core 
temperature. On the contrary, local cryotherapy that induces cutaneous 
vasoconstriction at the periphery typically limits the systemic exposure of blood to 
cold tissues, and thus core temperature is often unaffected. However, as was evident 
by the reduction in core temperature in the PCM condition in present study, it was 
likely that blood flow to skin was maintained during PCM treatment. This effect likely 
sufficiently exposed the circulating blood to the cold tissues allowing for a comparable 
reduction in convective heat delivery to occur from the core to the periphery during 
the application period. It is likely that a similar effect would not be observed in the 
PCM treatment condition following exercise as the local cooling stimulus might be too 
little to influence convective cooling. Previous studies have shown that the rate of 
core temperature reduction during post-exercise CWI is dependent on temperature, 
duration, the time from the end of exercise to commencement of CWI treatment, and 
perhaps most importantly that intermittent protocols result in a significantly greater 
decrement in core temperature compared to continuous protocols (Stephens, Sharpe, 
Gore, Miller, Slater, et al., 2018). Therefore, the results of the present study may not 
translate directly to an exercise paradigm.  
Monitoring indices of HRV, as indicators of autonomic nervous system activity, has 
been of increasing interest among athletes (Stephens, Halson, Miller, Slater, & 
Askew, 2018). This is because during exercise sympathetic activity is increased, 
while a concomitant progressive parasympathetic reactivation occurs in the post-
exercise period with a sympathetic withdrawal (Al Haddad et al., 2010). In over-
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trained or under-recovered athletes an imbalance can occur in this cycle. Therefore 
the restoration of cardiovascular homeostasis is an important component of overall 
recovery and interventions that increase HRV are thought to be advantageous to 
exercise recovery (Dong, 2016). Post-exercise CWI has been shown to accelerate 
recovery of HRV (Al Haddad et al., 2010; Almeida et al., 2016). Both authors 
concluded that water immersion is a simple and efficient means of triggering post-
exercise parasympathetic reactivation, lowering sympathetic tone, and restoring 
cardiac autonomic modulation. In the present study there was a decrease in HR and 
an increase in HRV from both treatments. The mechanisms with which both CWI and 
PCM stimulated this response are likely related to the effect of vasoconstriction. 
Exposure to cryotherapy reduces HR as a result of increased stroke volume, which 
may be a result of cold-induced vasoconstriction. The finding that both PCM and CWI 
reduced HR and HRV was again surprising considering that PCM was applied locally. 
Theoretically CWI should have had a greater effect on cardiac parasympathetic 
activity compared with the PCM treatment, due to the systemic as opposed to local 
vasoconstriction that can induce greater increases in central blood volume or faster 
reductions in core temperature (Buchheit, Peiffer, Abbiss, & Laursen, 2009). As the 
reductions in core temperature were comparable across treatments it was evident 
that, under resting conditions, the local cryotherapy stimulus occurring from PCM 
cooling was enough to cause systemic effects. However, it remains imperative to 
again mention that this effect would likely have been suppressed following exercise.  
An interesting observation in the present study was the very clear divers reflex and 
Hunting reaction evident during the CWI treatment, but not during the PCM treatment. 
This phenomenon is brought about when superficial temperature rapidly drops and 
there is an initial re-distribution of warm blood from the periphery to the core in order 
to enable the preservation of core temperature. This rise in core temperature was 
apparent during the CWI treatment, which resulted in an increase in core temperature 
by 0.115°C (see Figure 19). This rise in core temperature corresponds with the 
elevated HR evident both immediately upon the commencement and cessation of 
CWI treatment, but not during PCM treatment (see Figure 20). As evident by the rise 
in core temperature during the CWI treatment, cold-induced vasoconstriction likely 
redistributed the peripheral blood into the thoracic vasculature, thereby increasing 
central blood volume and cardiac output which increased the HR during treatment. 
Indeed, this increase in HR, and the very likely accompanying increase in mean 
arterial blood pressure, is consistent with the cardiovascular cold pressor response 
(Lovallo, 1975; Raven, Wilkerson, Horvath, & Bolduan, 1975; Wray, Donato, 
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Nishiyama, & Richardson, 2007). Although HR was also slightly increased upon the 
initiation of PCM treatment, the spike was smaller. These results may have 
implications in athletes who already have elevated HRs following exercise. 
Furthermore, it is unknown what effect the periodic dilation of superficial tissues and 
warming of the core temperature during CWI treatment may have on recovery from 
exercise. However recent work investigating the effect of CWI on blood flow following 
exercise suggests that the results evident in the present study would not occur to 
similar magnitudes under exercising conditions (Mawhinney et al., 2013). The authors 
suggested that although the increased body temperature in individuals following 
exercise may reduce the overall degree of vasoconstriction, the vasoconstrictive 
response would be maintained throughout immersion, preventing the associated 
onset of cold-induced vasodilation. 
Since this study did not utilise an exercise intervention prior to the treatments, both 
the magnitude and duration of the physiological effects cannot be extrapolated to 
what might occur in a post-exercise condition. Indeed, the rate of reduction in blood 
flow from cryotherapy is inversely related to the activity status of the individual; 
meaning that a reduction in blood flow from cryotherapy is less following exercise 
than at rest (Gregson et al., 2011; Ihsan et al., 2013; Mawhinney et al., 2013; 
Yanagisawa, Kudo, Takahashi, & Yoshioka, 2004). Gregson et al. (2011) have 
previously demonstrated that colder immersion temperatures result in a larger cold-
induced vasodilation response and thus higher cutaneous blood flow at rest. The 
authors explained that under resting conditions, increases in cutaneous blood flow 
during colder water immersion redistribute blood from the underlying muscle; 
consequently, colder water may be more effective in reducing muscle blood flow and 
inflammation at rest. However, this is response is not the same following exercise. 
Exercise increases body temperature and skin blood flow. The elevations in thermal 
load following exercise ultimately reduce the magnitude of vasoconstriction that 
occurs during CWI treatment (Mawhinney et al., 2013). Thus, the cryotherapy dose 
must be greater following exercise than what would be necessary at rest in order to 
induce significant changes in blood flow following exercise. Therefore, the reductions 
in muscle and core temperature evident in the present study may not be replicated or 
might occur at a lesser degree following exercise encompassing a substantial 
metabolic component. This might explain the lack of effect from PCM cooling on 
accelerating recovery following a marathon run demonstrated in chapter 5. The 
extreme metabolic stress experienced by the entire body following the marathon likely 
elevated muscle and core temperatures in the study participants more so than in the 
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participants in chapter 4. In this regard local application of PCM to one muscle group 
in marathon runners might have been too little of a cooling stimulus to elicit any 
beneficial recovery effects. 
This study was not without limitations. Firstly, the shorter overall data collection period 
during the CWI trial compared with the PCM trial complicated the comparisons 
between treatments. However, it was not practical to have study participants remain 
instrumented for an additional 1 hour 45 minutes following CWI to match the PCM 
duration, especially since it was a crossover design. A post CWI duration of 2 hours 
was sufficient to demonstrate the magnitude and duration of effects on recovery, 
especially since it has been demonstrated that intramuscular temperature does not 
return to baseline for up to 4 hours following CWI administered after exercise 
(Johnson, Moore, Moore, & Oliver, 1979). The 3 hours PCM duration was chosen to 
replicate the treatment time in field testing (Clifford et al., 2018), and the 1 hour 
recovery time was deemed sufficient and practical for study participants who were 
sitting for more than 4 hours. Previous studies have demonstrated that the cooling 
effect in calf muscles is maintained for 3-4 hours following CWI in normothermic 
individuals due to inactivity (Myrer et al., 2001; Oliver & Johnson, 1976). Therefore, it 
was not feasible to keep study participants instrumented to monitor temperatures that 
likely would not have returned to baseline.  
Secondly, this study utilised a cohort of male participants with thigh skinfolds 
averaging 9.9 ± 5.2 mm. Reductions in intramuscular temperature were correlated 
with skinfold thickness during both treatments, due to the insulating effect of adiposity 
(Otte et al., 2002; Stephens et al., 2017). It has previously been shown that body 
composition influences the magnitude of change in the skin, muscle, and core 
temperature during and after CWI (Stephens, Halson, Miller, Slater, & Askew, 2018). 
It has also been suggested that muscle mass and its regional distribution, body 
surface area to mass ratio, age and ethnicity influence thermal and physiological 
responses to water immersion (Stephens et al., 2017). Therefore, the results of this 
study should be cautiously interpreted when relating them to a more heterogeneous 
group. This study should be repeated in a female population since women generally 
have greater subcutaneous body fat compared to men, and because for a given 
change in body temperature, as occurs during and from exercise, females require a 
greater cooling stimulus to maintain thermal comfort levels (Vargas et al., 2019). The 
results from this study might further differ in a female population due to the added 
variable of sex hormone-related fluctuations in body temperature and some 
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thermoregulatory processes during the menstrual cycle (Kaciuba-Uscilko & Grucza, 
2001). Consequently, the results of this study should be extrapolated with a degree 
of caution to the effect of CWI or PCM on intramuscular and core temperature in 
females and following exercise in both genders.  
6.5 Conclusion 
This was the first examination of the effect of PCM cooling on intramuscular 
temperature, core temperature and cardiovascular function. The magnitude of 
temperature reduction from prolonged PCM application was similar to that occurring 
during CWI treatment, but critically, PCM provided a cooling effect that was sustained 
for the entire duration of treatment and was better tolerated than CWI. The 
physiological effects evident in the present chapter might explain the previously 
reported benefits of PCM cooling in reducing muscle damage and accelerating 
recovery following eccentric exercise (chapter 4) as well as in professional soccer 
players (Brownstein et al., 2019; Clifford et al., 2018). However, as the present study 
implemented both treatments in resting individuals, future research should examine 
the impact of PCM application on intramuscular and core temperatures following 
exercise of both mechanical and metabolic nature, as well as in a more 
heterogeneous group. 
6.6 Perspectives 
This chapter aimed to determine the effects from 3 hours of PCM cooling and 15 
minutes of CWI, controlled for treatment temperature (15°C PCM and 15 ± 1°C CWI), 
on the intramuscular, core, and skin-temperature and cardiovascular responses. 
Although the magnitude of temperature reduction from both PCM and CWI was 
comparable, CWI reduced intramuscular temperature faster while PCM maintained 
the reduction in intramuscular temperature for longer (throughout the duration of PCM 
treatment). Importantly, this chapter demonstrated that both superficial (1cm) and 
deep (3cm) intramuscular temperatures remained reduced for the full duration of 
PCM treatment. These findings, in addition to the favourable reductions in skin and 
core temperature, indicate that prolonged exposure to cold via PCM does not result 
in thermal discomfort or risk of cold-related injury. This study further confirmed that, 
during application, both cryotherapy modalities exerted a central effect on core 
temperature and HR. These results suggest that the beneficial effect observed from 
indirect PCM cooling in chapter 4 was indeed a true systemic effect.  
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The findings of the present study, that both PCM and CWI reduce intramuscular 
temperatures to the same degree, support the use of PCM for prolonging the duration 
of cryotherapy exposure in order to prolong the effects on muscle and core 
temperature. The results from this investigation suggest that prolonged PCM is an 
efficacious alternative to CWI, in terms of reducing intramuscular and core 
temperatures. However, the present study utilised a thermoneutral non-exercising 
model. Thus, whether similar reductions in muscle and core temperatures would 
occur in exercising individuals can not be directly inferred from these results. 
Nevertheless, based on the known thermal and cardiovascular responses to CWI 
following exercise (Stephens et al., 2017), it is fair to assume that the physiological 
effects evident in the present study would have occurred to a lesser degree in the 
previous two chapters (due to the larger thermal gradients apparent following 
exercise vs in resting individuals). Furthermore, it is likely that the lack of effect in 
chapter 5 but not in chapter 4 could have been a result of a larger thermal gradient in 
the participants following the marathon in chapter 5 than following the isolated 
eccentric exercise in chapter 4. Ultimately, the findings from the present chapter 
provide evidence to support the overall aim of the thesis, which is to establish the 
efficacy of PCM as an alternative cryotherapy intervention for recovery from EIMD. 
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7.0 PROLONGED COOLING WITH 
PHASE CHANGE MATERIAL 
ENHANCES RECOVERY AND DOES 
NOT AFFECT THE SUBSEQUENT 
REPEATED BOUT EFFECT 
FOLLOWING EXERCISE 
 
 
 
 
 
 
This chapter has been accepted for publication: 
Kwiecien SY, McHugh MP, Hicks KM, Keane K, Howatson G. (2019). Prolonged 
cooling with phase change material enhances recovery and does not affect the 
subsequent repeated bout effect following exercise. Eur J Appl Physiol. 120(2), 413-
423.  
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7.1 Introduction 
The physiological response occurring during eccentric contractions places high 
mechanical stress on the involved muscles (see section 2.1.1). Mechanical stress 
results in EIMD and is accompanied by soreness, decrements in performance such 
as strength loss, a rise in serum CK concentration and changes in muscle morphology 
occurring after the acute bout of exercise (Brown et al., 1997; Ebbeling & Clarkson, 
1989; Howatson et al., 2007; McHugh et al., 2001, 1999; Nosaka & Clarkson, 1995). 
However, a prior bout of eccentric exercise provides a rapid adaptation and protection 
against both primary and secondary muscle damage in subsequent exercise sessions 
(RBE; Clarkson et al., 1987b; see section 2.1.3). The RBE is a protective effect 
against further muscle damage (Evans et al., 1986; Hyldahl, Chen, & Nosaka, 2017; 
McHugh, 2003) as evident by an attenuation in the signs and symptoms of EIMD 
following a second bout of exercise (Howatson & van Someren, 2008; Nosaka & 
Clarkson, 1995). However, athletes can still experience muscle damage albeit the 
stages of muscle damage in trained athletes are shorter, and the overall magnitude 
of EIMD is less than what it would be in untrained individuals.  
Athletes commonly utilise a plethora of recovery modalities to mitigate the acute and 
chronic signs and symptoms of EIMD, in an effort to recover faster and gain a 
competitive advantage. Cryotherapy, in the form of CWI, is one of the most popular 
recovery modalities utilised by athletes for its ability to diminish perceptions of 
soreness (see section 2.2.5.3.2). However, CWI treatment duration, limited by 
treatment temperature, is insufficient to markedly influence the physiological 
mechanisms responsible for accelerating recovery of the signs and symptoms of 
EIMD. In order to overcome these limitations, the use of a cooling modality capable 
of prolonging the duration of cryotherapy exposure was introduced in chapter 4. The 
ability of PCM to safely maintain reduced intramuscular and core temperatures, 
comparable to CWI, was demonstrated in chapter 6. However, in chapter 4, PCM was 
applied following only a single session of exercise. Therefore, it remains unknown 
whether the RBE can still be induced in a subsequent bout of exercise if PCM 
accelerated recovery after an initial bout of exercise. 
Cryotherapy interventions that suppress the acute inflammatory response and 
accelerate recovery might negatively affect the damage-repair-adaptation processes 
of skeletal muscle (Woods, Lu, & Lowder, 2000), functional performance and 
proprioceptive acuity (Costello & Donnelly, 2011), and might hinder normal adaptive 
training responses to strenuous exercise (Figueiredo et al., 2016; Fröhlich et al., 
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2014; Roberts, Raastad, et al., 2015; Yamane, Ohnishi, & Matsumoto, 2015; Yamane 
et al., 2005). Hence it remains imperative to recognize the paradox between the use 
of cryotherapy to facilitate recovery and the potential negative effects that may be 
caused by blunting the stress response (White & Wells, 2013). Especially since some 
degree of inflammation, which plays a crucial role in the remodeling and adaptation 
of skeletal muscle is required for the resolution of muscle fibre damage resulting from 
an exercise insult. Indeed, CWI after routine strength workouts has been shown to 
attenuate training-induced adaptations during several weeks of training (Yamane et 
al., 2005). However, the effects of cryotherapy interventions on the RBE and whether 
they inhibit the RBE are not well understood.  
The overall aim of this thesis is to determine whether prolonged PCM cooling can be 
effectively utilised for recovery following exercise. However, chapter 4 only 
established the efficacy of prolonged PCM cooling for accelerating recovery following 
a single exercise exposure. Therefore, it remains imperative to determine its efficacy 
between repeat bouts of exercise. Hence this chapter aimed to determine whether 
prolonged PCM cooling after an initial bout of eccentric exercise blunts the adaptive 
response that protects against damage following a subsequent bout of eccentric 
exercise. Additionally, in order to examine the effects of prolonged cooling on blood 
markers of muscle damage and inflammation following exercise of mechanical 
nature, it was necessary to measure these variables in this chapter as they were not 
assessed in chapter 4.  The hypothesis was twofold: i) that prolonged PCM cooling 
would accelerate recovery from eccentric exercise compared to a control, and that ii) 
the accelerated recovery from an initial bout of strenuous quadriceps exercise would 
reduce the adaptive response to a subsequent bout of strenuous quadriceps 
exercise. 
7.2 Methods 
7.2.1 Participants 
A sample size analyses was performed based on the strength results from chapter 4 
and Clifford’s (2018) work. It was estimated that a minimum of 13 participants per 
group were needed to detect a 10% difference in strength with a power of 0. 80 and 
an alpha level of 0.05. Consequently, twenty-six male participants (mean ± SD; age, 
25 ± 6 years; height, 179.5 ± 5.6 cm; body mass, 82.9 ± 11.9 kg) volunteered to 
participate in this study. All participants were trained athletes participating in sport, 
e.g. ice hockey, basketball, soccer, Gaelic football, powerlifting. Participants 
124 
 
completed the experimental protocol during their offseason. Participants were free 
from injury within the past 6 months. Participants were instructed to refrain from taking 
non-steroidal anti-inflammatory drugs, nutritional supplements, pharmacological 
interventions, therapeutic interventions, and strenuous exercise unrelated to the 
present study for the duration of the two study periods. The institutional research 
ethics committee, in line with the Declaration of Helsinki, approved all procedures. 
7.2.2 Experimental Design 
Participants reported to the laboratory for two periods of four consecutive days, each 
period separated by two weeks. On day one participants performed bout 1 of 
eccentric quadriceps exercise on each leg and were randomised to receive either 
‘treatment’ frozen 15°C PCM or ‘control’ room temperature PCM applied to the 
quadriceps for 6 hours, starting immediately following the exercise. Two weeks later 
participants performed bout 2 and repeated an identical bout of eccentric exercise. 
All participants received room temperature PCM post-exercise following bout 2. Prior 
to each eccentric exercise bout, and on each of the subsequent days, assessments 
of soreness, strength (Newton meters; Nm), and blood markers of muscle damage 
(CK) and inflammation (hsCRP) were made (Figure 21). 
 
 
 
Figure 21: Experimental protocol for one bout of isolated eccentric quadriceps 
exercise. The protocol was repeated for bout two, with the exception that both 
treatment and control conditions received room temperature PCM following exercise. 
(Note: figure not to scale). 
 
7.2.3 Phase Change Material Application 
Upon initial completion of the eccentric exercise protocol, participants in the treatment 
group immediately applied frozen 15°C PCM to the quadriceps of both legs while 
participants in the control group applied melted room temperature PCM to both legs, 
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for a total of 6 hours. Upon completion of the exercise protocol 2 weeks later, both 
treatment groups applied room temperature PCM to both legs for a total of 6 hours. 
For complete PCM application procedures, please refer to section 3.5 and Figure 7. 
7.2.4 Strength Assessment  
Strength was tested at each of 50°, 80° and 100° knee flexion. For complete strength 
testing procedures, please refer to section 3.8.  
7.2.5 Eccentric Exercise Protocol 
The eccentric exercise protocol consisted of 120 eccentric quadriceps contractions 
(10 sets, 12 repetitions), with the range of motion set at 40° (0° = full extension) to 
100° knee flexion. For thorough detail of the eccentric exercise protocol, please refer 
to section 3.9.  
7.2.6 Soreness Assessment 
For procedures to assess muscle soreness, please refer to section 3.10.  
7.2.7 Skin Temperature Measurement 
For procedures to assess skin temperature, please refer to section 3.6.  
7.2.8 Compression Pressure Measurement 
For procedures to measure compression pressure, please refer to section 3.7.  
7.2.9 Blood Sampling and Analysis 
For a detailed explanation of blood sampling and analysis, please refer to section 
3.11. 
7.2.10 Statistical Analysis  
All data are presented as mean ± SD. Since torque differences between angles were 
not relevant to the effect PCM cooling had on the recovery of strength, strength was 
reported as the average of each leg at each of the three test angles for assessing 
strength loss on the days after eccentric exercise. In order to remove the effect of 
inter-individual variation in knee extension strength, strength on the 3 days following 
eccentric exercise was expressed as a percentage change relative to baseline 
strength of each respective bout. The effect of PCM cooling across exercise bouts on 
average strength loss, soreness, CK, and hsCRP on the days after eccentric exercise 
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was assessed using 2 x 2 x 4 mixed-model ANOVA. The two levels for the treatment 
factor were PCM cooling and control. The two levels for the bout factor were initial 
bout (bout 1) and repeated bout (bout 2). The four levels for the time factor were 
baseline, day 1, day 2, and day 3 after the eccentric exercise. Strength prior to the 
initial eccentric exercise bout was compared to strength prior to the repeated bout 
using 2 x 2 x 3 treatment by bout by angle mixed-model ANOVA. The purpose of 
these analyses was to see if there was a shift in the angle-torque relationship 
consistent with the RBE, with a relative increase in torque at long muscle lengths and 
a decline at short muscle lengths as shown by McHugh & Tetro, (2003). The average 
skin temperature during each bout was compared between treatments using a mixed-
model ANOVA. 
Normality of all data sets was examined using the Shapiro-Wilk test and where 
necessary data were logged transformed to establish a normal distribution (CK was 
the only variable that had to be log transformed). Additionally, CK as a percentage 
change from baseline was analysed using Friedman Tests for the effect of time and 
Wilcoxon Signed Ranks Test for pairwise comparisons. Mauchly’s test was used to 
assess assumptions of sphericity and, where necessary, Greenhouse–Geisser 
corrections were used. Where there was a significant treatment or treatment by time 
interaction effect, differences between treatments at any particular time interval were 
assessed with independent t-tests using Bonferroni corrections for planned pairwise 
comparisons. Where appropriate, Cohen’s d ES statistics were calculated to provide 
magnitude of effects; with the magnitude of effects considered either small (0.20-
0.49), medium (0.50-0.79), and large (>0.80). The upper and lower limit of 95% 
confidence intervals (CI) for least significant difference are reported where relevant. 
Statistical analyses were performed using SPSS v.21 (IBM, Armonk, NY, USA) and 
a P-value of less than 0.05 was considered statistically significant.  
7.3 Results 
7.3.1 Strength 
In bout 1 quadriceps muscle strength showed a main effect of time (F = 9.9, P < 
0.0001, ES = 1.28; Figure 22), indicating the presence of muscle damage after the 
initial bout of isolated eccentric exercise. In bout 1 overall recovery of MIVC was 
independent of treatment (P = 0.75); however, the significant interaction effect (F = 
5.5, P = 0.002, ES = 0.96) indicated that over time there was a greater recovery of 
strength in the PCM treatment vs the control group (PCM time effect: F = 24.6, P = < 
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0.0001, ES = 2.86, PCM CI: 98.4-103.0%; control time effect: P = 0.143, control CI: 
92.1-100.8%). By contrast, quadriceps muscle strength also showed a main effect of 
time in the repeated bout (F = 4.5, P = 0.011, ES = 0.87), but there was no group (P 
= 0.058) or interaction effect (P = 0.172). While there was no significant overall bout 
(P = 0.093) or treatment effect (P = 0.910), there was a significant bout*treatment 
interaction (F = 5.7, P = 0.025, ES = 0.98; PCM B1 CI: 97.4-104.0%, B2 CI: 96.7-
102.4%; control B1 CI: 93.2-99.8%, B2 CI: 100.6-106.4%) and a significant 
treatment*bout*time interaction (F = 5.4, P = 0.002, ES = 0.95). Expectedly, post hoc 
analyses indicated that only the control condition exhibited a significant bout effect (F 
= 6.2, P = 0.028, ES = 1.44, control B1 CI: 92.1-100.8%, B2 CI: 100.3-106.7%; PCM 
bout effect: P = 0.573). 
There was no change in the baseline angle-torque relationship between the initial and 
repeated bouts (P = 0.90). Further the overall bout by treatment effect at baseline 
was P = 0.052. However, in the PCM cooling group, baseline strength increased 
across all three angles by 10% from the initial bout to the repeated bout (F = 17.8, P 
= 0.001, ES = 2.43, CI: 11.3 to 35.5; increased by 23.4 ± 20 Nm in the second bout 
but remained unchanged between bouts in the control group (< 1% difference; P = 
0.809). For illustrative purposes, torque data for each day of data collection of each 
bout are presented in Table 9 to demonstrate the return of function following the 
exercise protocol. 
During eccentric exercise in bout 1, average peak torque (Nm) increased by 9% from 
the first to the 10th set (F = 8.0, P < 0.0001, ES = 1.15), but this was not different 
between treatments (P = 0.319; 6.5% increase in PCM treatment vs. 11.6% increase 
in control). In bout 2, eccentric torque was not different from the first to the 10th set 
(P = 0.515), and there was no difference between treatments (P = 0.142). For bout 1, 
eccentric torque was 100 ± 1.0% of isometric peak torque for PCM treatment (P = 
0.991) and 102 ± 1.0% for control (P = 0.689). For bout 2, eccentric torque was 102 
± 1.2% for PCM treatment (P = 0.564) and 115 ± 1.3% for control (P = 0.032, ES = 
0.95). Target intensity over the 10 sets was not different from the initial to the repeated 
bout for PCM treatment (P = 0.392), but increased by 10% in the control group (F = 
9.4, P = 0.011, ES = 1.85; B1 CI: 6.7-12.8%, B2 CI: 5.3-24.5%). 
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Table 9: Isometric strength (MIVC) of the quadriceps averaged across all 3 test 
angles of the PCM treatment and control group reported as net torque values (Nm) 
on each day after eccentric exercise for each bout of exercise. 
 
 PCM (Nm) Control (Nm) 
 Bout 1 Bout 2 Bout 1 Bout 2 
Baseline 222 ± 46 246 ± 53 231 ± 46 233 ± 53 
Day 1 210 ± 52 238 ± 53 219 ± 52 238 ± 53 
Day 2 224 ± 52 244 ± 46 219 ± 52 239 ± 46 
Day 3 239 ± 56 248 ± 47 225 ± 56 248 ± 47 
Time Effect P < 0.0001 P = 0.113 P = 0.157 P = 0.061 
Note: Values are mean ± SD. 
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7.3.2 Soreness 
Overall soreness was lower in the PCM treatment group than in the control group (F 
= 4.5, P = 0.044, ES = 0.87; PCM CI: 0.9-2.0, control CI: 1.7-2.7). In bout 1 quadriceps 
muscle soreness showed a main effect of time (F = 77.6, P < 0.0001, ES = 3.60; 
Figure 23). In bout 1 overall recovery of soreness was independent of treatment (P = 
0.098); however over time soreness recovered faster in the PCM treatment group 
than in the control group (F = 4.1, P = 0.009, ES = 0.83; PCM CI: 1.4-2.7, control CI: 
2.1-3.4), indicating an attenuated recovery of soreness in the PCM treatment group. 
Although there was also a main time effect for soreness in bout 2 (F = 31.6, P < 
0.0001, ES = 2.29), there was no difference in between treatments, as evident by the 
non-significant group (P = 0.070) and interaction (P = 0.061) effects. Consistent with 
a RBE soreness was overall lower in bout 2 than in bout 1 (F = 26.2, P < 0.001, ES 
= 1.32; B1 CI: 2.0-2.8, B2 CI: 0.8-1.7).  
7.3.3 Skin Temperature 
There was an overall treatment effect for skin temperature (F = 118.9, P < 0.0001, 
ES = 5.44; PCM CI: 27.4-29.0°C, control CI: 32.9-34.3°C). In the first bout, PCM 
treatment resulted in an average skin temperature of 23.9 ± 0.7°C for the 6-hour 
treatment duration compared with 33.9 ± 0.9°C during the control condition. Skin 
temperature did not differ between treatments in the second bout (P = 0.264). 
7.3.4 Compression Pressure 
Compression pressure was not different between treatments or across bouts in both 
seated (P = 0.621) or standing (P = 0.209) positions. Average compression pressure 
was 14.5 ± 1.7 mm Hg while seated and 8.7 ± 1.4 mm Hg while standing, which is 
negligible compared with the pressure needed to influence recovery through 
compression garments (14.8 ± 2.2 mm Hg while standing; Hill et al., 2017). 
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7.3.5 Blood Markers 
Both the initial (time effect: F = 4.6, P = 0.031, ES = 0.88) and repeated bouts (time 
effect: F = 17.3, P < 0.0001, ES = 1.70) caused elevations in CK (% baseline; Figure 
24a), with no difference between treatments or treatments over time in either bout. 
Despite % baseline CK showing a trend towards a bout effect, this was not significant 
(P = 0.067). Across the two bouts of exercise lnCK was overall lower for the PCM 
treatment group than for control (PCM: 2.25 vs control: 2.44; F = 5.1, P = 0.033, ES 
= 0.92; PCM CI: 2.14-2.37, control CI: 2.32-2.56). In bout 1, lnCK (log transformed) 
was elevated over time (Figure 24b; F = 21.2, P < 0.0001, ES = 1.88), and was overall 
higher in the control group vs the PCM treatment group (F = 5.3, P = 0.031, ES = 
0.94; PCM CI: 2.09-2.35, control CI: 2.30-2.57) with no difference in elevation 
between treatments over time (P = 0.896). Although there was also a main time effect 
for lnCK in bout 2 (F = 17.1, P < 0.0001, ES = 1.69), there was no difference between 
treatments (treatment effect: P = 0.160) or treatment groups over time (treatment by 
time effect: P = 0.099). The overall lnCK response was comparable across both bouts 
(bout effect: P = 0.516) and was not different across treatments (bout by treatment 
effect: P = 0.632).  
Overall, hsCRP was unaffected by the exercise stimulus regardless of bout (Table 
10), with no difference between bouts (P = 0.358) and no difference between 
treatments (treatment effect: P = 0.376, bout by treatment effect: P = 0.447).  
 
Table 10: Inflammatory indices response (hsCRP) in the blood before (baseline) and 
for 3 days (Day 1, 2, and 3) after the eccentric exercise for each bout of exercise in 
the PCM and control groups. 
 
 PCM (ug/ml) Control (ug/ml) 
 Bout 1 Bout 2 Bout 1 Bout 2 
Baseline 0.66±0.48 0.73±0.57 0.76±0.48 0.86±0.57 
Day 1 0.80±0.52 0.80±0.83 0.87±0.52 1.24±0.83 
Day 2 0.71±0.57 0.98±0.72 0.83±0.57 1.19±0.72 
Day 3 0.76±0.55 0.86±0.70 0.81±0.55 1.11±0.70 
Time Effect P = 0.531 P = 0.324 P = 0.498 P = 0.175 
Note: Values are mean ± SD. 
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7.4 Discussion 
This study investigated whether protection provided by PCM cooling after an initial 
bout of eccentric exercise compromised the RBE. The exercise was successful in 
inducing muscle damage in bout 1, which was evident by the strength loss one day 
following the exercise in the control group (Figure 22). In the initial bout, PCM cooling 
accelerated recovery of strength and soreness vs the control group with no difference 
in CK elevation and minimal hsCRP elevation in either group. After the repeated bout 
there was no difference in strength, soreness, CK or hsCRP between groups, 
indicating that the protection provided by PCM cooling in the initial bout was not 
compromised when cooling was not provided after the repeated bout. This is the first 
investigation to examine the effect of prolonged cooling from PCM on the RBE, and 
the first investigation to demonstrate that PCM did not compromise the adaptive 
response associated with the RBE in bout 2. The findings following the exercise in 
bout 1, that PCM cooling augmented quadriceps muscle strength and accelerated 
recovery of soreness compared to the control condition by day 3, support the findings 
of chapter 4 which demonstrated PCM to be an effective strategy when recovering 
from EIMD of mechanical nature performed by untrained individuals.  
Athletes have adopted CWI as a popular recovery modality aimed at limiting muscle 
damage and accelerating recovery (Versey et al., 2013). In a majority of the literature, 
single post-exercise CWI treatments have been used, with some studies 
administering CWI at intervals of 24 hours. Unlike the results of the present study and 
of chapter 4, the literature has failed to exhibit a favourable effect of CWI on the 
recovery of muscle strength using single immersion protocols (Leeder et al., 2012). 
When multiple immersions were administered within the first 24 hours following lower 
body exercise, CWI was effective in accelerating recovery of muscle strength 
compared to control (Skurvydas et al., 2006). Repeat immersions within the first 24 
hours are logical, considering that exacerbation of muscle injury in the post-exercise 
period occurs in several stages (Paulsen et al., 2010); parts of which do not initiate 
until 2-6 hours following exercise (Armstrong et al., 1991). Unfortunately, multiple 
immersion sessions within this window may be inconvenient for athletes. Especially 
considering that access to CWI equipment over multiple sessions is difficult, and 
could mean that athletes need to remain at the training facility for long periods 
following competition or training. Prolonging the duration of cryotherapy application, 
with little logistical challenges, is an attractive benefit of PCM. 
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In addition to accelerating recovery of strength, PCM cooling also significantly 
reduced soreness compared to the control condition in bout 1. This was consistent 
with the results of chapters 4, as well as our research concurrent to this thesis 
applying PCM for 3 hours following a soccer match (Clifford et al., 2018). Importantly, 
although not significant, a trend was evident for reduced soreness from PCM cooling 
in bout 2 (P = 0.061). Thus, the findings of the present study imply that prolonged 
PCM cooling not only accelerated recovery of soreness following an initial bout of 
exercise, but this effect also did not inhibit the adaptive RBE response. Reduced 
soreness is also the most consistent effect of CWI (Bleakley et al., 2012; Hohenauer 
et al., 2015; Leeder et al., 2012; Machado et al., 2016). However, the overall effect of 
CWI on soreness has been proposed to be dependent on exercise mode, as well as 
the degree of muscle damage, or the training status of the individual. Both Leeder et 
al. (2011) and Ihsan et al. (2016) have suggested that CWI seems to be more 
effective in ameliorating effects of EIMD, such as soreness, induced by whole-body 
prolonged endurance exercise, intermittent based exercise, or high-intensity 
exercise, than following eccentric exercise. Although this was not the case as evident 
in chapter 5 of this thesis, prolonged PCM cooling was effective in accelerating 
recovery of soreness following a single exercise bout (chapter 4) as well as following 
the repeat exercise bouts in the present study. 
This was the first study to measure CK following prolonged PCM cooling applied after 
eccentric exercise. There was a clear elevation in CK in bout 1 with no effect of PCM 
cooling and a clear RBE that was not different between treatments (Figure 24). 
Studies have previously demonstrated an RBE for CK (Howatson et al., 2007; 
Nosaka, Sakamoto, Newton, & Sacco, 2001). The lack of effect from PCM cooling on 
CK elevation in bout 1 was consistent with CWI literature showing no effect of CWI 
on CK efflux on the days after exercise (Anderson et al., 2018; Bailey et al., 2007; 
Bleakley & Davison, 2009; Fonseca et al., 2016; Halson et al., 2008; Howatson et al., 
2009b; Leeder et al., 2015; Pointon et al., 2011b; Rowsell et al., 2009). This was also 
the first study to measure CRP following PCM cooling applied after eccentric exercise. 
Unfortunately, the exercise stress was insufficient to elevate CRP. Based on previous 
work, it was anticipated that performing bilateral eccentric quadriceps exercise at a 
high intensity would sufficiently elevate CRP (Margaritelis et al., 2015; Michailidis et 
al., 2013; Paulsen et al., 2005). However, compared to the present study which 
involved 120 eccentric contractions of each leg in the exercise protocol, the studies 
mentioned above performed 300 eccentric contractions (Michailidis et al., 2013; 
Paulsen et al., 2005), or 70 eccentric contractions repeated over multiple days 
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(Margaritelis et al., 2015) at various ranges of motion. The exercise protocol in the 
present study was perhaps insufficient in inducing myofibrillar disruption that would 
result in inflammation. Other studies have shown no elevation in CRP from similar 
eccentric protocols (Bowtell, Sumners, Dyer, Fox, & Mileva, 2011). Studies using 
CRP to quantify the inflammatory response following CWI have also reported no 
effect (Banfi et al., 2007; Halson et al., 2008; Ingram et al., 2009)  
This study was not without limitations. Primarily, the recovery of force to values above 
baseline in the PCM treatment condition in bout 1 indicates a potential learning effect. 
However, neither the isometric strength net torque values at baseline nor the average 
peak torque of the eccentric exercise were different between groups. Further as the 
same experienced investigator performed each MIVC whilst giving good instruction 
and stabilization and adhering strictly to the standardized procedure, it seems unlikely 
that only the treatment group experienced a learning effect. Thus, the results are a 
true treatment effect and comparable to the recovery of strength evident in chapter 4 
of this thesis. Although the participants performed the eccentric exercise at 101% of 
their MIVC at 80° of knee flexion, the muscle damage response in bout 1 was smaller 
than anticipated. The lower limbs are less susceptible to EIMD than the limbs of the 
upper extremity (Saka et al., 2009), because the lower limbs are regularly exposed to 
prior bouts of eccentric exercise during day-to-day locomotion. The literature primarily 
utilises an upper extremity model to study EIMD (Clarkson & Tremblay, 1988; 
Newham, 1988; Nosaka, Clarkson, McGuiggin, & Byrne, 1991; Nosaka & Newton, 
2002b). The upper limb muscle groups are less accustomed to eccentric loading and 
for this reason are more susceptible to damage but lack specificity when making 
inference to many sports and exercise (Howatson & van Someren, 2008). In the 
present study, participants performed eccentric contractions from 40-100° knee 
flexion to maximise the damage response. Strength loss and soreness have been 
previously demonstrated performing the same intensity isokinetic eccentric exercise 
from 70-110° knee flexion (McHugh & Pasiakos, 2004). By asking participants to 
reach a target torque of 90% MIVC during the eccentric exercise protocol in the 
present study, it transpired that participants exceeded the target torque and reached 
100% of their MIVC, or greater. In bout 2, although the participants in the control 
condition exceeded 100% of their MIVC torque, performing the eccentric exercise at 
a greater intensity did not confound the results, as there was a RBE for all variables 
on the days following exercise. Further, participants hit the target torque at the lower 
spectrum of the knee flexion range of motion and therefore did not do much eccentric 
work at the longer muscle lengths. In retrospect, a range of motion between 70-110° 
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would have necessitated peak torque occurring at greater knee flexion causing more 
damage. Compounding this problem, participants were relatively well trained in the 
quadriceps (college ice hockey, and other sports requiring strong quadriceps). While 
these participants would have been susceptible to damage at long muscle lengths, 
they were likely protected against damage with the eccentric peak torque occurring 
at a shorter muscle length than intended. 
Current evidence indicates that CWI is not universally beneficial for adaptation to 
exercise. In particular, regular repeat immersions during strength training attenuate 
muscle adaptations, and improvements in both maximal strength (Roberts, Raastad, 
et al., 2015; Yamane et al., 2015) and muscle mass (Fyfe et al., 2019; Roberts, 
Raastad, et al., 2015; Yamane et al., 2015). One of the proposed mechanisms behind 
these effects is an attenuation in the molecular mechanisms regulating resistance 
training adaptations (Broatch et al., 2018; Earp, Hatfield, Sherman, Lee, & Kraemer, 
2019; Figueiredo et al., 2016; Lindsay, Carr, Othman, et al., 2015; Lindsay, Othman, 
Prebble, Davies, & Gieseg, 2016; Roberts, Raastad, et al., 2015). However, athletes 
commonly perform dynamic exercises during training and competition, as well as 
participate in multiple exercise sessions over a season of sport, and sometimes even 
over 24 hours. In particular, in sporting events with multiple games occurring within 
short periods of each other, such as tournament play or fixture congestion, facilitating 
recovery is a priority over muscle adaptation. Hence, in the regular season of many 
sports, the goal of in-season management of the athlete is to facilitate recovery and 
avoid catabolism as opposed to inducing anabolic training adaptations. Thus, 
although the exercise paradigm utilized in the present study and in chapter 4 
implemented an isolated exercise model which does not directly compare to the 
dynamic exercises most commonly performed by athletes, prolonged PCM cooling 
might still be efficacious in accelerating recovery following dynamic or team sport 
exercise as was evident in concurrent work related to this thesis (Brownstein et al., 
2019; Clifford et al., 2018). Specifically, prolonged PCM cooling could be useful during 
periods of training when the exercise stress is higher than normal or when there is 
inadequate time for recovery, without concern of a detrimental effect on the adaptive 
response.  
7.5 Conclusion 
The only study to date examining the effects of CWI following exercise on the RBE 
failed to show any favourable effect on variables of EIMD following the initial bout of 
exercise (Howatson et al., 2009b). Thus, both the CWI and control groups exhibited 
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a RBE that was not compromised by the CWI. In contrast, following the initial bout of 
exercise in the present study, recovery of strength and soreness were accelerated 
from prolonged PCM cooling. Importantly, the adaptive response was not 
compromised by the prolonged cooling. Although the findings of this chapter and of 
chapter 4 established the efficacy of PCM to expedite recovery following an isolated 
exercise resulting in EIMD, these results can not be directly translated to a 
competitive athletic environment involving dynamic whole body movements and 
multiple bouts of exercise. However, implementing a full body exercise stress, 
comparable to an athletes training or competition regimen, was beyond the scope of 
this investigation. Thus, the present study supports the use of prolonged PCM cooling 
for its ability to mitigate decrements of strength and soreness following isolated 
exercise of mechanical nature while not interfering with the adaptive RBE response. 
The present study adds to evidence indicating that prolonged PCM cooling following 
eccentric exercise could enhance both short- and longer-term recovery of strength 
and soreness. The precise mechanisms for accelerated recovery from prolonged 
PCM cooling remain to be elucidated.  
7.6 Perspectives 
Since the overall aim of this thesis is to elucidate the effects of PCM on recovery from 
exercise, it was pertinent to establish these effects not only following a single exercise 
session but also on subsequent exercise bouts. Especially since the RBE is a 
naturally occurring adaptive response. The previous chapters implemented prolonged 
PCM cooling following a single bout of exercise. It is well understood that a second 
bout of comparable eccentric exercise reduces the signs and symptoms of EIMD. 
Thus, this chapter investigated the influence prolonged PCM cooling had on the RBE. 
It was possible that if PCM cooling blunted the inflammatory response in the first bout 
of exercise, the RBE would not have been evident in the second bout in the PCM 
treatment group. This would have indicated that PCM cooling had a detrimental effect 
on the normal RBE. However, this response was not the case, as evident by the lack 
of strength loss and lower soreness in the PCM group in bout two of the present 
chapter.  
The findings of the present study support the findings from chapter 4 by 
demonstrating that PCM cooling enhances the recovery of strength and reduces 
soreness following a single bout of eccentric exercise. Further, this study provides 
new information about the effect, or lack thereof, of prolonged PCM cooling on blood 
markers of muscle damage following eccentric exercise, which were not measured in 
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chapter 4. Although PCM cooling did not affect the CK response in bout 1 or the 
hsCRP response in both bouts, following the second bout of exercise CK recovered 
more rapidly in the group receiving PCM treatment. Importantly, these data show for 
the first time that prolonged PCM cooling does not compromise the adaptive response 
associated with the RBE. The findings of this chapter, coupled with the results of the 
previous chapters, address the overall aim of the thesis by indicating that prolonged 
PCM cooling can be utilised by athletes to accelerate recovery over repeated bouts 
of eccentric exercise without hindering the adaptive response.  
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8.0 GENERAL DISCUSSION AND 
FUTURE DIRECTIONS 
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8.1 Chapter Summary 
Interventions that attempt to attenuate the signs and symptoms of EIMD and 
accelerate recovery following exercise have become popular among athletes in order 
to gain a competitive advantage. Cryotherapy, the application of cold for therapeutic 
purposes, has recently gained popularity. The most popular form of cryotherapy, CWI, 
has received a great deal of attention in the literature. Despite its growing popularity, 
there remains conflicting evidence to support the use of CWI for recovery from 
exercise. Most commonly, CWI is reported to be beneficial for reducing DOMS 
(Bleakley et al., 2012; Leeder et al., 2012); and its effects on accelerating recovery of 
other variables are negligible (Poppendieck et al., 2013). Furthermore, there is some 
evidence suggesting that the therapeutic effects attributed to cryotherapy treatment 
might be due to a placebo effect (Broatch et al., 2014). Several factors could explain 
the overall lack of effect of CWI, and other cryotherapy modalities, on recovery from 
exercise. These include variability in the exercise model, immersion temperature, 
duration, and frequency. Ultimately, the magnitude of change in tissue temperature 
has been positively correlated with cryotherapy methods of longer duration (Peiffer, 
Abbiss, Watson, et al., 2009). Consequently, the overall aim of this thesis was to 
investigate and establish the efficacy of a novel cryotherapy modality (PCM) capable 
of prolonging the cooling duration on accelerating recovery from exercise (see figure 
25). 
The first experimental chapter of this thesis was a pilot study aiming to establish the 
efficacy of PCM cooling as an alternative cryotherapy intervention for recovery of 
strength and soreness in the quadriceps on the days following bilateral isolated 
eccentric exercise. The results from the initial study served as a proof of concept by 
establishing that prolonged PCM cooling accelerated recovery of strength and 
soreness following muscle damage of mechanical nature in a single muscle group. 
Since there were three treatment groups: direct cooling, indirect cooling, and control; 
and the treatment effects for strength and soreness were not different between the 
direct and indirect cooling conditions, the results indicated that a systemic effect might 
have occurred in the indirect cooling leg from the leg that received direct cooling. This 
study also demonstrated the practical utility of a wearable garment to deliver 
prolonged cooling to muscles after damaging exercise, and suggested that PCM worn 
for 6 hours was well tolerated. 
The second chapter implemented a metabolic stress exercise model in order to 
determine the efficacy of PCM cooling for accelerating recovery following a marathon 
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run. In addition to measuring strength and soreness, which were also measured in 
the pilot study, this investigation also measured CMJ height and blood markers of 
muscle damage (CK) and inflammation (hsCRP). The marathon led to decreases in 
muscle function, increases in perceptions of soreness, and increases in blood 
markers of muscle damage and inflammation. Despite the positive effects from 
prolonged PCM cooling evident in the pilot study, the application of 3 hours of PCM 
cooling did not offer an advantage for accelerating recovery of any of the variables 
following the marathon run. Overall, these results suggested that PCM cooling is not 
an effective recovery modality for exercise encompassing a large metabolic 
component.  
The third chapter determined the degree of cooling occurring at the skin, in the 
muscle, and in the body while 3 hours of PCM cooling were applied to the quadriceps. 
These effects were also measured in a 15-minute temperature matched (15°C) CWI 
treatment. The cardiovascular response to both cryotherapy modalities was also 
determined. In this investigation, the magnitude of temperature reduction from PCM 
was comparable to CWI, but the intramuscular temperature was decreased for longer 
for the duration of PCM cooling. Additionally, a central effect was confirmed by the 
reduction in core temperature and the increase in HRV, during both treatments. These 
findings provide evidence that the effects at the musculature from PCM cooling are 
comparable to those from CWI treatment and explain in part the accelerated recovery 
from PCM cooling in the pilot study.  
The final investigation was designed to build on the findings of the pilot study in a 
larger sample of participants, with a between-groups design to negate the potential 
confounding effect of a systemic effect. The exercise protocol was repeated by all 
participants two weeks later in order to establish the effects of prolonged PCM cooling 
on the adaptive response to exercise. Additionally, the blood markers that were 
measured in chapter 5 were also measured in this study. Unlike the marathon run in 
chapter 5, the results indicated that the isolated eccentric exercise did not increase 
the markers of muscle damage and inflammation. However, the results supported the 
findings of chapter 4, as the recovery of strength and soreness were again 
accelerated, while also demonstrating that prolonged cooling did not interfere with the 
RBE. 
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Figure 25: Schematic illustration of the main findings establishing the efficacy of a 
novel cryotherapy modality (PCM) capable of prolonging the cooling duration on 
accelerating recovery from exercise. Blue arrow illustrates the physiological effects 
of PCM cooling in an unexercised thermoneutral individual (chapter 6). Red arrow 
illustrates the effects of PCM cooling in an individual following metabolic stress, a 
marathon run (chapter 5). Green arrow illustrates the effects of PCM cooling in an 
individual following one bout of mechanical stress, isolated quadriceps eccentric 
exercise (chapter 5), and the effects from PCM cooling following a repeated bout of 
the same exercise (chapter 7). The yellow arrows indicate questions arising from 
the results presented throughout the chapters encompassing this thesis. The 
question of whether the beneficial effects from PCM cooling on accelerating 
recovery of strength and soreness following one bout of isolated eccentric exercise 
was answered in chapter 7. 
 
8.2 Discussion 
Athletes have been turning to a wide range of recovery modalities in order to alleviate 
the signs and symptoms of EIMD. A modality capable of reducing the severity of 
muscle damage and lessening the strength loss and soreness that are a common 
consequence resulting from EIMD would accelerate the recovery period. The results 
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from the investigations encompassing this thesis provide novel findings that ultimately 
may give athletes a competitive advantage over their peers, if implemented 
appropriately. The chapters included within this thesis exploited the ability of a novel 
cryotherapy modality, PCM frozen at 15°C, to deliver a single dose of prolonged 
cooling. In humans, prolonging the duration of cooling has previously only been 
achieved by repeating cryotherapy treatments. Extending the positive effects 
associated with cryotherapy, based from data evident in animal models (see section 
2.2.2), may translate to greater recovery following exercise; but to date results in 
humans are scarce and inconclusive. 
The findings of this thesis suggest that prolonging the duration of cooling successfully 
accelerates recovery of strength and soreness following isolated eccentric exercise 
(chapter 4), and that this effect does not inhibit the RBE (chapter 7); but that 
prolonged cooling does not elicit comparable effects following a marathon run 
(chapter 5). These results generally concur with the existing body of literature that 
supports the use of CWI for accelerating subjective measures of soreness following 
exercise (see section 2.2.5.3.2). However, the findings from this series of 
investigations have led to some novel conclusions. Primarily that, unlike CWI which 
has generally failed to show any benefit on the recovery of strength (see section 
2.2.5.3.3), prolonged PCM cooling was capable of successfully accelerating recovery 
of strength following eccentric exercise and that this acute effect did not hinder the 
adaptive response to exercise when the exercise was repeated. Furthermore, the 
investigations demonstrated that prolonged PCM cooling was effective in accelerating 
recovery following eccentric exercise but not following marathon running. Although 
investigating the mechanism behind why prolonged PCM cooling accelerated 
recovery following mechanical stress but not metabolic stress were beyond the scope 
of this thesis, this finding led to some interesting speculations. Secondarily, the results 
of chapter 6 provided data to support the physiological cooling efficacy of the 
prolonged duration of PCM whilst contrasting these effects with a temperature 
matched CWI protocol. The results from chapter 6 additionally presented the novel 
effects from local prolonged PCM cooling vs systemic short duration CWI on the 
autonomic response in individuals at rest, and surprisingly concluded that local PCM 
cooling successfully affected the neural activity of the heart.  
Whilst this PhD has identified the ability for PCM cooling to accelerate recovery of 
strength loss and soreness following isolated eccentric exercise, the finding that 
prolonged PCM cooling was ineffective in accelerating recovery following marathon 
running was surprising. The finding that PCM cooling was unsuccessful in 
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accelerating recovery following exercise encompassing a large metabolic component 
but not following exercise encompassing a mechanical component, is contradictory 
to previous reviews. Previously, Ihsan et al. (2016) and Leeder et al. (2011) both 
concluded that CWI is more effective in alleviating symptoms of EIMD following 
exercise with a high metabolic cost, such as endurance, high intensity, or team sport 
exercise, but not following eccentric exercise. Collectively these reviews suggest that 
CWI is more effective for recovery from metabolically stressful exercise, as opposed 
to mechanically stressful exercise. Furthermore, in their review, White & Wells (2013) 
proposed that CWI may be especially beneficial for recovery from metabolically 
stressful exercise because of its ability to restore cardiovascular function. However, 
when utilising PCM as the cryotherapy modality, the results from the chapters 
encompassing this thesis oppose the aforementioned findings. 
Although exercise associated with either mechanical or metabolic stresses results in 
similar events including increased cytosolic Ca2+, sarcolemmal permeability, muscle 
fibre oedema, disruption to cell structures and resultant soreness and strength loss, 
there is a difference in the aetiology and extent of muscle fibre damage, temporal 
sequence of events and magnitude of the inflammatory response (White & Wells, 
2013; see section 2.1.1 for review). Mechanical stress imposed on the skeletal muscle 
during exercise results in direct physical disruption of the sarcolemma, sarcomeres, 
and the E-C coupling system within the muscle (Armstrong, Ogilvie, & Schwane, 
1983). Ultimately, muscle strength is proposed to be reduced due to disrupted 
sarcomeres within the myofibrils and damage to the E-C coupling system (Armstrong 
et al., 1991; Proske & Allen, 2005; Warren, Ingalls, Lowe, & Armstrong, 2001). On 
the other hand, physical disruption occurs indirectly as a result of metabolic 
deficiencies following exercise with a large metabolic component such as marathon 
running, and a significant central fatigue component contributes to the impairments 
in strength (Millet et al., 2003; Minett & Duffield, 2014). Indeed, Skurvydas et al. 
(2016) proposed different mechanisms that influence the recovery of strength 
following mechanical vs metabolic stress. Namely, that mechanically demanding 
contractions result in prolonged reductions in strength due to myofibrillar loss of 
integrity; while strength loss following metabolically demanding exercise is likely due 
to reduced Ca2+ release at the sarcoplasmic reticulum and/or myofibrillar Ca2+ 
sensitivity. Since PCM was effective for accelerating recovery from EIMD induced 
through mechanical stress throughout this thesis, but not metabolic stress, it is 
possible that PCM cooling ameliorated the magnitude of structural disruption 
associated with mechanical stress. It is further possible that a beneficial effect from 
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PCM cooling following metabolically stressful exercise, such as a marathon, might 
only become evident once metabolic activity within the muscle is sufficiently reduced. 
Therefore, understanding that there are different mechanisms involved in the 
processes associated with mechanically vs metabolically induced EIMD, and that 
there are likely several mechanisms involved in the cryotherapy mediated recovery 
from exercise, it is reasonable to believe that cryotherapy could facilitate recovery 
from metabolically stressful exercise differently than from mechanically stressful 
exercise. 
Although the findings of this thesis suggested that the exercise modality used to 
induce EIMD seems to influence the effectiveness of PCM in facilitating recovery, it 
was beyond the scope of research to determine the physiological mechanisms behind 
this effect. Following exercise, the inflammatory response involves the mobilisation of 
neutrophils and lymphocytes to the damaged muscle tissue via soluble intercellular 
adhesion molecule 1, and a production of pro-inflammatory cytokines in muscle 
(Clarkson & Hubal, 2002; Peake et al., 2005; Paulsen et al., 2012). Together, these 
substances cause intramuscular degradation, which amplifies the initial muscle 
damage (Clarkson & Hubal, 2002; Peake et al., 2005; Paulsen et al., 2012). In theory, 
following EIMD, the physiological responses to cold exposure whereby 
vasoconstriction reduces the permeability of blood vessels to immune cells and 
reduces the exposure of the peripheral tissues to inflammatory cells (Hausswirth et 
al., 2011; Lee et al., 2005; Pournot et al., 2011; Ferreira-Junior et al., 2014) should 
attenuate the acute inflammatory process and enhance recovery by protecting the 
muscle from secondary muscle damage. An attenuated secondary damage response 
was indirectly evident by the accelerated recovery of strength following the isolated 
eccentric exercise in chapters 4 and 7. However, chapter 7 indicated that the isolated 
eccentric exercise was insufficiently damaging to cause elevations in systemic 
inflammation as measured using hsCRP throughout this thesis. This finding is not 
surprising as humans can experience symptoms of EIMD without presenting signs of 
inflammation (i.e., leucocyte infiltration) in the muscle tissue (Malm et al., 2000; 
Paulsen et al., 2010, 2010, 2012; Raastad, Risoy, Benestad, Fjeld, & Hallen, 2003). 
Ultimately, since the exercise stimulus in chapters 4 and 7 was not stressful enough 
to increase inflammation, it is difficult to elucidate what effect, if any, PCM cooling has 
on the inflammatory response following eccentric exercise. On the contrary, the 
marathon in chapter 5 resulted in both strength loss and an elevated hsCRP 
response. It is commonly assumed that cryotherapy accelerates recovery from 
muscle damage by decreasing the inflammatory process. If cryotherapy were to 
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decrease the pro-inflammatory response, causing fewer neutrophils and lymphocytes 
to transmigrate into the damaged muscle tissue, this effect would be reflected by a 
decrease in hsCRP. However, the mechanisms behind this effect are largely 
unknown and the ability of cryotherapy to accelerate recovery may likely be attributed 
to mechanisms other than a reduction in inflammation, such as the magnitude of 
tissue cooling itself.  
The rate of post-exercise recovery is related to the extent of the load imposed on the 
various physiological and neuromuscular systems by the exercise bout (Nédélec et 
al., 2012). Since marathon running involves multiple muscle groups, is associated 
with systemic hyperthermia, and a large central fatigue component, the physiological 
demands of the marathon run in chapter 6 were likely far greater than the isolated 
eccentric exercise in chapters 4 and 7. It is then likely that the differing physiological 
demands of the two exercise types contributed to the disparity in the ability of 
prolonged local PCM cooling to accelerate recovery following eccentric exercise, but 
not following a marathon run. Therefore, the PCM mediated recovery was likely 
dependant on the cryotherapy dose being large enough to successfully mediate the 
magnitude of damage resulting from metabolic stress. Since the magnitude of 
damage was much greater following the marathon run compared to the eccentric 
exercise, as evident by the elevated inflammatory response in chapter 5 but not 
chapter 7, it is possible that the magnitude of local PCM cooling was insufficient 
following the marathon but sufficient following the eccentric exercise. As an example, 
previous studies that have successfully implemented CWI for the accelerated 
recovery of strength have all done so following exercise in the heat, which results in 
increased thermal strain and central fatigue (Ihsan et al. 2016; Minett et al., 2014; 
Pointon et al., 2011b). In the aforementioned studies, recovery of strength was 
concomitant with the amelioration of voluntary activation and core temperature. 
Therefore, under a large thermal load, CWI may alleviate some of the exercise-
induced cerebral perturbations either directly or via its effect on core temperature 
(Ihsan et al., 2016). Therefore, since the isolated eccentric exercise performed in 
chapters 4 and 7 likely did not induce substantial thermal strain or central fatigue, the 
magnitude of PCM cooling was sufficient to ameliorate the secondary effects 
associated with the EIMD processes. On the contrary, since PCM was only applied 
locally to the quadriceps following the marathon in chapter 5, it is possible that the 
degree of cooling might have been insufficient to ameliorate the damaging 
mechanisms occurring as a result of the substantial amount of metabolic stress. 
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PCM cooling differs from all other cryotherapy modalities in its ability to deliver cooling 
for a prolonged duration. Clearly the dose of PCM cooling within the chapters 
encompassing this thesis was sufficient to influence recovery following the isolated 
eccentric exercise but not following the marathon run. However, the total duration of 
PCM cooling was 6 hours following the eccentric exercise in chapters 4 and 7, but 
only 3 hours following the marathon run in chapter 5. Although core temperature was 
not measured during the exercises in the aforementioned chapters, endurance type 
protocols characteristically result in a greater level of systemic hyperthermia and an 
elevated thermal load compared with isolated exercise such as resistance exercise 
(Deschenes et al., 1998; Mortensen et al., 2008). Core temperature was however 
measured in chapter 6 of this thesis. Chapter 6 demonstrated that local PCM 
application was capable of reducing core temperature and restoring autonomic 
balance in individuals in a rested state. Although not directly investigated in this 
thesis, it is likely that a comparable response would not have been evident from the 
local PCM cooling, particularly not in the individuals having completed a marathon 
run. Although the local PCM cooling in chapter 6 provided enough of a thermal 
stimulus to influence convective cooling which decreased core temperature, it is likely 
that convective cooling from local PCM application would not occur in individuals 
under a significant thermal load. Specifically in the individuals who completed a 
marathon run it is likely that an insufficient surface area was exposed to the cold 
stimulus at the periphery, limiting the exposure of the blood to the cold tissues, and 
thus inhibiting a change in the core temperature. For this reason CWI, which exposes 
a larger surface area of the body to the cold stimulus resulting in greater temperature 
gradients for tissue cooling post-exercise, should overcome this issue. However, 
Wislon et al. (2018) have previously unsuccessfully administered CWI as a recovery 
strategy following a marathon run. The results of chapter 6 indicated that CWI can 
induce a rapid drop in muscle and core temperatures while PCM cooling provides a 
gradual prolonged decrease in temperatures. Therefore, if the goal is to maximise the 
tolerable decline in peripheral muscle temperature whilst simultaneously delivering a 
cooling stimulus capable of eliciting central effects on core temperature for a 
sustained duration, athletes and practitioners might opt to combine the two 
treatments. Particularly if the exercise stimulus was likely to have increased the 
individuals thermal load. In practice, once an athlete completed a CWI treatment, 
quickly decreasing their intramuscular and core temperature, they could apply PCM 
over muscle groups they wish to keep cool in order to maintain the reduction of both 
peripheral and central temperatures. This could allow the athlete to sustain the 
treatment effect from CWI for a longer duration in the immediate post-exercise period. 
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All the while allowing the athlete to return to normal post-exercise activities (e.g. meal, 
relaxation, recreational activities) while receiving a cryotherapy dose.  
Alternatively, animal models have previously shown that a window of opportunity for 
intervention with cryotherapy lies within the first 30 minutes after injury (Merrick & 
McBrier, 2010). Therefore, a decrease in the muscle temperature during this period 
can prevent the exacerbation of the secondary damage response (Merrick et al., 
1999). Reducing muscle temperature and creating a local hypothermic environment 
during the window of opportunity may decrease the metabolic activity within the 
muscle. Ultimately, reducing muscle metabolism would prevent excessive Ca2+ 
excretion into the cytosol, which would inhibit glycolysis and the degradation of ATP 
by myofibrillar adenosine triphosphatase. This effect would be particularly efficacious 
for recovery following endurance exercise because it would inhibit the disrupted Ca2+ 
homeostasis that results in strength loss following metabolically demanding exercise. 
Unfortunately reductions in muscle temperature to the degree suggested to reduce 
muscle metabolism in animals (Sapega et al., 1988) have not been demonstrated in 
humans in the literature or in chapter 6 of this thesis. This issue was further 
compounded by the fact that the participants did not apply the PCM cooling until on 
average 80 minutes after exercise cessation following the marathon in chapter 5. On 
the contrary, the participants in chapters 4 and 7 received the PCM within 10 minutes 
of exercise cessation. Similarly, the PCM in Clifford’s (2018) and Brownstein's (2019) 
investigations was administered within 45 and 30 minutes of cessation of exercise, 
respectively. The rapid deployment of PCM following the isolated eccentric exercise 
that took 40 minutes to complete in chapters 4 and 7 of this thesis and following the 
90 minute soccer games (Brownstein et al., 2019; Clifford et al., 2018) was a likely 
variable leading to the success of PCM in accelerating recovery. Conversely, since 
the rate of secondary injury is slowly developing and long-lasting (> 5-hour duration; 
Merrick & McBrier, 2010), the delay in the application of PCM following the marathon 
meant that the PCM were likely applied too late into this process. Muscle damage is 
likely induced before the marathon run is concluded; thus, some prolonged duration 
of overlap exists between the exercise being performed and the muscle damage 
occurring. This overlap was likely greater during the marathon run than in the studies 
showing a beneficial effect from PCM, where the exercise took between 40-90 
minutes to complete. Although not methodologically possible following the marathon 
in chapter 5 of this thesis, athletes, particularly those completing exercise of long 
durations, should make every effort to prioritise the application of cryotherapy as soon 
as possible upon cessation of exercise.  
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Perhaps most pertinent to athletic populations are the direct findings of chapter 7 of 
this thesis. Chapter 7 administered PCM cooling following isolated eccentric exercise 
and implemented a repeated bout of exercise in order to observe the effects of cooling 
induced accelerated recovery evident in chapter 4 on the RBE.  Since the magnitude 
of the protective effect of the RBE is a naturally occurring adaptive mechanism, if the 
recovery modality blunted the inflammatory response following the first bout of 
exercise, the RBE might have been attenuated following the second bout of exercise. 
Repressing acute inflammation may negatively affect the repair and regenerative 
processes of skeletal muscle (Woods, Lu, & Lowder, 2000) and may be detrimental 
to muscle (Barnett, 2006; Yamane et al., 2005), and functional performance (Costello 
& Donnelly, 2011). Thus athletes may be concerned that inhibiting this response 
would put them at a training and performance disadvantage. Especially because 
repetitive CWI exposures have previously been shown to effect long-term adaptation 
to training by blunting chronic adaptations (Higgins et al., 2011; Yamane et al., 2005); 
such as attenuating muscular and vascular adaptations (Yamane, Ohnishi, & 
Matsumoto, 2015; Motoi Yamane et al., 2005), suppressing the cellular signalling 
required for adaptation (Lindsay, Othman, Prebble, Davies, & Gieseg, 2016) and 
activation and deregulation of the inflammatory process (Lindsay et al., 2015). 
Furthermore, the literature suggests that chronic CWI exposure impedes 
hypertrophic/strength adaptations (Figueiredo et al., 2016; Fröhlich et al., 2014; 
Roberts, Raastad, et al., 2015; Yamane et al., 2015; Yamane et al., 2005). Although 
the PCM application in chapter 7 was not repeated following the second bout of 
exercise, this was done intentionally in order to clarify the effects of accelerated 
recovery on acute adaptation. Chapter 7 demonstrated that although PCM cooling 
attenuated the severity of strength loss and soreness following the first bout of 
exercise, the RBE was not inhibited in the PCM treatment group following bout 2. This 
finding indicated that PCM cooling does not inhibit the adaptive response to exercise. 
Therefore, athletes interested in implementing PCM cooling into part of their recovery 
practice may opt to forgo cryotherapy as a recovery modality during their pre-season, 
when building muscular strength is a priority. However, when maintaining 
performance is a priority over building muscle during the in-season, athletes should 
not be concerned about the acute effects of PCM cooling for accelerating recovery 
inhibiting the adaptive response between exercise sessions. Ultimately, the benefits 
of PCM for providing acute recovery could increase an athletes total time training or 
the overall training load in subsequent sessions during intense athlete schedules.  
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This thesis aimed to investigate the novel ability of PCM to prolong the cryotherapy 
dose on the efficacy of recovery from exercise. The results from this thesis could have 
a number of important practical implications and might indirectly inform the real-world 
utilisation of PCM for recovery by athletes during training and competition. 
Collectively the results presented throughout this thesis support previous findings 
successfully utilising CWI for reducing muscle soreness. Additionally, the results 
support for the first time the concept of prolonging the cooling period through the use 
of 15°C PCM to elicit beneficial effects on recovery of strength loss following eccentric 
exercise, and that a prolonged duration of cooling does not inhibit the RBE. 
Furthermore, the prolonged duration of cooling delivered by the PCM throughout the 
studies was well tolerated, and no adverse events were reported. For these reasons 
PCM might be a better cryotherapy alterative than CWI particularly in scenarios when 
interventions like CWI are logistically challenging to implement. Not only does PCM 
cooling allow for the dose of cooling to be prolonged, but PCM cooling provides 
athletes with the ability to continue with their activities of daily living while 
simultaneously receiving a cryotherapy dose. Ultimately PCM cooling at 15°C offers 
rapid and convenient deployment of a recovery strategy capable of accelerating the 
signs and symptoms associated with EIMD. 
The series of investigations encompassing this thesis have culminated into 5 main 
conclusive points (see Figure 25): 1) six hours of PCM cooling is an efficacious 
strategy for accelerating recovery of strength and soreness following isolated 
eccentric exercise and 2) this effect does not inhibit the RBE, but 3) three hours of 
PCM cooling was not effective at attenuating the deleterious effects of EIMD following 
a marathon run, which suggests that 4) either the mechanism with which prolonged 
PCM cooling accelerates recovery differ between mechanically and metabolically 
induced EIMD, or the magnitude of cooling was sufficient following the eccentric 
exercise but not following the marathon, and finally 5) the evidence from chapter 6 
suggests that in rested individuals the efficacy of 3 hours of PCM cooling on reducing 
intramuscular temperature, core temperature, and the cardiovascular response is 
comparable to that of CWI however these effects can not be directly translated to an 
exercise paradigm.  
8.3 Limitations and Future Research Directions 
While the series of investigations encompassing this thesis have produced a number 
of novel and interesting findings, they are not without limitations and have raised 
several questions for future research. Firstly the isolated eccentric exercise protocol 
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implemented in chapters 4 and 7 does not allow for the results to be directly translated 
to an athletes training or competition regimen. For example, although the PCM 
cooling was efficacious in accelerating recovery of strength and soreness in chapters 
4 and 7, the exercise stress was isolated to a single muscle group.  As was discussed 
in the previous section, full body exercise might elevate the thermal load to such a 
degree that the local cooling stimulus is no longer effective. On this note, in concurrent 
work related to this thesis (Brownstein et al., 2019; Clifford et al., 2018), PCM were 
applied following a soccer match which is an exercise encompassing both mechanical 
and metabolic stress components. In both cases recovery following the soccer match 
was accelerated in the groups receiving PCM treatment. This finding lends support 
towards the applicability of the positive results from chapters 4 and 7 of this thesis in 
all-encompassing athletic environments. However, when paired with the results of 
chapter 5 which showed no effect of PCM on accelerating recovery following a 
marathon, this finding also suggests that the dose or duration of PCM cooling should 
be tailored to the exercise type. Especially because exercise is heterogeneous and it 
would be erroneous to recommend a perennial PCM dose without accounting for the 
exercise type.  
The variable efficacy of PCM cooling in accelerating recovery throughout the chapters 
of this thesis indicates that the magnitude of cooling is important. Although chapter 6 
established the cooling efficacy of 3 hours of prolonged PCM cooling, and 
demonstrated that the magnitude of cooling was comparable to a temperature 
matched CWI protocol, the participants subjected to the cryotherapy treatments were 
in a rested state. It is highly likely that the magnitude of change in the muscle, and 
core temperature, and cardiovascular response evident in chapter 6 would be 
reduced in individuals having just completed exercise. Investigations examining the 
physiological response of PCM cooling following both mechanically and metabolically 
induced EIMD are necessary in order to elucidate whether the magnitude of the PCM 
cooling effect differs between these two conditions. Investigating these effects would 
also help answer what was the magnitude of cooling in the chapters implementing 
the eccentric exercises that allowed for the successful reduction in the damage 
response. Furthermore, investigating these effects whilst manipulating the amount of 
skin surface area exposed to PCM following a marathon would allow for conclusions 
to be made regarding the appropriate magnitude of cooling necessary in order to 
successfully influence recovery following metabolically stressful exercise.  
Although beyond the scope of this investigation, recent research suggests that 
implementing the chronic use of cold modalities such as CWI can be detrimental to 
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training adaptations in athletes. Concern exists as to whether repetitive CWI exposure 
affects long-term adaptation to training by blunting chronic adaptations (Higgins et al., 
2011; Yamane et al., 2005). Especially since some of the acute post-exercise effects 
purportedly blunted by CWI also stimulate exercise-induced adaptations (Broatch et 
al., 2018). Although the investigation in chapter 7 of this thesis only administered 
PCM cooling following the first bout of exercise, the results indicated that an acute 
dose of prolonged cooling was not detrimental to the adaptive response. Since the 
series of investigations encompassing this thesis administered a single session of 
PCM cooling, it would be of value to monitor the effects of chronic PCM treatment on 
recovery indices. Additionally, in the future, it would be worthwhile to determine 
whether chronic use of PCM has detrimental effects similar to those seen from CWI. 
However, since chronic CWI has demonstrated alterations in the response of tissue 
and core temperature, blood flow, inflammation and metabolism (Versey et al., 2013), 
it might be likely that the hypothetically smaller overall magnitude of cooling from local 
PCM application would prevent these alterations from occurring. 
As with all cryotherapy modalities, when subsequent exercise is performed shortly 
after cooling, muscle temperatures may be unfavourably cold inhibiting subsequent 
performance (García-Manso et al., 2011; Halson et al., 2008; Versey et al., 2013; 
Wilcock, Cronin, & Hing, 2006b). A reduction in skin temperature by 10-13°C can 
promote a reduction of 10-33 % in nerve conduction velocity (Algafly, George, & 
Herrington, 2007). Further, for every 1°C reduction in muscle temperature, a 3-6% 
reduction in contractile force has been demonstrated (Costello et al., 2012a; 
Sargeant, 1987). Muscle temperature reduced to suboptimal physiological levels 
(Algafly & George, 2007; Costello et al., 2012a) are associated with decreased 
muscular contractile speed (Abramson, 1966; Bergh & Ekblom, 1979; Howard, 
Kraemer, Stanley, Armstrong, & Maresh, 1994; Rutkove, 2001), strength (Herrera, 
Sandoval, Camargo, & Salvini, 2010; Johnson & Leider, 1977; Rutkove, 2001; Yona, 
1997), and altered neuromuscular properties (Dewhurst et al., 2009; Vieira, Oliveira, 
Costa, Herrera, & Salvini, 2013). Thus, local PCM cooling is not recommended in 
athletes performing high-intensity, explosive exercise unless an adequate warm-up 
is completed to increase internal body temperatures. On the contrary, when exercise 
is performed in warm environments, and/or when core temperature is elevated 
resulting in performance decrements, PCM between exercise bouts can be utilised to 
pre-cool prior to the subsequent exercise. In this scenario it would be most beneficial 
for PCM to be applied to the torso in the form of a cooling vest. Alternatively, PCM 
may have an application during the training component of exercise encompassing 
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primarily metabolic stress such as a marathon run. As was evident in chapter 5, the 
marathon run significantly increased systemic inflammation. If runners reach similar 
levels of inflammation during their training, PCM in between exercise bouts might be 
applicable as more of a recovery strategy in the lead up to the actual marathon itself. 
Prolonging the dose of cooling in between exercise sessions in these athletes might 
also restore vagal tone and normalise parasympathetic modulation of HR in between 
intense training sessions. On this note, more work is required to elucidate the 
mechanisms through which cryotherapy influences the inflammatory response 
following exercise.  
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9.1 Appendix 1 Northumbria Informed Consent 
Informed Consent Form 
 
 
 
 
Project Title:  
Principal Investigator: Susan Kwiecien  
Investigator Contact Details:  
Participant Number:  
               please tick  
  where applicable 
I have read and understood the Participant Information Sheet.  
 
I have had an opportunity to ask questions and discuss this study and I have received 
satisfactory answers. 
 
 
I understand I am free to withdraw from the study at any time, without having to give 
a reason for withdrawing, and without prejudice. 
 
 
I agree to take part in this study.  
 
I would like to receive feedback on the overall results of the study at the email 
address given below.  I understand that I will not receive individual feedback on my 
own performance. 
Email address…………………………………………………………………… 
 
 
 
 
 
Signature of participant.......................................................    Date.....……………….. 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
 Signature of Parent / Guardian in the case of a minor  
......................................................................................... 
 
 
Signature of researcher.......................................................    Date.....………………. 
(NAME IN BLOCK LETTERS)....................................................………………………. 
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9.2 Appendix 2 Northwell Health Informed Consent 
Informed Consent Summation/Participant Signature 
You have read the above description of the research study. You have been told of 
the risks and benefits involved and all your questions have been answered to your 
satisfaction. A member of the research team will answer any future questions you 
may have. You voluntarily agree to join this study and know that you can withdraw 
from the study at any time without penalty. By signing this form, you have not given 
up any of your legal rights. 
 
____________________________ _______________________ _____________ 
Printed Name of Participant  Participants Signature                 Date 
 
____________________________ _______________________ ______________ 
Witness’s Printed Name  Witness’s Signature                  Date 
(Note: A witness can be a member of the research team, but cannot be the same 
person signing consent as the investigator) 
 
Investigator’s Statement  
In addition to advising the above participant of other forms of treatment and therapy 
which are appropriate, I have offered an opportunity for further explanation of the 
risks and discomforts which are, or may be associated with this study and to answer 
any further questions relating to it. 
 
_________________________________ ____________ 
Investigator’s signature                                      Date  
  
_____________________________________________ 
Investigator’s printed name                                              
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